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GENERAL INTRODUCTION  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Part of this chapter has been published as a tutorial review: Verkade, J. M. M.; van Hemert, L. J. C.; 
Quaedflieg, P. J. L. M.; Rutjes, F. P. J. T. Chem. Soc. Rev. 2008, 37, 29–41. An updated review has 
been published in Hoekman, S.; Verkade, J. M. M.; Rutjes, F. P. J. T. Enantioselective 
organocatalyzed reactions II, Mahrwald, R.; Ed., Springer, New York, 2011, pp. 343–378. 
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1.1 Introduction 
The concept of organocatalysis was recognised as early as in 1928 by Wolfgang Langenbeck1 
(Fig. 1). Its synthetic potential, however, was for a long time not recognised until approximately 
one decade ago, when it was reinvented as a viable approach for producing enantiomerically 
pure compounds. 
 
Figure 1 Early recognition of organocatalysis.1 
 
Dalko and Moisan2 defined organocatalysis as “the acceleration of chemical reactions with a 
substoichiometric amount of an organic compound which does not contain a metal ion.” 
While for a long time only isolated cases existed, around the year 2000 numerous successful 
examples of asymmetric organocatalytic reactions had been developed.3 In this Chapter we 
aim to address organocatalytic versions of the well-known Mannich reaction in particular.4 
Key element in Mannich reactions is an iminium intermediate 2, which is susceptible to 
nucleophilic attack by a variety of nucleophiles such as enolised ketones (1) or equivalents 
thereof, resulting in carbon-carbon bond formation adjacent to the nitrogen atom (Scheme 
1). 
 
Scheme 1 Essentials of the Mannich reaction. 
 
The products, so-called Mannich bases (3), are β-amino ketones, which are versatile 
intermediates in organic synthesis and have especially proven their value in the synthesis of 
alkaloids. The Mannich reaction by now has also been firmly established as a viable 
approach to prepare the Mannich bases in enantio- and diastereomerically pure form via 
organocatalysis.5,6 In the following overview, several organocatalytic approaches will be 
highlighted, which can be divided in catalysis by chiral amines (via enamine formation) 
(Section 1.2), chiral Brønsted bases (Section 1.3), chiral Brønsted acids (Section 1.4) and 
phase transfer catalysts and other quaternary (internal) salts (Section 1.5).  
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1.2 Catalysis by enamine forming chiral amines 
Chiral amines have the potential to react with so-called Mannich donors such as ketones or 
aldehydes. The resulting chiral enamines can react with a Mannich acceptor, usually a 
prochiral aldimine, thereby introducing one or two chiral centres in the Mannich product. 
The catalytic cycle is completed by regeneration of the amine catalyst through hydrolysis. 
The products are β-amino aldehydes or β-amino ketones, which are optionally substituted at 
the α-position. 
 
1.2.1 Syn-selective approaches 
1.2.1.1 N-PMP-substituted Mannich acceptors 
In the 1970s, the research groups of Hajos–Parrish and Eder–Sauer–Wiechert independently 
found that proline could enantioselectively catalyse an intramolecular aldol reaction.7 Not 
until 2000, List et al. hypothesised that proline might catalyse, besides the aldol reaction, 
analogous Mannich reactions in an asymmetric fashion.8 They reported that a one-pot three-
component reaction involving a ketone, an aldehyde and a primary amine provided the 
desired Mannich product in enantiopure form. As an example, reaction of L-proline, p-
nitrobenzaldehyde (4), acetone (5) and p-anisidine (6) in DMF led to the desired Mannich 
adduct 10 in 50% yield with an ee of 94% (Scheme 2). This proceeds via the chiral proline -
derived enamine 8, which reacts with the in situ formed prochiral iminium intermediate 7 in 
a stereoselective manner. The initially formed iminium adduct 9 hydrolyses in the process 
and the released proline can enter the next catalytic cycle. The corresponding aldol product 
(reaction of acetone with the aldehyde 4) is formed as a side-product. 
 
Scheme 2 The first proline-catalysed asymmetric Mannich reaction.  
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After this discovery, an evaluation of the scope and optimal reaction conditions was 
initiated. Various proline-resembling compounds were examined as potential catalysts.9 
Several ketones such as butanone, methoxyacetone and hydroxyacetone also furnished the 
desired products 11 in high yields (92–96%) and with excellent ee (>99%) (Scheme 3). 
Importantly, in all instances a high syn-selectivity (95% de) was observed. While in case of 
methoxy and hydroxy substituents single regioisomers were formed, a methyl substituent 
(butanone) provided a 2.5:1 regioisomeric mixture of products.  
 
Scheme 3 Variation of the ketone component. 
 
Structurally diverse aldehydes were also tested in the asymmetric Mannich reaction. α-
Unbranched aldehydes appeared efficient substrates providing yields up to 90% combined 
with good to excellent ee values. Evaluation of the scope of the primary amine show ed the 
necessity of a p-methoxy substituent on the aromatic ring. Remarkably, replacement of p-
anisidine with p-chloroaniline caused a marked decrease in enantioselectivity (84% ee), and 
introduction of o-hydroxy- or o-methoxyaniline led to almost complete disappearance of 
enantioselectivity (<10% ee). A distinct advantage of the use of p-anisidine is that the 
Mannich reaction leads to p-methoxyphenyl (PMP)-protected amines, which can be 
oxidatively converted into the corresponding free amines (vide infra). While optimising the 
reaction conditions, it also appeared that the proline loading could be reduced to 10 mol% 
and the product could still be obtained in good yield (>90%) in a reasonable reaction time 
(~5 h).  
Shortly after List, the Barbas group published similar results on proline-catalysed 
asymmetric Mannich reactions.10,11 They independently discovered the previously 
mentioned one-pot three-component proline-catalysed asymmetric Mannich reaction. 
However, their focus quickly turned to conditions involving preformed imines. For example, 
in 2002 a highly enantioselective proline-catalysed reaction of ketones 13 with N-PMP ethyl 
iminoglyoxylate (14) was reported, which gave the corresponding β-keto-α-amino acid 
derivatives 15 in high yields. Exploration of the scope involving several ketones showed that 
all reactions proceeded smoothly, typically affording the desired products in good yields 
(70–80%) and high stereoselectivity (d.r. >95:5 (syn/anti), ee up to >99%). When 
unsymmetric methyl ketones were used, reaction with the imine mostly occurred with the 
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most substituted enamine intermediate. Mannich reactions of ketones with PMP-protected 
iminoglyoxylate 14 proceeded well in a wide variety of organic solvents including dimethyl 
sulfoxide (DMSO). 
 
Scheme 4 Mannich reactions with iminoglyoxylates. 
 
Mechanistically, the stereochemical outcome of all of these reactions can be explained by 
invoking a transition state as depicted in Fig. 2. The stereochemical repulsion between the 
PMP-group and the proline moiety, in combination with protonation of the imine by the acid 
functionality of proline, accounts for a si-face attack of the (E)-aldimine (from p-anisidine 
and acceptor aldehyde) by the si-face of the (E)-enamine formed by the ketone and proline.9 
This model explains the stereochemical outcome of many similar reactions that have 
appeared in literature. 
 
Figure 2 Mechanistic rationale for the stereoselectivity. 
 
In order to extend the scope of the proline-catalysed asymmetric Mannich reaction, Barbas 
and co-workers investigated the application of unmodified aldehydes (rather than ketones) 
as the donor.12 In 2002, they discovered that the reaction of isovaleraldehyde (16, R1 = iPr) 
with ethyl iminoglyoxylate 14 in DMSO afforded the Mannich adducts 17 (R1 = iPr) in high 
yield (80%) with good stereoselectivity (d.r. > 10:1 (syn/anti), 87% ee). To broaden the 
scope of this transformation, a number of aliphatic aldehydes 16 were reacted with 14 
under the same conditions (Scheme 5). 
 
Scheme 5 Unmodified aldehydes as Mannich donors. 
 
While the obtained ee was always higher than 90%, it was shown that better 
diastereoselectivities were obtained with larger substituents on the aldehyde donor (R 1 = 
Me < Et < iPr < n-pentyl). It was also observed that the obtained diastereomeric ratios 
resulting from aldehydes with smaller α-substituents (e.g. R1 = Et, iPr) were significantly 
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higher if determined immediately after aqueous work-up than after additional column 
chromatography. This indicates that epimerisation takes place during the purification on 
silica gel. The undesired epimerisation could be successfully suppressed by slow addition of 
propionaldehyde (18) to a solution of aromatic N-PMP-protected aldimines 19 in DMF in the 
presence of L-proline, followed by in situ reduction of the aldehyde function. This yielded the 
intended 1,3-amino alcohols 20 in reasonable yields, excellent enantioselectivities (90–99% 
ee) and modest to good diastereoselectivities (d.r. up to > 10:1 (syn/anti)) (Scheme 6). The 
diastereoselectivity was virtually complete (>19:1 (syn/anti)) when heptanal was used as 
the donor (not shown).  
 
Scheme 6 Synthesis of 1,3-amino alcohols. 
 
As a next step, Barbas, Córdova and Hayashi simultaneously reported the viability of a one-
pot three-component asymmetric Mannich reaction between two different aldehydes (cross-
Mannich reaction).12,13,14 The temperature appeared to be a crucial factor for a successful 
outcome. Typical reaction temperatures of –20 to –10 °C were necessary in order to 
suppress side reactions such as the cross- and homo-aldol reaction.12,14 The reaction was 
also highly solvent dependent, proceeding poorly in acetonitrile, dichloromethane, THF and 
toluene, but giving high yields and selectivities in DMF and NMP instead. 14 
Under optimised conditions, addition of an aliphatic donor aldehyde 16 to a mixture of p-
anisidine, an acceptor aldehyde 21 and L-proline, followed by subsequent in situ reduction, 
afforded 1,3-amino alcohols 22 in good yields with excellent enantioselectivities (up to 
>99% ee) and good diastereoselectivities (d.r. up to >19:1  (syn/anti)) (Scheme 7). The 
immediate reduction step suppresses decomposition or epimerisation of the β-amino 
aldehydes during work-up. 
The scope of this reaction was extensively investigated by the aforementioned groups. 
Various aliphatic aldehydes were used as Mannich donors 16 and generally good results 
were obtained. However, it was observed that use of acetaldehyde and 2-substituted 
acetaldehydes did not result in the expected products. 
The scope of the acceptor aldehyde 21 was also explored. Benzaldehyde, substituted 
benzaldehydes and heteroaromatic aldehydes appeared suitable Mannich acceptors, 
whereas the use of aliphatic aldehydes not in all cases led to high selectivities and yields. In 
the absence of a second aldehyde, proline catalysed the direct asymmetric Mannich reaction 
of one aliphatic aldehyde being both the donor and acceptor component. 12,14 
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Ethyl glyoxylate was also successfully employed as acceptor aldehyde in the proline-
catalysed one-pot three-component reaction with aliphatic donor aldehydes and p-anisidine. 
The resulting β-formyl-α-amino acid derivatives were isolated as such (without reduction) 
in good yields and excellent diastereo- and enantioselectivities.13 
 
Scheme 7 Cross-Mannich reactions. 
 
Córdova also reported that the reaction of ketones 13 with aqueous formaldehyde (23) and an 
aromatic amine 24 furnished α-aminomethylated ketones 25a and 25b in very good yields and 
selectivities (Scheme 8).15 When acyclic ketones with R1 = H were employed, product 25a was 
predominantly formed. Bolm and co-worker showed that this proline-catalysed α-
aminomethylation was accelerated, e.g. with the use of a microwave.16 They also demonstrated 
that the catalyst loading could be lowered to 0.5% while still obtaining the desired product in 
acceptable yields and selectivities.  
 
Scheme 8 Proline-catalysed α-aminomethylation. 
 
Hayashi et al. then developed a new strategy to stereoselectively synthesise syn- or anti-γ-amino 
secondary alcohols (Scheme 9).17 Instead of reducing the Mannich product 26 with NaBH4, it was 
directly reacted with a Ph-nucleophile (Ph2CuLi or Ph3ZnLi) to generate a secondary alcohol. 
Because this step proceeded only with poor diastereoselectivity, the resulting alcohol was 
oxidised to the ketone and by adding LiAlH(OtBu)3 or catecholborane, the latter was 
subsequently reduced to syn- or anti-27, respectively.  
 
Scheme 9 Synthesis of syn- or anti-1,3-amino secondary alcohols. 
 
In 2005, the first direct catalytic enantioselective Mannich reaction that provides β -amino-α-
oxyaldehydes 28 and 3-amino tetroses 29 was reported by Córdova et al. 3-Amino tetroses 
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29 were obtained through a proline-catalysed homo-Mannich reaction of protected 
glycolaldehydes 31 (Scheme 10).18 The enantioselectivity of this reaction was high (up to 
>99% ee), but the diastereoselectivity was disappointing with a d.r. ranging from 1:1 to 4:1 
(syn/anti). 
 
Scheme 10 Formation of 3-amino tetroses. 
 
The analogous proline-catalysed addition of protected glycolaldehydes 32 to aromatic 
imines 33 afforded β-amino-α-oxyaldehydes 28 in good yields (up to 96%) and high 
enantioselectivity (up to 99% ee). The diastereoselectivity was generally moderate (Scheme 
11).  
 
Scheme 11 Formation of β-amino-α-oxyaldehydes. 
 
Córdova et al. also investigated the influence of water on the proline-catalysed Mannich 
reaction. As an example, a one-step synthesis of carbohydrate derivatives 34 via amino acid-
mediated Mannich reactions with protected dihydroxyacetone derivative 35 as the 
nucleophile was successfully developed (Scheme 12). It was shown that the reaction 
proceeded more successfully than under water-free conditions. Still, the stereochemical 
outcome of this one-pot reaction was in accordance with that of previously reported proline-
catalysed Mannich reactions. Hence, this methodology provides a direct enantioselective 
entry for the catalytic synthesis of amino sugars. A small excess  of water potentially 
facilitates proton transfer in the transition state, which both lowers the LUMO of the 
incoming electrophile and directs the enantioselectivity of the newly formed stereocentres. 
The higher Brønsted acidity of the amino acid in the presence of water and polar aprotic 
organic solvents plausibly accounts for the observed higher stereoselectivity.  
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Scheme 12 One-step synthesis of carbohydrate fragments. 
 
Fustero et al. developed a direct and convenient strategy for the synthesis of acyclic 
fluorinated α-alkyl-β-amino acid derivatives 38 involving a Mannich condensation of 
fluorinated aldimines 37 with aliphatic aldehydes 16 in the presence of L- or D-proline, 
followed by reduction of the resulting aldehyde with NaBH4 (Scheme 13).19 Although the 
yields were moderate (31–50%), the selectivity was outstanding in all cases (d.r. >19:1  
(syn/anti), ee 99%; Rf = CF3, C2F5, CF2Cl and CF2Ph). This strategy can be used for the 
selective synthesis of syn-γ-fluorinated, α-alkyl-β-amino esters and allows the introduction 
of diversity into both the β-fluoroalkyl and α-alkyl groups of these compounds. 
 
 
Scheme 13 Synthesis of fluorinated α-alkyl-β-amino acid derivatives. 
 
Westermann et al. reported the employment of protected dihydroxyacetone 35 and imine 14 
in Mannich reactions (Scheme 14).20 In polar solvents (formamide or 2,2,2-trifluoroethanol 
(TFE)) and in the presence of L-proline as the catalyst, the desired product 39 was obtained 
(yields up to 76%, d.r. up to 97:3 (syn/anti), ee up to 99%).  
The reaction was accelerated by the use of microwaves. After 10 min irradiation at 300 W, 
product 39 was obtained in 72% yield with high diastereo- and enantioselectivities (d.r. 
90:10 (syn/anti), ee 94%). A decrease in irradiating power led to a lower yield, although the 
selectivities remained the same.  
 
Scheme 14 Protected dihydroxyacetone as Mannich donor. 
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The group of Enders also reported a direct organocatalytic synthesis of carbohydrate 
fragments starting from the acetonide of dihydroxyacetone (35). Various protected 
carbohydrates and amino sugars could be assembled in one step by an almost completely 
diastereo- and enantioselective proline-catalysed reaction with the in situ formed imine of p-
anisidine (6) and an acceptor aldehyde 36 (Scheme 15).21 Suitable reaction temperatures 
ranged from 2 °C to ambient temperature. At lower temperatures a decrease in diastereo- 
and enantioselectivity was observed. The use of catalyst 37 generally led to an enhancement 
of the reaction rate, due to its superior solubility properties.  
 
Scheme 15 Protected dihydroxyacetone as Mannich donor. 
 
So far, only proline or derivatives thereof were used in the asymmetric three-component 
Mannich reaction. Córdova et al. reported the use of alternative linear chiral amines and 
amino acids to catalyse the direct Mannich reaction with high enantioselectivities (Scheme 
16).22 By stirring cyclohexanone (41), p-anisidine (6), p-nitrobenzaldehyde (4), L-Serine 
(43a) and DMSO for 48 h, the corresponding Mannich product 42 was formed in 60% yield, 
6:1 d.r. (syn/anti) and 94% ee (Scheme 15). In comparison, the same reaction using proline 
as catalyst gave 42 in a 50% yield with a d.r. of 2:1 and 84% ee. 
Several acyclic chiral amines and amino acids were screened for the direct one-pot three-
component Mannich reaction. A large number of amino acids catalysed the reaction with 
high enantioselectivities. After a reaction time of 14 h in the presence of L-alanine (43b) as 
the catalyst, 42 was isolated in 42% yield and 98% ee. Increasing the reaction time to 48 h 
with the addition of 5 equiv of water increased the yield to 68%, however, the ee decreased 
to 86%. Loss of enantioselectivity occurred at prolonged reaction times. In order to increase 
the nucleophilicity of the amine and the yield of the Mannich product, one equivalent of 
dicyclohexyl amine was added to the reaction mixture, which also reduced the ee decrease of 
42. The aliphatic amino acids 43a, 43c, 43h and 43i catalysed the asymmetric formation of 
42 with 2:1–6:1 d.r. and 91–94% ee. The addition of a small amount of water slightly 
improved the yield of 39. The use of amino derivatives such as 43j improved the solubility 
as well as the catalytic efficiency of the organocatalysts in the asymmetric formation of 42 
(yield 89%, d.r. 3:1, ee 94%, 12 h). 
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Hence, Córdova demonstrated that there are a large number of novel, simple organocatalysts 
that can be derived from acyclic natural and nonproteogenic amino acids, which could 
potentially be used as catalysts for the direct Mannich reaction. 
 
Scheme 16 Screening of various catalysts. 
 
Despite the fact that proline has often been shown to catalyse reactions in high enantio- and 
diastereoselectivity, a few drawbacks to the use of proline exist. Firstly, the proline -
catalysed reaction is generally conducted in solvents such as DMF, dioxane, DMSO and NMP, 
due to the relatively low solubility of proline in apolar solvents. Secondly, high levels of 
catalyst loading (10–30 mol%) are usually required. Ley et al. identified three relatively 
small organocatalysts 44, 45 and 46, which proved to work as efficiently in apolar solvents 
such as DCM23 at significantly lower catalyst loadings (Scheme 17).  
 
Scheme 17 Non-amino acid organocatalysts. 
 
A representative example is the reaction of cyclohexanone with N-PMP-protected glyoxylate 
ester 14 giving the corresponding product by using only 1–5 mol% of catalyst 44 in various 
organic solvents (e.g. DCM, MeCN, THF) without affecting the yield and enantioselectivity of 
the reaction. More generally, the reaction of ketone 47 with 14 proceeded with at least the 
same efficiency as the corresponding proline-catalysed reaction (Scheme 18). The 
applicability of these new catalysts in apolar solvents looks promising in case of ketone 
donors, but whether they are also useful with aldehyde donors was not disclosed. Extension 
to one-pot three-component reactions has also not been reported to the best of our 
knowledge. 
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Scheme 18 Application of catalyst 44. 
 
Recently, a new application of catalyst 44 was developed by Barbas et al. It appeared 
effective in catalysing the reaction between masked 2-amino ketones and N-PMP-protected 
imines.24 The use of masked 2-amino ketones was considered of interest due to the 
instability of the free amines. After optimising the conditions, a series of azido ketones  49 
was reacted with p-anisidine (6) and an aldehyde 21 in the presence of catalyst 44 (Scheme 
19). The azido ketones reacted regioselectively affording the α-azido-β-amino ketones 50 in 
high yields (80–96%), enantio- and diastereoselectivities (ee 82–99%, d.r. up to 91:9 
(syn/anti)). 
 
Scheme 19 Synthesis of α-azido-β-amino ketones. 
 
Remarkably, when phthalimidoacetone (N-phthaloyl-protected amino acetone) 51 was 
employed, reversed regioselectivity was observed. Reaction with N-PMP-protected imines 
provided Mannich products 52 in good yields and reasonable selectivities (Scheme 20). 
 
Scheme 20 Reactions of phthalimidoacetone. 
 
In 2004, Wang et al. disclosed another alternative for proline catalysis.25 They discovered 
that pyrrolidine-sulfonamide catalyst 53 was able to induce stereoselectivity in the reaction 
of cyclohexanone 41 and N-PMP-protected ethyl glyoxylate (14). The Mannich adduct 54 
was obtained in very high syn-selectivity and excellent enantioselectivity (Scheme 21). 
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Scheme 21 Pyrrolidine-sulfonamide-catalysed Mannich reaction. 
 
A solvent screening revealed high activities in both protic and aprotic solvents. Yields 
varying from 76% in MeNO2 up to 90% in DMSO were observed whereas the solvent did not 
significantly influence the stereochemical outcome of the reaction. Compound  54 was in all 
cases obtained with >95% ee and a d.r. of >95:5 (syn/anti). This catalyst has a broad scope, 
affords products with excellent selectivity and is applicable in various solvents, thus it might 
in selected cases be an attractive alternative to proline. However, from an economic point of 
view proline is favoured, since both enantiomers are commercially available at low cost.  
The solubility problem in proline catalysis also prompted Hayashi and co-workers to 
develop a more soluble catalyst. They identified trans-4-tert-butyldimethylsiloxy-L-proline 
40 as a more active variant of proline (Scheme 15).26 For instance, the one-pot three-
component reactions of ketones, p-anisidine and aldehydes which was extremely slow in 
DMF with proline as the catalyst, proceeded within 20–24 h in moderate yields (48–63%) 
and excellent enantioselectivity (90–98% ee) with catalyst 40. 
In 2012, Kumar et al. elegantly exploited proline-catalysis in a formal (3+2) cycloaddition of 
succinaldehyde and N-PMP-aldehydes. The Mannich reaction was followed by an acid-
promoted in situ reductive amination, leading to highly functionalised trans-substituted 
pyrrolidines (Scheme 22).27 
 
Scheme 22 Two-step synthesis of N-PMP-protected pyrrolidines. 
 
In the preceding reactions, the p-methoxyphenyl (PMP) group was used as the imino 
protecting group. For quite some time, ceric ammonium nitrate (CAN) has been advocated as 
the method of choice for the oxidative removal of the PMP group.28 This proceeds via 
oxidation of the anisidine moiety into the corresponding iminoquinone 58, followed by 
aqueous hydrolysis of the imine to liberate the amine (Scheme 23). Mainly due to the 
moderate reproducibility and laborious nature of the CAN-mediated deprotection, more 
efficient, alternative methods have been developed in recent years for PMP removal. These 
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methods will be discussed in Chapters 2 and 3. 
 
Scheme 23 PMP deprotection. 
 
1.2.1.2 N-oxycarbonyl- and N-acyl substituted Mannich acceptors  
Enders and co-workers reported the first example of tert-butoxycarbonyl (Boc) as the imine 
protecting group in proline-catalysed Mannich reactions (Scheme 24).29 The resulting 
products were formed in good yields and selectivities (e.g. R1 = Ph, 85%, de > 99%, ee = 
96%). 
 
Scheme 24 Boc-protected Mannich acceptors. 
 
Soon thereafter, Córdova and List almost simultaneously reported extensive studies on the 
use of N-Boc imines as Mannich acceptors (Scheme 25). The Córdova group reported that 
proline, but also (R,S)-4-hydroxyproline was able to stereoselectively catalyse the Mannich 
reaction between aryl-substituted N-Boc imines and aliphatic aldehydes in high yields (62–
85%) and selectivities (d.r. >19:1, ee up to >99%).30 The rather moisture-sensitive N-Boc 
protected imines 60 can be prepared via a two-step protocol, involving reaction of tert-butyl 
carbamate (62), p-toluenesulfinic acid (63) (or alike) and an aldehyde (36), followed by 
basic elimination (Scheme 25). 
 
Scheme 25 Synthesis of N-Boc imines. 
 
Córdova later realised that the second step could be conducted in situ and found that the 
proline-catalysed reaction of 64 with aldehydes 65 in the presence of KF as the base 
smoothly produced the desired β-amino aldehydes 66 with high selectivities (Scheme 26).31  
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Scheme 26 Mannich reaction with in situ formed N-Boc imines. 
 
Virtually simultaneously, Melchiorre and co-workers disclosed the same concept, but instead 
of proline they employed pyrrolidine-substituted tetrazole 44 as the catalyst for syn-
selective reactions. They added Cbz to the list of applicable imine protecting  groups.32 
As mentioned above, List also reported the synthesis of N-Boc-protected amino aldehydes 
71 employing proline as the catalyst (Scheme 27), but additionally found that acetone could 
be used as Mannich donor (73% yield, ee >98%).33 It was recognised that this method is 
limited by the requirement of preformation of the imines and the incompatibility with 
aliphatic imines. Both limitations do not apply to N-PMP-protected imines. The group of List 
later discovered that also acetaldehyde could be employed as the Mannich donor.34 
 
Scheme 27 Use of Boc-protected Mannich acceptors. 
 
The aforementioned solubility issues were also dealt with by Carter and co-worker.35 They 
developed a cheap and soluble proline derivative 70 which effectively catalyses the reaction of a 
variety of ketones and aldehydes 67 with N-Boc- and N-PMP-protected imines 71 in apolar 
solvents such as DCE, DCM and the industrially more attractive 2-Me-THF. 
 
Scheme 28 Use of a an apolar proline-derived catalyst. 
 
A protected taxol side chain (76), obviously an interesting target structure (see: Chapter 6), was 
elegantly constructed by Córdova et al. via a D-proline-catalysed reaction of Bn-protected 
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hydroxyacetaldehyde 73 with N-phenacyl-protected imine 74, followed by NaClO2 oxidation 
(Scheme 29).36 
 
Scheme 29 Synthesis of protected taxol side chain via proline catalysis. 
 
Tan et al. developed an interesting route for the synthesis of α-fluorinated Mannich products.37 
They discovered that the bicyclic guanidine catalyst 77 smoothly catalysed the reaction of β-keto 
acetyloxazolidinone 79 with N-protected imines 78. Subsequent ethanolysis, deacetylation and 
protonation led to the syn-fluorinated product 81 (Scheme 30), albeit without full retention of 
diastereoselectivity (decrease from 99:1 to 4:1) . 
 
Scheme 30 Synthesis of α-fluorinated β-amino esters. 
 
The same bicyclic guanidine catalyst was also capable of catalysing the reaction between 
malonic acid half thioesters 82 and N-tosylimines 83. Unfortunately, only low 
diastereoselectivities were observed, but enantioselectivities were reasonable.38 
 
Scheme 31 Mannich reaction of malonic acid half thioesters. 
 
The organocatalysed Mannich reaction of acetaldehyde (85) and N-benzoyl imine 87 using 
pyrrolidine derived 89 as the catalyst was elegantly linked up to an electrophilic amination with 
di-tert-butylazodicarboxylate (86) by the group of Greck.39 A one-pot procedure including 
NaBH4 reduction led to the formation of product 88 in moderate yields but excellent 
selectivities.  
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Scheme 32 Mannich reaction followed by electrophilic amination. 
 
As reported by Maruoka et al., vicinal diamines 91 were also accessible when N-Cbz-
protected amino acetaldehydes 90 were employed as Mannich donors in the presence of L-
proline as the catalyst.40 
 
 
Scheme 33 Synthesis of vicinal diamines with L-proline as the catalyst. 
 
1.2.2 Anti-selective approaches 
Section 1.2.1 focused on the preparation of syn-Mannich adduct. In 2002, Barbas et al. 
reported an (S)-2-methoxymethylpyrrolidine (SMP) (92)-catalysed asymmetric Mannich-
type reaction of unmodified aldehydes 16 with PMP-protected iminoethyl glyoxylate 14, 
which proceeded in a highly anti-selective manner (Scheme 34).41 They screened various 
catalysts in the reaction of isovaleraldehyde (16, R1 = iPr) and found that commercially 
available SMP gave optimal results affording the desired β-formyl-functionalised leucine 
derivative 93 (R1 = iPr) in 48% yield, reasonable ee (69%) and with high diastereoselectivity 
(d.r. >1:10 (syn/anti)). The ee could be improved to 82% by switching the solvent from 
dioxane to DMSO. Reaction of other aldehydes (e.g. R1 = Et, nBu, iPr, n-pentyl) also afforded 
products 93 in modest to good ee (74–92%) and with a diastereomeric ratio that increased 
with the bulkiness of the aldehyde donor. Similar to proline-catalysis, reactions of aldehydes 
with smaller α-substituents (e.g. R1 = Et, iPr) resulted in significantly higher diastereomeric 
ratios if determined immediately after aqueous work-up than after additional column 
chromatography, indicating that epimerisation readily takes place.  
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Scheme 34 anti-Selective Mannich reactions using SMP as the organocatalyst 
 
The stereochemical outcome of the SMP-catalysed reaction was explained through assuming the 
transition state, depicted in Fig. 3. The si-face of the N-PMP imine is attacked by re-face of the 
SMP-enamine. In proline-catalysed reactions, the si-face of N-PMP-imines is attacked by the si-
face of the proline-enamine (Fig. 2). 
 
Figure 3 Mechanistic rationale for the anti-stereoselectivity of SMP-catalysed reactions. 
 
Unfortunately, the scope of this reaction seemed rather limited. For example, it was not 
possible to obtain the anti-adduct from an SMP-catalysed reaction of propionaldehyde and 
the imine formed from p-nitrobenzaldehyde and p-anisidine. In this case, low diastereo- and 
enantioselectivity was observed.12a Jørgensen and co-workers demonstrated that silylated 
α,α-diarylprolinol 89 (Scheme 32) catalyses the reaction depicted in Scheme 34 with 
significantly improved selectivity.42 Diastereomeric ratios up to 92:8 and ee values in the 
range of 94–98% were observed. The same catalyst was utilised by Hayashi et al. to catalyse 
the reaction of in situ generated N-Ts and N-Ns imines, which also afforded anti-products.43 
 
A related catalyst (Me3Si-protected α,α-diphenylprolinol) was used by Fustero et al. to prepare 
fluorinated amino alcohols.44 Not surprisingly, employment of this catalyst and of catalyst 91 
gave anti-products, whereas the use of proline afforded the corresponding syn-products (vide 
supra). Melchiorre and co-workers successfully employed a silylated α,α-diarylprolinol as the 
catalyst for the Mannich reaction of in situ generated N-Boc and N-Cbz imines.32 Another catalyst 
variation was reported by Palomo et al. They introduced a 4-hydroxysubstituted Me3Si-
protected α,α-dihexylprolinol, which in the presence of p-nitrobenzoic acid, effectively catalysed 
the reaction of N-tosyl and N-nosyl imines to afford anti-products.45 
The group of Maruoka developed new chiral amino sulfonamide catalysts for the formation 
of the anti-Mannich product of aldehydes and α-imino esters (Scheme 35).46 The first 
designed catalyst 96a (5 mol%) was tested in the Mannich reaction of isovaleraldehyde 16 
(R1 = iPr) and α-imino ester 94 (R2 = Et) in dioxane giving aldehyde 95 in 60% yield, but 
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without significant diastereoselectivity. Modification of the catalyst to 96b resulted in 
excellent reactivity and stereoselectivity (yield 93%, d.r. >1:20 (syn/anti), 99% ee). 
Reactions between other aldehydes 16 and α-imino esters 94 were carried out in dioxane at 
room temperature. In the case of primary alkyl aldehydes (R1 = Me, nBu, Bn), 1 mol% of 96b 
was sufficient to synthesise products 95 with excellent selectivities (yield >92%, d.r. >11:1, 
ee >99%). 
 
Scheme 35 Chiral amino sulfonamide-catalysed Mannich reactions. 
 
A few years later, it was reported that 96b could also efficiently catalyse the reaction between N-
Boc imines and acetaldehyde in a stereoselective manner. When substituted acetaldehydes were 
employed, predominantly anti-products were obtained.47 Vicinal diamines were accessible when 
N-Cbz-protected amino acetaldehydes were used as Mannich donors.40 This method was utilised 
in the total synthesis of marine alkaloid (–)-agelastatin A, a potent antitumor agent. 
In 2006, the same group reported the synthesis of a novel pyrrolidine-based catalyst 97, 
giving good results (yield 82–93%, d.r. >11:1 (anti/syn), ee 90–95%) with aldehydes (R1 = H, 
R2 = nPr, iPr, tBu) as the nucleophiles (Scheme 35). Less reactive ketones could also be used 
as nucleophiles, leading to the corresponding anti-β-amino ketones in good yields and 
selectivities (yield 95–99%, d.r. >20:1 (anti/syn), ee > 93%).48 
 
Scheme 36 Use of the novel pyrrolidine-based catalyst 97. 
 
Barbas and co-workers also contributed to the search for anti-selective organocatalysts. 
They designed a novel pyrrolidine-derived catalyst with subsituents on the 3- and 5-
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positions (98), showing excellent anti-selectivity in the reaction of aldehydes with N-PMP-
protected glyoxylate esters (Scheme 37).49 
 
Scheme 37 Use of the 3,5-disubstituted pyrrolidine catalyst 98 in Mannich reactions. 
 
Remarkably, the Mannich reaction with ketones and 98 as the catalyst was not very 
effective, but it was shown that the demethylated congener 101 efficiently catalysed the 
latter reaction. Both cyclic and linear ketones could be successfully applied, affording the 
corresponding β-amino ketones in good yields and excellent selectivities (Scheme 38). 
 
Scheme 38 Use of the 3-substituted pyrrolidine catalyst 101 in Mannich reactions. 
 
Interestingly, with α-hydroxyketones as donors, no diastereoselectivity was observed. In 
case linear α-amino acids (L-Trp and O-tBu-L-Thr) were applied as catalysts, α-hydroxy-β-
amino ketones were formed in moderate to high selectivities (d.r. up to >19:1 (anti/syn), ee 
up to 98%) (Scheme 39).50 
 
Scheme 39 L-Trp- and O-tBu-L-Thr-catalysed Mannich reaction with anti-selectivity. 
 
Córdova and co-workers also reported highly enantioselective anti-catalysts for the 
asymmetric Mannich reactions. Readily prepared Me3Si-protected diphenyl- and di(2-
naphthyl)prolinol appeared effective in catalysing the reaction of aldehydes with N-PMP-
protected ethyl iminoglyoxylate, giving rise to β-amino aldehydes in good yields and 
selectivities.51 Additionally it was found that β-amino acids and in particular β-homovaline 
could be effectively used as a catalyst in the reaction of ketones and N-PMP-protected α-
iminoethyl glyoxylate, giving anti-β-amino ketones.52 
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Threonine-derived organocatalysts were reported by the group of Lu as effective catalysts in 
purely aqueous systems.53 For example, O-TBDPS-protected threonine could catalyse the 
reaction of O-benzyl hydroxyacetone (104) with a variety of in situ formed p-anisidine-
derived imines with reasonable selectivities (ee 62–97%, d.r. 3:2 to 20:1 (anti/syn)) 
(Scheme 40). Aliphatic aldehydes were also investigated, but gave decreased yields and 
selectivities.  
 
Scheme 40 O-Benzyl hydroxyacetone as donor. 
 
Peng et al., who discovered an anti-selective secondary amine-thiourea catalyst 105 (Fig. 4),54 
also observed another interesting phenomenon. While the outcome of the organocatalysed 
Mannich reaction is generally mainly catalyst controlled, they reported an example with solvent-
controlled selectivity.55 
 
Figure 4 Secondary amine thiourea catalyst. 
 
They observed that in the presence of threonine-derived catalyst 103, the reaction of isatin 
imines 104 with hydroxyacetone (105), conducted in Et2O leads to predominant formation of 
anti-products 106, whereas employment of toluene as the solvent affords syn-products 107 
(Scheme 41). 
 
Scheme 41 Solvent-controlled selectivity. 
 
Another interesting approach came from the Glorius group. Instead of designing a new catalyst, 
they reasoned that proline, although generally affording syn-products, could be forced to deliver 
anti-products when the starting imine would be locked in a Z-configuration. This hypothesis was 
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confirmed via the synthesis of a series of amino ketones 112. The protecting group could be 
readily removed through hydrogenolysis in EtOH/H2O.56  
 
Scheme 42 Forced anti-selective catalysis with proline. 
 
1.3 Catalysis by Brønsted bases 
In the previous section, the crucial C-C-bond forming step in a Mannich reaction occurred 
through the reaction of an enamine nucleophile with a protonated imine. The protonation of 
the imine is essential to render it sufficiently electrophilic to react with the enantiomerically 
pure nucleophilic enamine. It is, however, also possible to react nucleophiles with neutral 
imines, although in these cases generally an electron-withdrawing substituent on the imine 
nitrogen is required to enhance its electrophilicity. The nucleophile is often an active 
methylene compound which, upon deprotonation by a chiral amine, provides a chiral 
intimate ion pair of which the anion reacts with the Mannich acceptor in an enantioselective 
fashion. The presence of a thiourea moiety can assist, most likely through cooperative 
hydrogen bonding with the imine precursor, thereby rendering it more active towards 
nucleophilic attack. In addition, the hydrogen bonding properties of  the thiourea moiety can 
also be invoked to account for increased reactivity of the nucleophile (vide infra). 
 
1.3.1 Use of cinchona alkaloid-derived bases 
Chincona alkaloids have proven to be exceptionally effective in catalysing a plethora of 
asymmetric transformations, including the Mannich reaction.57 Schaus and co-workers have 
developed a diastereo- and enantioselective direct Mannich reaction of β-ketoesters 114 with 
acyl aryl imines 115 catalysed by the alkaloids cinchonine (116) and cinchonidine (117) 
(Scheme 43) to synthesise enantioenriched dihydropyrimidones and β-amino alcohols.58 
Employment of 116 or 117 led to opposite enantioselectivities. The stereoselective control was 
explained through complexation of the chiral alkaloid with the nucleophile. Reaction of β-
ketoester 114 with aryl methyl carbamate 115 (R3 = OMe) in the presence of catalyst 116, 
proceeded in good yield with moderate enantio- and varying diastereoselectivity. They 
expanded the scope of this reaction by including α-substituted β-keto esters and β-diketones as 
donors, thereby gaining access to structures with α-quaternary centres. Additionally, aryl-
propenyl acylimines appeared suitable as Mannich acceptors.  
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Scheme 43 Cinchona alkaloid catalysis. 
 
Chan et al. reported that a cinchona alkaloid derivative served as a catalyst for the Mannich type 
formal (2+3) cyclisation of N-tosyl imines with methyl isocyanoacetate.59 The 
diastereoselectivity of this reaction was reasonable while the enantioselectivity was low. The 
Schaus group reported that the hydroquinine-derived thiourea 121 could serve as an effective 
catalyst. The reaction between dimethyl malonate 119 and a variety of methyl carbamate-
protected aromatic imines 120 afforded the corresponding Mannich adducts 122 in good 
selectivities and almost quantitative yields (Scheme 44).60 Computational modelling studies 
established that malonate anion stabilisation via a chiral ion pair with the hydroquinine moiety 
and simultaneous hydrogen bonding of the thiourea part of the molecule with the anion 
accounted for the excellent selectivity of this reaction. 
 
 
Scheme 44 Cinchona alkaloid 121 with thiourea moiety. 
 
Catalyst 121 also effectively facilitated the stereoselective reaction of glycine-derived Schiff 
bases and in situ generated N-Boc imines.61 
Well aware of the beneficial effect of co-operative hydrogen-bonding catalysis with readily 
available cinchona alkaloids, Deng and co-workers investigated the use of cinchona alkaloids 
bearing a thiourea functionality as catalysts (123 and 124) for the addition of malonates to 
N-Boc-protected imines (Fig. 5). After optimisation of reaction conditions, the desired 
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products were obtained in excellent yields (up to 99%) and enantioselectivities (ee up to 
99%). The imine scope was not limited to aromatic imines, but also aliphatic acceptors could 
be applied. β-Keto esters could also be used as donors, providing access to β-keto amines 
albeit with only moderate diastereomeric control.62 Dixon et al. reported comparable results 
for reactions with Boc- and Cbz-protected aldimines catalysed by a slightly different 
catalyst.63 
 
Figure 5 Cinchona alkaloids 123 and 124 with thiourea moiety. 
 
A major drawback of the use of N-Boc-protected imines is the low stability of particularly 
aliphatic imines. This was recognised by Deng et al. and overcome by the implementation of 
gradual and in situ generation of N-alkyloxycarbonyl-protected imines from stable α-
aminosulfones.64 This also led to higher optical purities when employing catalyst 124 due to 
the relatively high concentration of the catalyst compared to the imine. In one example, with 
the same amount of catalyst, 95% ee was obtained with in situ generation of the imine, 
whilst employment of a preformed imine afforded the desired product in only 74% ee. 
Additional examples involving the use of N-alkyloxycarbonyl-protected α-aminosulfones and 
dibenzylmalonate provided further insight into the scope of this reaction (Scheme 45). 
 
Scheme 45 Addition of dibenzyl malonate to in situ generated N-alkyloxy-protected imines. 
 
An interesting variation on this motif was reported by the Jørgensen group. They described a 
highly enantioselective procedure for the reaction of α-aryl-substituted cyanoacetates 128 
with N-Boc protected iminoglyoxylates 129 in the presence of a chiral tertiary amine 
catalyst (Scheme 46).65 
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Scheme 46 Use of α-Aryl-substituted cyanoacetates as donors. 
 
Various catalysts were screened for the reaction of 128 (R1 = nPr; Ar = Ph) with 129 (R2 = 
Et), and commercially available (DHQD)2PYR (131) gave the best diastereo- and 
enantioselectivity (Fig. 6). The scope of α-aryl-substituted cyanoacetates was investigated 
and it was found that in all cases similarly high selectivities could be observed, but in the 
case of a 2-bromosubstituted aryl moiety, the nature of the ester group of 129 seemed to 
direct the selectivity. An ethyl group completely inverted the diastereoselectivity, whereas 
the enantioselectivity disappeared almost completely. 
 
Figure 6 (DHQD)2PYR. 
 
The substrate tolerance of the catalytic system was further demonstrated by the use of the 
cyclic β-ketoester 132 (Scheme 47). The reaction smoothly afforded Mannich base 134 in a 
high yield and essentially as a single isomer in excellent ee. 
 
Scheme 47 Cyclic β-keto ester 132 as Mannich donor. 
 
The concept of combining the basic amine functionality of cinchona alkaloids with the acidic 
protons of (thio)urea moieties was also picked up by Coltart et al.66 They utilised organocatalyst 
138 to simultaneously activate and deprotonate thioester 135. The resulting enolate attacks N-
sulfonyl imines 136 to eventually afford Mannich products 137 in good diastereoselectivity. 
Unfortunately, the enantioselectivity was low. 
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Scheme 48 Mannich reaction of thioesters with N-sulfonylimines. 
 
Lu et al. found a moderately enantioselective approach to enhance the low reactivity of aryl 
methyl ketones (e.g. acetophenone). They employed cinchonine-based bifunctional 139 as the 
catalyst for the decarboxylative addition of β-keto esters 140 to N-SO2-PMP imines 141.67  
 
Scheme 49 Decarboxylative addition of β-keto esters to N-SO2-PMP imines. 
 
Another cinchona-based thiourea was disclosed by the Yang group. They developed catalyst 143 
(Fig. 7), which catalysed the reaction of diethyl malonates with N-benzothiazole imines.68 The 
observed enantioselectivities were moderate and the reaction times were long.  
 
Figure 7 Cinchona-derived catalyst 143. 
 
A one-pot enolate-mediated Mannich reaction, promoted by the bifunctional quinidine thiourea 
catalyst 146, was recently disclosed by Zhao et al.69 After condensation of Ts-amine (144) with 
an aromatic aldehyde, the enolised ketone attacks the resulting imine, resulting in the enantio- 
and diastereoselective formation of N-tosylated β-amino ketones 147. 
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Scheme 50 One-pot bifunctional quinidine-thiourea catalysis. 
 
1.3.2 Use of other chiral bases 
The results achieved with cinchona alkaloid-derived thiourea catalysts prompted Takemoto 
et al. to investigate potential of the simple thiourea compound 150 in the Mannich 
reaction.70 It effectively catalysed the reaction of diethyl malonate with N-Boc-protected 
aldimines as opposed to other N-protected aldimines. Although the thiourea catalyst led to 
high enantioselectivities for reacting β-keto esters with aldimines, no diastereoselectivity 
was observed. This was possibly due to epimerisation of the product. Subsequently, cyclic 
1,3-dicarbonyl compounds 149 were used as substrates (Scheme 51). The product 151 was 
obtained in 89% yield and the selectivities were good (ee 88%, d.r. 92:8). A series of 
reactions with cyclic substrates was disclosed, but the selectivities were generally fairly 
modest. The authors suggested that a dual activition of the electrophile and the nucleophile 
accounted for the observed selectivity, but no definite proof was provided.  
 
Scheme 51 Thiourea catalyst-promoted Mannich reactions. 
 
A more sterically hindered congener of 150 was employed by Yan et al. for the synthesis of O-
ethyl tetronic acid derivatives 151.71 After the Mannich reaction between ethyl 4-chloro-3-
oxobutanoate (152) and N-Boc imines (153) catalysed by thiourea derivative 154, a 
triethylamine-mediated cyclisation in the same pot afforded the desired products in good yields 
and moderate to good selectivity. 
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Scheme 52 Synthesis of O-ethyl tetronic acid derivatives. 
 
Thiourea-catalysed reactions had already been reported previously by Jacobsen and co-
workers in 2002. At that time, they recognised that the conditions required for the removal 
of N-aryl protecting groups posed a serious drawback to the organocatalysed reactions 
described above. As a result, they reported an efficient route to N-Boc-protected β-amino 
acids via the enantioselective addition of silyl ketene acetals to N-Boc aldimines catalysed by 
thiourea catalyst 156 (Fig. 8).72 
 
Figure 8 Thiourea catalyst 156. 
 
Addition of silyl ketene acetal 157 to N-Boc-protected o-, m-, p- and unsubstituted 
arylimines 70 proceeded with generally good enantioselectivity (88–93% yield, up to 97% 
ee) to afford the Mannich bases 158 (Scheme 53). It is however noteworthy that reactions 
were conducted at –40 to –30 °C to suppress the non-catalytic (racemic) pathway. Aliphatic 
N-Boc-protected imines were not investigated since no useful method was available for their 
synthesis. 
 
Scheme 53 Thiourea-based catalysis with silyl ketene acetals. 
 
The same catalyst was later found to efficiently catalyse the reaction of N-Boc imines 159 with 
benzothiazolesulfonyl-derived ketones 160. The products could be converted to allylic amines 
161 through reduction with NaBH4, whereas treatment with NaSEt gave rise to β-amino ketones 
162.73 
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Scheme 54 Mannich reaction of benzothiazolesulfonyl-derived ketones. 
 
Kim and Kang developed a set of catalysts with both axial and central chiral elements of which 
164 appeared to perform best in the reaction of β-keto ester 163and N-Boc aldimines 153.74 
 
Scheme 55 Mannich reaction of a β-keto ester with N-Boc aldimines. 
 
Long reaction times were generally employed but the selectivities were virtually complete. A 
similar reaction could be catalysed by rosin-derived amine-thiourea 166 (Fig. 9), developed by 
Wang et al. Besides β-keto esters, their system also accepted lactones as the Mannich donors.75 A 
modified version (167) was developed for the synthesis of cyclic thioureas.76 
 
Figure 9 Rosin-derived thiourea catalysts. 
 
Only secondary and tertiary amine thiourea catalysts were reported to effectively catalyse the 
Mannich reaction until Tsogoeva et al.77 found that the reaction of ketones 13 and N-
benzoylhydrazones 168 proceeds in the presence of primary amine 169 (Scheme 56). Despite 
the high enantioselectivity, a virtual absence of diastereoselectivity in the reaction renders this 
catalyst less suitable for substituted ketones as the Mannich donors. As an addition, the authors 
found evidence based on 18O studies that this reaction not exclusively follows an enamine 
pathway, but also partially proceeds through an enol mechanism. 
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Scheme 56 Primary amine thiourea-catalysed Mannich reaction of ketones and hydrazones. 
 
1.4 Catalysis by chiral Brønsted acids  
A third pathway for enantioselective organocatalysed Mannich reactions proceeds via 
enantiopure Brønsted acids. Instead of reacting with an enantiopure nucleophile (Section 
1.2), the imine is protonated by the chiral acid, which leads to the formation of an iminium 
ion with an enantiopure counterion. This counterion directs the incoming nucleophile and 
leads to an optically active Mannich product. Most often, the acids involved are readily 
accessible enantiopure phosphoric acids. 
An early example was reported by Akiyama and co-workers.78 They synthesised a series of 
chiral phosphate catalysts, of which phosphoric acid 173 proved to give the best results. For 
example, reaction of the aromatic aldimines 171 with silyl ketene acetal 172 (R1 = R2 = Me) 
catalysed by 173 afforded the Mannich bases 174 in excellent yield (98–100%) and 
reasonable enantioselectivity (80–89% ee) (Scheme 57). Addition of monosubstituted silyl 
ketene acetals 172 (R1 = H, R2 = Me, Bn) to aromatic aldimines 171 led to highly syn-
selective reactions (d.r. 87:13 to 95:5 (syn/anti)), while the enantioselectivity was also 
maintained (81–96% ee). In addition, it was concluded that the hydroxy-substitutent on the 
o-position of the protecting group was essential to ensure high levels of enantioselectivity.  
 
Scheme 57 Enantioselective phosphoric acid catalysis. 
 
In a later report, Ishihara et al. demonstrated that the performance of chiral phosphoric acid 
catalyst (175) largely depends on the counterion M.79 The reaction of N-Boc aldimines 70 with 
acetylacetone (176) proceeded with opposite enantioselectivity when the counterion was 
exchanged from H+ to Ca2+. The steric demand of the Ar-substituent also appeared of great 
General introduction 
 
 
39 
importance. When it was changed from 4-(β-naph)-C6H4 to 9-Anthryl, a lower and opposite 
enantioselectivity was observed. This implies a match/mismatch condition. With H+ as the 
counterion, the presence of the more demanding 9-anthryl substitutent is preferred to obtain 
high enantioselectivity. With Ca2+ as the counterion, 4-(β-naph)-C6H4 as the Ar-substituent led to 
higher and opposite enantioselectivity. Scheme 58 shows the most successful combinations. 
 
Scheme 58 Influence of aryl-substituent and counterion on enantioselectivity with 172 as the catalyst. 
 
Expecting to have different electronic and steric properties, the novel Brønsted acid 178, 
based on the well-known TADDOL scaffold, was prepared by the group of Akiyama (Fig. 
10).80 By varying the Ar functionality and the alkyl groups on the acetal moiety, the catalyst 
initially showed only modest selectivity (ee 31–73%) for the Mannich reaction of aromatic 
aldimines and ketene silyl acetals. However, when the imine protective group was changed 
from o-hydroxyphenyl to o-hydroxy-p-methylphenyl, a dramatic increase of the 
enantiomeric excesses to 85–92% was observed without diminishing the yields.  
 
Figure 10 TADDOL-based catalyst. 
 
Yamamoto et al. reported the introduction of the concept of Brønsted acid-assisted chiral 
Brønsted acid (BBA) catalysis for the design of 179 as a new asymmetric Mannich catalyst 
(Scheme 59).81 The BBA catalyst bears two acidic protons. Mechanistically, the imine 180 is 
activated by the reasonably acidic hydroxy group, while the bis(triflyl)methyl proton 
simultaneously fixes the OH-N bond, thereby stabilising the configuration of the chiral 
transition state. Attack of the silyl ketene acetals 181 affords products 182. The chemical 
yield initially did not exceed 53%, but the reactivity was improved by adding 2,6-xylenol as 
an achiral proton source to trap the silicon species resulting from the reaction. Various  N-
phenyl-protected β-amino esters were obtained with a maximum ee of 77%. It was also 
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shown that the N-protective group could be replaced by a diarylmethyl moiety, giving 
enantioselectivities up to 87%.  
 
Scheme 59 Brønsted acid-assisted chiral Brønsted acid catalysis. 
 
Terada et al. used the chiral phosphoric acid catalyst 183 to catalyse the enantioselective 
addition of acetylacetone 176 to the p- and o-substituted N-Boc-protected aromatic 
aldimines 70, providing the Mannich bases 184 in high yields (93–99%) and high 
enantioselectivity (90–98% ee) (Scheme 60).82 
 
Scheme 60 Chiral phosphate catalysis. 
 
Schoepke et al. reported the first enantioselective Brønsted acid-assisted chiral Brønsted 
acid-catalysed direct Mannich reaction of the poorly reactive acetophenone. 83 They reasoned 
that activation of the aldimine should occur via ion pair formation with the chiral Brøns ted 
acid, while activation of the ketone donor must be mediated by an achiral acid which cannot 
form an ion pair with the aldimine. Elaborating this concept, the reaction of acetophenone 
with the N-4-chlorophenyl-protected aldimine 185 was investigated using the chiral BINOL-
phosphate 187 in combination with acetic acid, which led to a high selectivity (76% ee) 
(Scheme 61). The scope was also evaluated to show that aromatic and heteroaromatic 
aldimines could be applied in the reaction with acetophenone to a fford the corresponding β-
amino ketones in moderate yields and selectivities. 
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Scheme 61 Brønsted acid-assisted chiral Brønsted acid-catalysis. 
 
The use of acetophenone as the Mannich donor was also reported by Dixon and co-worker, 
but they had to preactivate the ketone as its enamine with morpholine.84 They tested a 
variety of modified BINOL structures as catalysts in the reaction of enamine 190 with the N-
Boc protected aldimine 189 and found that the best results were obtained with (S)-H8-
BINOL 191. Only aromatic substrates were reported as acceptable donors and acceptors for 
this catalyst. Yields were good, but enantiomeric excesses were generally moderate (mostly 
in 60–80% range) (Scheme 62). 
 
Scheme 62 Preactivated acetophenone as Mannich donor. 
 
Ishihara et al. developed an asymmetric route towards binaphthyl-disulfonic acid (195, BINSA). 
In combination with two equiv of an achiral organic base (196), it could serve as an effective 
catalyst for the enantioselective addition of diketones to N-alkyloxycarbonyl imines.85 
 
Scheme 63 Combined Brønsted acid/base-catalysed Mannich reaction. 
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The previous examples showed enantioselective Brønsted-catalysed reactions, leading to 
compounds with only one chiral centre. Gong et al. were the first to report anti-selective 
examples of chiral Brønsted acid-catalysed reactions.86 Reasonable diastereoselectivities 
(d.r. in the 80:20 to 98:2 range) were observed in the reaction of cyclic ketones with aniline 
and aromatic aldehydes and catalysts 198b or 198d (Scheme 63), while enantioselectivities 
were generally high (90–95% ee). In the presence of 198a or 198c, the reaction of acyclic 
ketones with aromatic aldehydes in the presence of (substituted) aniline also proceeded 
with high enantioselectivities (up to 86% ee). No diastereoselective examples were 
reported.  
 
Scheme 64 anti-Selective Brønsted acid-catalysed reactions. 
 
Maruoka et al. expanded the field of Brønsted-acid catalysis by introducing axially chiral 
dicarboxylic acids.87 After identification of the optimal reaction conditions and catalyst 
design (Scheme 65), it was found that besides tert-butyl diazoacetate (R1 = CO2tBu), also 
dimethyl (diazomethyl)phosphonate (R1 = PO(OMe)2) and tolyl (diazomethyl)sulfone (R1 = 
SO2Tol) could be used as effective Mannich donors in the reaction with N-Boc imines.  
 
Scheme 65 Axially chiral dicarboxylic acid catalysis. 
 
Another effective catalyst for the reaction of dialkyl diazomethylphosphonates with N-
alkyloxycarbonyl imines was described by the Peng group.88 An extensive catalyst screening 
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revealed that phosphoric acid 208 efficiently promotes the deprotonation of the diazo 
carbon of 207, while it simultaneously protonates the N-alkyloxycarbonyl imine 206 in an 
asymmetric fashion. In the presence of a diminutive amount of catalyst (0.1 mol%), the 
resulting Mannich products were formed in very high yield and selectivity.  
 
 
Scheme 66 Axially chiral phosphoric acid catalysis. 
 
1.5 Phase transfer catalysts and quaternary salts 
As the final class, the group of phase transfer catalysts and other quaternary salts is 
discussed. Similar to chiral Brønsted acids, these catalysts form well-defined complexes with 
the electrophile. Thereby, one side of this electrophile is shielded, which paves the way for 
an enantioselective outcome of the catalytic Mannich reaction. 
Maruoka et al. disclosed an N-spiro C2-symmetric chiral quaternary ammonium bromide 
(211)-catalysed reaction of glycinate Schiff base 210 with N-PMP protected imine 14.89 This 
early example of a phase-transfer-catalysed Mannich reaction proceeded with a high 
enantio- but only moderate diastereoselectivity (Scheme 67). 
 
Scheme 67 N-spiro C2-symmetric chiral quaternary ammonium bromide-catalysed Mannich reaction. 
 
The in situ formation of N-alkyloxycarbonyl-protected imines and their use as Mannich 
acceptors was also reported by Sgarzani and co-workers.90 Cinchona alkaloid 216 was 
designed, which showed excellent enantioselectivity in the reaction of p-anisyl malonate 214 
Chapter 1 
 
44 
with various in situ generated N-Boc- or N-Cbz-protected aldimines. Both aliphatic and 
aromatic α-amido p-tolylsulfones were tolerated. The enantiomeric excesses were generally 
in the 84–98% range (Scheme 68). 
 
Scheme 68 In situ generation of N-alkyloxycarbonyl-protected imines. 
 
A Mannich-type addition of β-phenylsulfonyl acetonitriles to N-Boc protected α-amido 
sulfones or imines catalysed by quinidine derived 217 was reported by Palomo et al.91. 
Although the yields were reasonable, the enantioselectivities were far from optimal.  
Figure 11 A quinidine-derived PTC. 
 
 
 
 
Another quinidine-derived catalyst 218 was employed to catalyse for the first time the 
reaction of arylsulfonylacetates 219 with in situ formed N-Boc imines.92 The resulting 
Mannich products 221 were formed in low diastereoselectivity but the enantioselectivities 
were high. The authors transformed the adducts into compounds  222 and 223 (Scheme 69) 
which lacked chirality at the previously sulfonyl-bonded carbon atom. Since these products 
were eventually obtained in high enantioselectivity it was proven that the formation of the 
initially observed mixture of diastereomers was caused by epimerisation of the 
aforementioned chiral centre.  
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Scheme 69 Arylsulfonylacetates as versatile Mannich donors. 
 
The first example of betaine catalysis was disclosed by Ooi et al.93 They developed a new 
catalyst design with catalyst 226 as the best performing example in terms of product yield 
and selectivity. α-Nitrocarboxylates were reacted with N-Boc imines in the presence of the 
catalyst which resulted in the formation of the desired products with high 
enantioselectivities but only moderate diastereoselectivities (Scheme 70). 
 
Scheme 70 Betaine-catalysed Mannich-type reaction. 
 
A much more simple betaine type catalyst was developed a couple of years later by the same 
group.94 Catalyst 228 appeared to be the most successful of a set of C1-symmetric internal 
ion pairs in the catalysis of the reaction of N-Boc imines and 2-benzyloxythiazol-5(4H)-ones 
(Scheme 71). 
 
Scheme 71 C1-symmetric betaine catalysed Mannich-type reaction. 
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The products could be obtained in high ee and a reasonable anti-selectivity was observed. 
For R1 and R2 = Ph, it was shown that 229 could easily be converted into the corresponding 
α-aryl-α,β-diamino acid ester and amide. 
 
Another interesting contribution from the Ooi group to the field of ion pair catalysis was the 
incorporation of a participating anion, which influence was previously neglected. 95 They 
found a significant rate enhancement for the reaction of N-sulfonyl imines 231 with 
azlactones 230, when substituting the formate anion for a pivalate anion. Unfortunately, this 
replacement did not improve the initial virtual absence of enantioselectivity. By altering its 
geometry from (M,S) to (P,S) the authors ultimately prepared an efficient and stereoselective 
catalyst. Products 233 could be obtained with high enantiomeric excesses, but 
diastereoselectivities stayed behind (Scheme 72). 
 
Scheme 72 Tetraamino phosphonium carboxylate-catalysed Mannich-type reaction. 
 
Maruoka et al. after having discovered that chiral quaternary phosphonium salt 235 could 
effectively catalyse the asymmetric Michael addition, found that the same catalyst was also 
applicable as a catalyst for the Mannich reaction of 3-aryloxindoles with N-Boc imines 
(Scheme 73).96  
 
Scheme 73 Chiral phosphonium salt catalysis. 
 
Products 236 were obtained in near quantitative yields and excellent diastereoselectivities. 
Unfortunately, the observed enantioselectivity was somewhat lower.  
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A new catalyst design was reported by the Gong group in 2012.97 They developed a complex 
chiral bis(betaine) catalyst 237 with multiple functionalities for the reaction of azlactones 238 
and aliphatic imines 230. The products 239 were obtained in high enantio- but low 
diastereoselectivity. 
 
Scheme 74 Bis(betaine)-catalysed Mannich reaction. 
 
1.6 Discussion  
This survey of organocatalytic Mannich reactions leads us to conclude that this is a 
promising field from which many new applications in the synthesis of biologically active 
compounds will emerge. It also becomes evident that the use of proline as the catalyst gives 
easy access to syn-products in high yields with high regio-, chemo-, diastereo- and 
enantioselectivity. Since proline is commercially available in L- and D-form, the products can 
also be obtained in both enantiomeric forms. Both one-pot three-component reactions and 
reactions with preformed imines have extensively been studied using unmodified ketones 
and aldehydes as Mannich donors. It should be noted that a relatively high catalyst loading is 
generally used (typically 10–30 mol%). Some research groups have developed new, more 
soluble catalysts to increase the dissolved catalyst concentration. However, this led to more 
expensive catalysts of which the scope still needs to be fully investigated. Moreover, since 
proline catalysis only gives access to syn-adducts, the development of anti-directing catalysts 
was also desired. Nowadays, a series of enamine-forming amines are available that affords 
the anti-products in good selectivity.  
Besides catalysis by proline and derivatives, other chiral bases such as cinchona alkaloids 
have been successfully employed in combination with electron-poor imines and active 
methylene compounds. Success in this particular reaction is often facilitated by introducing 
thiourea moieties, that interact with the system through cooperative hydrogen bonding.  
Chiral Brønsted acids (mostly phosphoric acids) have been employed to include the iminium 
ion in a chiral intimate ion pair, which also results in enantioselective addition to the 
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iminium species.  
Some very recent reports disclose the use of quaternary (internal) salts as effective 
catalysts. The structure of most of these catalysts is based on the axially chiral binaphthyl 
core.  
 
1.7 Thesis outline 
During the past decade, substrate scope and product accessibility in the field of 
organocatalysis massively increased. Unfortunately, this development came with a price: 
Catalyst structures became increasingly intricate rendering their larger scale applica tions 
more costly. Even after more than 10 years of research since its discovery, the sheer low cost 
and high selectivity of proline still gives this catalyst a special position in the field of 
organocatalysis.  
The purpose of this Thesis is to further anchor the proline-catalysed Mannich reaction 
between currently well-established synthetic methods. This includes gaining further insight 
in optimal reaction conditions overcoming protecting group difficulties, and transforming 
the resulting products into relevant synthetic targets or building blocks. Moreover, this 
Thesis is one of the fruits of a collaboration of the Radboud University Nijmegen with DSM, 
Syncom and the University of Groningen. In this joint project (termed Ultimate Chiral 
Technologies), we focussed on the development of (new) stereoselective routes to multi -
chiral centre compounds and the evaluation of the industrial viability thereof. In this 
context, Chapter 2 describes a novel oxidative method to replace the ceric ammonium 
nitrate-mediated removal of the often used p-methoxyphenyl N-protecting group. In 
Chapter 3, the expansion of the collection of aforementioned deprotection methods with an 
enzymatic approach is described. Chapter 4 covers the selective transformation of β-amino 
ketones into the corresponding syn- and anti-1,3-amino alcohols. In Chapter 5, an entry into 
the synthesis of tetrahydroisoquinolines, starting from Mannich adducts is presented. 
Chapter 6 describes the development of an industrially viable reaction sequence, which 
enables the one-pot conversion of enantiopure 1,3-N-PMP-protected amino alcohols into 
protecting group-free β-2,3-disubstituted amino acids amino acids. This methodology has 
also been employed in an approach towards a synthesis of dioctatin A. In Chapter 7, the 
total synthesis of the naturally occurring alkaloid lasubine II is expounded. In the final 
Chapter 8, the research described in this thesis will be contemplated and some outlook and 
suggestions for future investigations will be presented.  
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2 
MILD AND EFFICIENT DEPROTECTION OF 
THE AMINE PROTECTING p-
METHOXYPHENYL (PMP) GROUP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter is based on: Verkade, J. M. M.; van Hemert, L. J. C.; Quaedflieg, P. J. L. M.; Alsters, P. 
L.; van Delft, F. L.; Rutjes, F. P. J. T. Tetrahedron Lett. 2006, 47, 8109–8113.  
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2.1 Introduction 
As described in Chapter 1, asymmetric Mannich reactions catalysed by L- or D-proline proceed 
smoothly using p-anisidine-derived Schiff bases of aldehydes and ketones.1 Moreover, in the 
advent of new catalytic strategies to produce enantiopure products,2 p-anisidine stands out as 
the starting material of choice for a variety of processes that involve imine intermediates. Other 
applications involve the (asymmetric) reduction of p-methoxyphenyl (PMP)-protected imines,3 
the involvement of p-anisidine in a three-component reaction to form N-PMP-protected amino 
acid amides,4 and application in asymmetric Diels–Alder reactions.5  
Furthermore, a Cu-catalysed procedure for introduction of the PMP group as a protecting group 
for amino functions has been described.6 Obviously, all of these strategies at one point require 
liberation of the desired amine by oxidative deprotection of the p-methoxyphenyl function 
(Scheme 1). 
 
Scheme 1 Deprotection of PMP-protected amines. 
 
The deprotection of the PMP group was identified by us as a crucial and important drawback for 
scale-up and commercial application of any type of methodology involving N-PMP intermediates, 
including the proline-catalysed Mannich reaction. Most literature refers to oxidative removal 
with ceric ammonium nitrate (CAN),7 but appears to neglect the serious disadvantages 
associated with it. Usually, a large excess of CAN (4 to 5 equiv) is required, the reaction has a 
laborious workup procedure involving column chromatography, CAN is expensive, and highly 
toxic. Some of these arguments also hold for phenyl iodoacetate (PhI(OAc)2), which has also 
been reported as a deprotecting agent.8 In recognition of these drawbacks, the Mioskowski 
group – in a search for better deprotection methods – reported an electrochemical procedure for 
the oxidative removal of the PMP substituent.9 However, electrochemical reactions are poorly 
amenable to scale-up because specific production equipment is required. 
 
2.2 Screening of various oxidants 
Based on these arguments, we set out to develop a new methodology that can be broadly applied 
for deprotection of the PMP group with cheap reagents and beneficial atom economy for 
potential large scale application in an industrial setting. We decided that the readily accessible 
reduced Mannich product 410 would be a useful starting point to search for oxidation reagents 
that might be effective in realising PMP deprotection. Initially, an HPLC assay was adopted that 
allowed us to determine the conversion in time (after 8 and 20 h) of PMP-protected amine 4 into 
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the corresponding free amine 5 upon treatment with varying amounts (1 or 4 equiv) of oxidant. 
As can be seen from Table 1, CAN and PhI(OAc)2 in the presence of one equivalent of sulfuric 
acid indeed were effective in doing so, albeit with moderate conversions. We were, however, 
pleasantly surprised to find that under these acidic conditions readily available and cheap 
oxidants such as trichloroisocyanuric acid (TCCA) and periodic acid (H5IO6) were effectively 
capable of removing the PMP group (Table 1, entries 7–12). The data show that the addition of a 
strong protic acid is crucial in the deprotection reactions, since without the acid the oxidants do 
not give any product formation at all (Table 1, entries 7 and 10). This is in agreement with the 
mechanism involving initial formation of the benzoquinone-derived imine 2, which is under the 
reaction conditions hydrolysed to the desired free amine 3 (Scheme 1). 
Table 1 Deprotection of PMP-protected amine 4* using various oxidants. 
 
Conditions: a) 1 or 4 equiv oxidant, 1 equiv H2SO4, 5 mol% benzoic acid (internal standard), MeCN/H2O 
1:1, rt. a Conversions were determined using HPLC (Inertsil ODS-3 column) on crude samples from the 
reaction mixture. b Carried out without addition of H2SO4. c Several byproducts were detected by HPLC. 
(DMP = Dess-Martin periodinane, PBP = pyridinium bromide perbromide, NCS = N-chlorosuccinimide, 
NBS = N-bromosuccinimide, NIS = N-iodosuccinimide). *d.r. and ee of 4 not determined for this screening 
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The decrease in yield upon going from 1 to 4 equiv of TCCA (Table 1, entries 8 and 9) may be 
explained by oxidation of the liberated amino alcohol in the latter case. Periodic acid shows a 
relatively low conversion after 8 h, but a very good conversion after 20 h (Table 1, entry 11), 
while additional equivalents of oxidant yielded no improvement (Table 1, entry 12). Other 
halogen containing oxidants have also been tested under these acidic conditions, such as the 
hypervalent Dess–Martin reagent (Table 1, entries 5 and 6), hypochlorous acid (Table 1, entries 
13 and 14), and a series of electrophilic halide reagents (Table 1, entries 15–25). Without 
exception, in all cases conversion of 4 into 5 was observed, but with reduced effiency compared 
to TCCA and periodic acid. Finally, several inorganic oxidants were applied, but appeared 
unsuccessful in this transformation (Table 1, entries 26–30). 
 
2.3 Preparative H5IO6 and TCCA induced deprotection of N-PMP-protected 
substrates 
To verify the results of our initial screening, we performed a series of preparative scale 
experiments on the initial substrate 4 as well as on the PMP-protected amines 6–11 with TCCA 
and periodic acid (Table 2). As can be judged from Table 2, the corresponding free amines 5 and 
12–17 were formed with satisfactory results. Subjection of PMP-protected benzylamine (6) to 
TCCA provided the free amine 12 in good yield, but the deprotection proceeded poorly with 
periodic acid which led us to conclude that for these conditions a substituent at the benzylic α-
position is desirable (Table 2, entries 1 and 2). From NMR analysis of the concentrated 
combined DCM layers from the workup, it was concluded that benzaldehyde was formed in the 
H5IO6 experiment. Indeed, PMP-protected α-methylbenzylamine (7) gave good yields of the 
desired product 13 with both oxidants (Table 2, entries 3 and 4). N-PMP-protected 4-
phenylbutan-2-amine (8) underwent facile deprotection in similar efficiency to give 4-
phenylbutan-2-amine (14), (Table 2, entries 5 and 6). Deprotection of the reduced Mannich 
adducts 4 and 9–10 also proceeded readily to furnish the corresponding amines in excellent 
yield (Table 2, entries 7–12). Finally, the tertiary amine 11 was subjected to the same 
conditions, and showed a good yield in case of TCCA deprotection, but did not produce a pure 
product when H5IO6 was used. It may be expected that the yields may be further increased by 
optimisation of the reaction conditions. It should be noted that these new PMP removal 
procedures are accompanied by a straightforward and practical workup, which is in sharp 
contrast with the laborious CAN chromatography protocol. In all cases, after completion of the 
reaction, workup involved washing the aqueous mixture with DCM (to remove benzoquinone) 
before adjustment to high pH (>10) and extraction with ethyl acetate. Upon acidification of the 
organic layer with a solution of HCl in ethyl acetate and subsequent concentration, the 
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deprotected amines were obtained in high purity as the corresponding HCl-salts and 
chromatography was not needed for further purification. 
Table 2 Preparative scale N-PMP deprotections.  
 
aConditions: 1 equiv H2SO4, 1 equiv H5IO6 or 0.5 equiv TCCA, MeCN/H2O 1:1, rt  
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2.4 Mechanism 
Although we have not studied the mechanism of oxidative PMP deprotection methods, in this 
section, two possible mechanisms will be discussed: 1. N-halogenation (Scheme 2) and 2. single-
electron transfer (SET) (Scheme 3). Both mechanisms entail the formation of an iminoquinone 
species, which upon hydrolysis leads to formation of the free amine and benzoquinone as the 
side product. The difference between both mechanisms lies in the oxidative first step. The first 
mechanism starts with attack of the free electron pair of the aniline nitrogen on the electrophilic 
halide source (e.g. H5IO6 or TCCA). Attack of water on the cationic intermediate in the second 
step followed by elimination of methanol gives rise to the aforemementioned iminoquinone 
species. However, halide-elimination may also occur via SN2-type attack of water on the OMe-
group. 
 
  
Scheme 2 N-dearylation via N-halogenation. 
 
The SET mechanism is initiated by abstraction of an electron from the electron-rich aromatic 
ring by the oxidant. The resulting radical cation is subsequently trapped with water, after which 
proton abstraction leads to a neutral radical. The desired iminoquinone is formed by H-atom 
abstraction, followed by recombination of an electron pair. 
 
Scheme 3 N-dearylation via single electron transfer. 
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2.5 Deprotection of α-hydroxy-substituted PMP-protected amines 
To further explore scope of the substrate of the deprotection method, we synthesised substrate 
19 with a hydroxy group β to the amino function (Scheme 4), which is a common reaction 
product of Mannich reactions. 
 
Scheme 4 Synthesis of 2,3-dihydroxy amines from hydroxyacetone. 
 
α-Hydroxy-β-amino ketone 18 was prepared via the proline-catalysed Mannich reaction as 
depicted in Scheme 4.11 Because β-amino ketone 18 displayed only limited stability, we reduced 
the ketone functionality prior to deprotection of the amino group. NaBH4 reduction gave diol 19 
in quantitative yield with a diastereomeric ratio of 4:1 for the resulting alcohols. Subsequent 
treatment of 19 with H5IO6 did not produce a pure product, presumably due to oxidative 
cleavage of the diol. Unfortunately, also by applying TCCA, diol 19 could not be obtained in 
reasonable purity. In both reactions, benzaldehyde was formed as a side product as could be 
concluded from 1H NMR analysis of the concentrated combined DCM layers.  
 
As described in Section 2.4, oxidation of the PMP group results in the formation of an 
iminoquinone species. The second step in the deprotection is the acidic hydrolysis of this 
iminoquinone. However, a hydroxyl function adjacent to the PMP-amino group, presumably C-C 
bond cleavage occurs, leading to formation of 2-hydroxypropionaldehyde and imine 21 (Scheme 
5). The latter compound is subsequently hydrolysed to p-hydroxyaniline and benzaldehyde. In 
the presence of a second equivalent of the oxidising agent, p-hydroxyaniline might be further 
oxidised, and upon hydrolysis, ultimately lead to the formation of ammonia and benzoquinone  
 
Scheme 5 Mechanism of benzaldehyde formation through oxidative cleavage. 
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We envisioned that this undesired cleavage could be circumvented through protection of the β-
OH-group. We realised that selective protection of the desired secondary OH-groups would be 
cumbersome.  
 
 
Scheme 6 Bis-OH protection followed by PMP removal. 
 
Protection of diol 19 with TBSCl resulted in formation of the fully protected diol 22 in 89% yield. 
Subsequent subjection to TCCA conditions enabled us to isolate the free amine in 77% yield, 
which proved the importance of protection of β-hydroxyl groups during N-PMP deprotection. 
 
2.6 Deprotection of other N-aryl protected amines 
Although less often employed as an amine protecting group, we also studied the removal of the 
o-methoxy-, p-hydroxy-, o-hydroxy- and p-methoxyphenyl groups. To this end, a series of N-aryl 
protected amines was synthesised via a reductive amination procedure starting from 4-
phenylbutan-2-one. 
 
N-Aryl-protected amines 24–27 were exposed to oxidative deprotection conditions (H5IO6 or 
TCCA). We found that p-hydroxy- and p-methoxy-substituted aryl groups could be removed 
without extensive side-product formation. However, with an electron-donating substituent in 
the o-position, reactions proceeded less efficient. To demonstrate the importance of an electron-
donating substituent on the aromatic ring, we also included an unsubstituted N-phenyl-
protected amine and found that the desired deprotected amine could only be obtained in trace 
amounts. 
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Table 3 Synthesis and deprotection of various N-aryl-protected amines. 
 
 
2.7 Conclusions 
In conclusion, the extensive use of the PMP-group in asymmetric organocatalysis requires facile 
and scalable deprotection procedures in order to render these processes economically viable. 
We have developed novel oxidative cleavage conditions involving a series of electrophilic halide 
reagents, which are effective if the deprotection is carried out at low pH. Periodic acid and 
trichloroisocyanuric acid were identified as particularly effective for N-deprotection, requiring 
only 1 and 0.5 equiv, respectively, to give a high yield of the desired amine. In case of 1,2-amino 
alcohols, protection of the hydroxyl substituent is required in order to avoid undesired oxidative 
C-C-bond cleavage. In addition, we found that our method is also applicable for other N-aryl 
(including o-OMe-, p-OH- and o-OH-phenyl) protected amines. 
 
2.8 Experimental section 
General remarks 
All chemicals were obtained from commercial sources and used without further purification unless stated 
otherwise. All reactions were carried out under ambient atmosphere unless stated otherwise. Rf values 
were obtained using thin layer chromatography (TLC), which was carried out on silica gel-coated plates 
(Merck 60 F254). Column chromatography was carried out using silica gel. Melting points were analysed 
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with Büchi melting point B-545. IR spectra were recorded on an ATI Mattson Genesis Series FTIR 
spectrometer, or a Bruker Tensor 27 FTIR spectrometer. NMR spectra were recorded on a Bruker 
DMX300, Varian Inova 400 or Bruker DPX200 spectrometer. 1H NMR chemical shifts are reported in parts 
per million (ppm) relative to a residual proton peak of the NMR solvent (δ = 7.26 ppm for CHCl3, δ = 3.31 
ppm for CD3OD, δ = 2.50 ppm for DMSO-d6. δ = 4.79 ppm for D2O. 13C NMR chemical shifts are reported in 
ppm relative to CDCl3 (77.0 ppm), CD3OD (49.0 ppm) or DMSO-d6 (39.5 ppm). Optical rotation were 
determined with a Perkin Elmer 241 polarimeter. High resolution mass spectra were recorded on a JEOL 
AccuTOF-CS or JEOL AccuTOF-GCv spectrometer. HPLC analysis was carried out on various Shimadzu 
HPLC-configurations using the stated columns and eluents. Detection was carried out using UV light.  
 
(2S,3S)-3-((4-Methoxyphenyl)amino)-2-methyl-3-phenylpropan-1-ol (4) 
Benzaldehyde (4.8 mL, 5.0 g, 47.1 mmol) was dissolved in NMP (50 mL). p-Anisidine 
(6.38 g, 51.8 mmol) and L-proline (0.54 g, 4.71 mmol) were added. The resulting 
mixture was stirred for 1 h and cooled to –20 °C, followed by addition of 
propionaldehyde (10.2 mL, 8.19 mL, 141 mmol). The mixture was stirred for 22 h 
and quenched by addition of 50 mL potassium phosphate buffer (pH 7, 50 mM). The resulting mixture was 
extracted with EtOAc (3 × 100 mL). The combined organic layers were dried (Na2SO4) and concentrated. 
The residue was dissolved in MeOH (250 mL) and cooled to 0 °C. Solid NaBH4 was slowly added to the 
reaction mixture while monitoring the temperature of the reaction mixture (T<10 °C). The reaction 
mixture was stirred for an additional 30 min and quenched with aqueous NaHCO3 (100 mL). EtOAc (350 
mL) and water (400 mL) were added and after separation, the aqueous layer was extracted with EtOAc 
(200 mL). The combined organic layers were dried (Na2SO4) and concentrated. The residue was taken up 
in diisopropyl ether (100 mL) and water (100 mL). After separation, the organic layer was washed with 
water (100 mL), saturated aqueous NaHCO3 (100 mL), dried (Na2SO4) and concentrated. The product was 
obtained as a white solid after crystallisation from diisopropyl ether (2.63 g, 9.69 mmol, 21%). The 
mother liquor was concentrated and the residue was purified by column chromatography 
(EtOAc/heptane 1/6 → 1/1). The product was obtained as a white solid (5.58 g, 20.6 mmol, 44%). 
 
Characterisation of product obtained from crystallisation. 
1H NMR (CDCl3, 300 MHz) δ (ppm) 7.38–7.18 (m, 5H), 6.71–6.64 (m, 2H), 6.55–6.48 (m, 2H), 4.51 (d, J = 4.3 
Hz, 1H), 3.68 (s, 3H), 3.65–3.62 (m, 2H), 2.25–2.09 (m, 1H), 0.93 (d, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 75 
MHz) δ (ppm) 152.2, 141.7, 141.3, 128.4, 127.0, 126.9, 115.1, 114.7, 66.2, 61.3, 55.7, 41.5, 12.1; HPLC: ee 
95% (Chiralpak AD-H (250 × 4.6 mm), flow 1.0 mL/min, heptane/2-propanol 80/20, retention times: 
minor enantiomer 7.8 min, major enantiomer 8.8 min); d.r. (1H NMR) > 19:1.1H NMR (CD3OD, 300 MHz) δ 
(ppm) 7.40–7.10 (m, 5H), 6.66–6.57 (m, 2H), 6.56–6.44 (m, 2H), 4.43 (d, J = 5.2 Hz, 1H), 3.62 (s, 3H), 3.55 
(dd, J = 10.7, 6.6 Hz, 1H), 3.38 (dd, J = 10.7, 5.8 Hz, 1H), 2.11–1.97 (m, 1H), 0.95 (d, J = 7.0 Hz, 3H). 1H NMR 
spectral data are in accordance with previously reported data.12 
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Characterisation of the product obtained from column chromatography. 
1H NMR (CDCl3, 300 MHz) δ (ppm) 7.36–7.17 (m, 5H), 6.73–6.65 (m, 2H), 6.56–6.47 (m, 2H), 4.51 (d, J = 4.3 
Hz, 1H, 3.68 (s, 3H), 3.65–3.62 (m, 2H), 2.26–2.09 (m, 1H), 0.93 (d, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 75 
MHz) δ (ppm) 152.1, 141.8, 141.3, 128.3, 127.0, 126.9, 115.1, 114.7, 66.2, 61.2, 55.7, 41.5, 12.0; ee > 99% 
(HPLC, Chiralpak AD-H (250 × 4.6 mm), flow 1.0 mL/min, heptane/2-propanol 80/20, retention times: 
minor enantiomer 7.8 min, major enantiomer 8.8 min), d.r. (1H NMR) > 15:1. 
 
(E)-4-Methoxy-N-(1-phenylethylidene)aniline (7a) 
Acetophenone (7.1 mL, 7.32 g, 60.9 mmol) was dissolved in toluene (100 mL). After 
addition of p-anisidine (5.00 g, 40.6 mmol) and p-toluenesulfonic acid monohydrate 
(17 mg, 0.089 mmol), the mixture was heated to reflux in a Dean–Stark apparatus 
during 1.5 h. The mixture was concentrated and the residue was crystallised from 
heptane. (yellow solid; 4.84 g, 26.9 mmol, 66%). 1H NMR (CDCl3, 300 MHz) δ (ppm) 
8.03–7.93 (m, 2H), 7.51–7.37 (m, 3H), 6.98–6.89 (m, 2H), 6.80–6.72 (m, 2H), 3.82 (s, 3H), 2.26 (s, 3H); 13C 
NMR (CDCl3, 75 MHz) δ (ppm) 165.7, 155.9, 144.8, 139.7, 130.3, 128.3, 127.1, 120.7, 114.2, 55.4, 17.3. 
NMR data are in accordance with previously reported data.13  
 
4-Methoxy-N-(1-phenylethyl)aniline (7) 
Under an atmosphere of argon, (E)-4-Methoxy-N-(1-phenylethylidene)aniline (7a) 
(vide supra) (2.00 g, 11.1 mmol) was dissolved in dry THF (50 mL), followed by 
addition of acetic acid (3.2 mL, 3.33 g, 55.5 mmol) and NaBH4 (1.26 g, 33.3 mmol). 
The resulting mixture was heated to reflux, stirred 30 min and cooled to rt. 
Saturated aqueous NaHCO3 was added (50 mL). The resulting mixture was 
extracted with Et2O (50 mL). The organic phase was dried (Na2SO4) and concentrated. The residue was 
purified by column chromatography (EtOAc/heptane 1/6), to afford 1.80 g (7.92 mmol, 71%) of a 
colorless oil, which crystallised upon standing. 
 
1H NMR (CDCl3, 300 MHz) δ (ppm) 7.39–7.27 (m, 4H), 7.26–7.18 (m, 1H), 6.74–6.65 (m, 2H), 6.51–6.43 (m, 
2H), 4.42 (q, J = 6.7 Hz, 1H), 3.70 (s, 3H), 1.50 (d, J = 6.7 Hz, 3H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 151.9, 
145.4, 141.5, 128.6, 126.8, 125.9, 114.7, 114.6, 55.7, 54.3, 25.1. 
NMR data in accordance with previously reported data.14 
 
4-Methoxy-N-(4-phenylbutan-2-yl)aniline (8) 
Under an argon atmosphere, p-anisidine (1.83 g, 0.0149 mol) was dissolved in 
DCM (30 mL). Benzylacetone (1.0 mL, 1.0 g, 6.7 mmol), acetic acid (0.85 mL, 
0.895 g, 14.9 mmol) and Na(OAc)3BH (4.01 g, 0.0189 mol) were added. The 
mixture was stirred for 2 h and quenched with aqueous saturated NaHCO3. 
After dilution with DCM (50 mL), the layers were separated. The organic layer 
was dried (Na2SO4) and concentrated. The residue was purified through column chromatography 
(EtOAc/heptane 1/9). Yield: 1.66 g (6.50 mmol, 97%) of a yellow oil. 1H NMR (CDCl3, 300 MHz) δ (ppm) 
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7.33–7.15 (m, 5H), 6.80–6.73 (m, 2H), 6.56–6.49 (m, 2H), 3.75 (s, 3H), 3.41 (sextet, J = 6.3 Hz, 1H), 2.73 (t, J 
= 7.9 Hz, 1H), 1.94–1.66 (m, 2H), 1.20 (d, J = 6.3 Hz, 3H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 151.9, 142.1, 
141.7, 128.4, 128.4, 125.8, 114.9, 114.8, 55.8, 49.0, 38.8, 32.5, 20.8. 
Spectral data are in accordance with previously reported data.15 
 
(2S,3S)-3-Amino-2-methyl-3-phenylpropan-1-ol hydrochloride (5.HCl) (entry 7) 
(2S,3S)-3-((4-Methoxyphenyl)amino)-2-methyl-3-phenylpropan-1-ol (4) (271 mg, 1.0 
mmol) was dissolved in MeCN/H2O (1:1, 20 mL), aqueous H2SO4 (1 mL, 1 M) was added 
followed by trichloroisocyanuric acid (116 mg, 1.0 mmol) and the resulting mixture 
was stirred for 16 h and subsequently washed with DCM (3 × 50 mL). Aqueous KOH was added (0.6 mL, 5 
M) and the aqueous solution was extracted with EtOAc (50 mL). All layers were combined and separated. 
Aqueous KOH was added (0.3 mL, 5 M), and the aqueous solution was extracted with EtOAc (50 mL). 
Aqueous KOH was added (0.3 mL, 5 M), and the aqueous solution was extracted with EtOAc (50 mL). The 
combined organic layers were dried (Na2SO4). 1 mL HCl in EtOAc (~2.3 M) was added and the mixture 
was concentrated. The residue was taken up in EtOAc and concentrated. The residue was taken up in DCM 
(50 mL) and concentrated (2 ×). The product was obtained as an off-white/red solid (198 mg, 0.98 mmol, 
98%) 1H NMR (CD3OD, 300 MHz) δ (ppm) 7.54–7.35 (m, 5H), 4.30 (d, J = 6.6 Hz, 1H), 3.44–3.32 (m, 2H), 
2.38–2.21 (m, 1H), 1.03 (d, J = 6.9 Hz, 1H); 13C NMR (CD3OD, 75 MHz) δ (ppm) 136.6, 130.1 (2C), 128.7, 
64.5, 60.0, 40.0, 13.7. 
Spectral data are in accordance with data obtained from 5.HCl (entry 8) (vide infra). 
 
(2S,3S)-3-Amino-2-methyl-3-phenylpropan-1-ol hydrochloride (5.HCl) (entry 8) 
(2S,3S)-3-((4-Methoxyphenyl)amino)-2-methyl-3-phenylpropan-1-ol (4) (271 mg, 1.0 
mmol) was dissolved in MeCN/H2O (1:1, 20 mL), aqueous H2SO4 (1M, 1 mL) was added 
followed by H5IO6 (228 mg, 1.0 mmol) and the resulting mixture was stirred for 19 h 
and subsequently washed with DCM (3 × 50 mL). Aqueous KOH was added (0.6 mL, 5 M) and the aqueous 
solution was extracted with EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the aqueous 
solution was extracted with EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the aqueous 
solution was extracted with EtOAc (50 mL). The combined organic layers were dried (Na2SO4, 1 mL HCl in 
EtOAc (~2.3 M) was added and the mixture was concentrated. The product was obtained as an off-white 
solidifying oil (181 mg, 0.90 mmol, 90%) 1H NMR (CD3OD, 300 MHz) δ (ppm) 7.56–7.35 (m, 5H), 4.32 (d, J 
= 6.5 Hz, 1H), 3.43–3.32 (m, 2H), 2.41–2.21 (m, 1H), 1.04 (d, J = 6.8 Hz, 3H); 13C NMR (CD3OD, 75 MHz) δ 
(ppm) 136.7, 130.0 (2C), 128.7, 64.5, 59.9, 40.0, 13.8; IR (cm-1) 3332, 3113, 2975, 2872, 1488, 1025, 705, 
558; HRMS [ESI+ (m/z)]: calcd for C10H16NO (M+H+) 166.12319, found 166.12458. 
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(2S,3S)-3-((4-Methoxyphenyl)amino)-2-methyl-3-(4-nitrophenyl)propan-1-ol (9) 
A mixture of p-nitrobenzaldehyde (7.12 g, 47.1 mmol), NMP (50 mL), p-anisidine 
(6.38 g, 51.8 mmol) and L-proline (0.54 g, 4.71 mmol) was stirred for 1.5 h and 
cooled to –20 °C. Propionaldehyde (10.2 mL, 8.19 g, 141 mmol) wad added slowly. 
The resulting mixture was stirred for 2 days and cooled to 0 °C. NaBH4 was added 
slowly. Subsequently, the reaction mixture was poured out in a mixture of a 
saturated aqueous NH4Cl and water (200 mL/200 mL). The mixture was extracted with diisopropyl ether 
(200 mL). The organic layer was washed with water (3 × 200 mL), aqueous saturated NaHCO3 (200 mL), 
dried (Na2SO4) and concentrated. The residue was purified by column chromatography (EtOAc/heptane 
1:6 → 1:1). After concentration, the orange solid (8.45 g) was dissolved in boiling diisopropyl ether. Some 
insoluble solids were filtered off and the hot solution was left standing for crystallisation. The product was 
obtained as orange crystals (5.31 g, 16.8 mmol, 36%) 1H NMR (CDCl3, 300 MHz) δ (ppm) 8.22–8.13 (m, 2H) 
(both diastereomers), 7.56–7.46 (m, 2H) (both diastereomers), 6.73–6.63 (m, 2H) (both diastereomers), 
6.47–6.40 (m, 2H) (both diastereomers), 4.65 (d, J = 4.0 Hz, 18/19H) (major diastereomer), 4.38 (d, J = 7.1 
Hz, 1/19H) (minor diastereomer), 3.68 (s, 3H) (both diastereomers), 3.76–3.58 (m, 2H) (both 
diastereomers), 2.28–2.11 (m, 1H) (both diastereomers), 0.91 (d, J = 7.1 Hz, 18/19 × 3H) (major 
diastereomer), 0.89 (d, J = 6.90 Hz, 1/19 × 3H) (minor diastereomer); 13C NMR (CDCl3, 75 MHz) δ (ppm) 
152.3, 150.4, 147.0, 140.7, 128.0, 123.6, 114.8, 114.7, 65.6, 60.5, 55.7, 41.4, 11.6; HPLC: d.r. 19:1 
(Chiralpak AD-H (250 × 4.6 mm), flow 1.0 mL/min, heptane/2-propanol 80/20, retention times: minor 
diastereomer 15.4 min, major diastereomer 17.2 min) ee > 99% (HPLC, Chiralpak AD-H (250 × 4.6 mm), 
flow 1.0 mL/min, heptane/2-propanol 80/20, retention times: minor enantiomer 10.5 min, major 
diastereomer 17.2 min); HRMS [ESI+ (m/z)]: calcd for C17H21N2O4 (M+H+) 317.15013, found 317.15000. 
NMR spectral data are in accordance with previously reported data.10 
 
(S)-4-((4-Methoxyphenyl)amino)-4-phenylbutan-2-one (10a) 
To a solution of p-anisidine in DMSO (20 mL) were added benzaldehyde (1.6 mL, 
1.72 g, 16.2 mmol) and L-proline (373 mg, 3.24 mmol). After 2 h of stirring, 
acetone (80 mL) was added. The resulting mixture was stirred for 18 h, quenched 
with aqueous saturated NaHCO3 (100 mL) and extracted with a 1:1 mixture of 
EtOAc and heptane (2 × 100 mL). The combined organic layers were dried (Na2SO4) and concentrated. The 
residue was purified by column chromatography (EtOAc/heptane 1:9 → 1:4). The product was obtained as 
a yellow oil, which crystallised partially upon storage in freezer (1.83 g, 6.79 mmol, 42%). 1H NMR (CDCl3, 
300 MHz) δ (ppm) 7.44–7.19 (m, 5H), 6.73–6.66 (m, 2H), 6.57–6.47 (m, 2H), 4.77 (t, J = 6.5 Hz, 1H), 3.69 (s, 
3H), 2.90 (d, J = 6.5 Hz, 2H), 2.10 (s, 3H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 207.2, 152.4, 142.7, 140.9, 
128.7, 127.3, 126.3, 115.3, 114.7, 55.6, 55.3, 51.3, 30.7; HPLC: ee: 95% (Chiralpak AD-H (250 × 4.6 mm), 
flow 1.0 mL/min, heptane/2-propanol 80/20, retention times: minor enantiomer 10.0 min, major 
enantiomer 12.7 min. 
NMR data are in accordance with previously reported data.16   
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(4S)-4-((4-Methoxyphenyl)amino)-4-phenylbutan-2-ol (10) 
Under an atmosphere of argon, (S)-4-((4-methoxyphenyl)amino)-4-phenylbutan-
2-one (10a) (425 mg, 1.58 mmol) (vide supra) was dissolved in MeOH (10 mL) 
and the resulting mixture was cooled to 0 °C. Solid NaBH4 (66 mg, 1.74 mmol) was 
added. After 20 min of stirring, saturated aqueous NaHCO3 (20 mL) was added. 
The aqueous mixture was extracted with DCM (2 × 50 mL). The combined organic layers were dried 
(Na2SO4) and concentrated. The residue was purified through column chromatography. The product was 
obtained as a yellow oil (352 mg, 1.30 mmol, 82%) 1H NMR (CDCl3, 300 MHz) δ (ppm) 7.36–7.18 (m, 5H) 
(both diastereomers), 6.72–6.65 (m, 2H) (both diastereomers), 6.60–6.49 (m, 2H) (both diastereomers), 
4.58 (dd, J = 6.8 Hz, J = 5.9 Hz, 2/3H) (major diastereomer), 4.47 (dd, J = 9.1, 5.0 Hz, 1/3H) (minor 
diastereomer), 4.08–3.97 (m, 1H) (both diastereomers), 3.69 (s, 3H) (both diastereomers), 2.00–1.82 (m, 
2H), 1.25 (d, J = 6.3 Hz, 2/3H) (major diastereomer), 1.22 (d, J = 6.2 Hz, 1/3H) (minor diastereomer) d.r. 
2:1 (1H NMR). 
1H NMR data are in accordance with previouly reported data.17  
 
(2S,3S)-3-((4-Methoxyphenyl)(methyl)amino)-2-methyl-3-(4-nitrophenyl)propan-1-ol (11) 
Under an atmosphere of argon, (2S,3S)-3-((4-methoxyphenyl)amino)-2-methyl-3-
(4-nitrophenyl)propan-1-ol (9) (3.0 g, 9.48 mmol) was dissolved in dry MeCN (50 
mL). K2CO3 (2.63 g, 19 mmol) and MeI (2.9 mL, 6.67 g, 47 mmol) were added. The 
mixture was heated to 40 °C, stirred for 5 days, allowed to come to rt, filtered and 
concentrated. The residue was purified by column chromatography 
(EtOAc/heptane 3/7). The product was obtained as a red oil (2.63 g, 7.96 mmol, 84%). 1H NMR (CDCl3, 300 
MHz) δ (ppm) 8.14–8.07 (m, 2H), 7.30–7.23 (m, 2H), 6.79 (s, 4H), 4.63 (d, J = 9.9 Hz, 1H), 3.75 (s, 3H), 3.58 
(dd, J = 10.8, 4.1 Hz, 1H), 3.37 (dd, J = 10.7, 5.2 Hz, 1H), 2.58 (s, 3H), 2.62–2.47 (m, 1H), 1.20 (d, J = 6.7 Hz, 
1H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 153.4, 147.0, 145.1, 144.7, 128.8, 123.3, 118.7, 114.5, 67.7, 65.1, 
55.6, 35.7, 34.1, 14.8; IR (cm-1) 3393, 2932, 2363, 1509, 1345; HRMS [ESI+ (m/z)]: calcd for C18H22N2O4Na 
(M+Na+) 353.14773, found 353.14829; Rf 0.44 (EtOAc/heptane 1:1). 
 
Benzylamine hydrochloride (12) (entry 1) 
N-Benzyl-4-methoxyaniline (213 mg, 1.0 mmol) was dissolved in MeCN/H2O (1:1, 20 mL), 
aqueous H2SO4 (1 mL, 1M) was added followed by trichloroisocyanuric acid (116 mg, 0.5 
mmol) and the resulting mixture was stirred overnight and subsequently washed with DCM 
(3 × 50 mL). Aqueous KOH was added (0.6 mL, 5 M) and the aqueous solution was extracted with EtOAc 
(50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the aqueous solution was extracted with EtOAc (50 
mL). Aqueous KOH was added (0.3 mL, 5 M ), and the aqueous solution was extracted with EtOAc (50 mL). 
The combined organic layers were dried (Na2SO4). 1 mL HCl in EtOAc (~2.3 M) was added and the mixture 
was concentrated. The product was obtained as an off-white solid (103 mg, 0.72 mmol, 72%) 1H NMR 
(CD3OD, 300 MHz) δ (ppm) 7.56–7.34 (m, 5H), 4.12 (s, 2H); 13C NMR (CD3OD, 75 MHz) δ (ppm) 134.4, 
130.2, 130.0, 44.3. 
1H NMR data are in accordance with previously reported data.18 
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Benzylamine hydrochloride (12) (entry 2) 
N-Benzyl-4-methoxyaniline (213 mg, 1.0 mmol) was dissolved in MeCN/H2O (1:1, 20 mL), 
aqueous H2SO4 (1 mL, 1M) was added followed by H5IO6 (228 mg, 0.5 mmol) and the 
resulting mixture was stirred overnight and subsequently washed with DCM (3 × 50 mL). 
Aqueous KOH was added (0.6 mL, 5 M) and the aqueous solution was extracted with EtOAc (50 mL). 
Aqueous KOH was added (0.3 mL, 5 M), and the aqueous solution was extracted with EtOAc (50 mL). 
Aqueous KOH was added (0.3 mL, 5 M), and the aqueous solution was extracted with EtOAc (50 mL). The 
combined organic layers were dried (Na2SO4). 1 mL HCl in EtOAc (~2.3 M) was added and the mixture 
was concentrated. The product was obtained as an off-white solid (47 mg, 0.33 mmol, 33%) 1H NMR 
(CD3OD, 300 MHz) δ (ppm) 7.60–7.33 (m, 5H), 4.12 (s, 2H); 13C NMR (CD3OD, 75 MHz) δ (ppm) 134.4, 
130.2, 130.0, 44.4. 
Spectral data are in accordance with data obtained from 12 (entry 1). 
 
1-Phenylethanamine hydrochloride (13) (entry 3) 
4-Methoxy-N-(1-phenylethyl)aniline (7) (227 mg, 1.0 mmol) was dissolved in MeCN/H2O 
(1:1, 20 mL), aqueous H2SO4 (1M, 1 mL) was added followed by trichoroisocyanuric acid 
(116 mg, 0.50 mmol). The resulting mixture was stirred for 19 h and subsequently 
washed with DCM (3 × 50 mL). Aqueous KOH was added (0.6 mL, 5 M) and the aqueous solution was 
extracted with EtOAc (3 × 50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the aqueous solution was 
extracted with EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the aqueous solution was 
extracted with EtOAc (50 mL). The combined organic layers were dried (Na2SO4). 1 mL HCl in EtOAc (~2.3 
M) was added and the mixture was concentrated. The product was obtained as a white solid (148 mg, 0.94 
mmol, 94%) 1H NMR (CD3OD, 300 MHz) δ (ppm) 7.49–7.36 (m, 5H), 4.45 (q, J = 6.9 Hz, 1H), 1.63 (d, J = 6.9 
Hz, 3H); 13C NMR (CD3OD, 75 MHz) δ (ppm) 139.6, 130.3, 130.2, 127.6, 52.4, 20.7. 
1H NMR data are in accordance with previously reported data.19  
 
1-Phenylethanamine hydrochloride (13) (entry 4) 
4-Methoxy-N-(1-phenylethyl)aniline (7) (227 mg, 1.0 mmol) was dissolved in MeCN/H2O 
(1:1, 20 mL), aqueous H2SO4 (1 mL, 1M) was added followed by H5IO6 (228 mg, 1.0 
mmol). The mixture was stirred for 19 h and subsequently washed with DCM (3 × 50 mL). 
Aqueous KOH was added (0.6 mL, 5 M) and the aqueous solution was extracted with EtOAc (50 mL). 
Aqueous KOH was added (0.3 mL, 5 M), and the aqueous solution was extracted with EtOAc (50 mL). 
Aqueous KOH was added (0.3 mL, 5 M), and the aqueous solution was extracted with EtOAc (50 mL). The 
combined organic layers were dried (Na2SO4). 1 mL HCl in EtOAc (~2.3 M) was added and the mixture 
was concentrated. The product was obtained as an off-white solid (128 mg, 0.81 mmol, 81%). 1H NMR 
(CD3OD, 300 MHz) δ (ppm) 7.56–7.34 (m, 5H), 4.47 (q, J = 6.9 Hz, 1H), 1.65 (d, J = 6.9 Hz, 3H); 13C NMR 
(CD3OD, 75 MHz) δ (ppm) 139.6, 130.3, 130.1, 127.7, 52.4, 20.8. 
NMR data are in accordance with NMR data obtained from 13 (entry 3). 
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4-Phenylbutan-2-amine hydrochloride (14) (entry 5) 
4-Methoxy-N-(4-phenylbutan-2-yl)aniline (8) (255 mg, 1.0 mmol) was dissolved in 
MeCN/H2O (1:1, 20 mL), aqueous H2SO4 (1M, 1 mL) was added followed by 
trichloroisocyanuric acid (116 mg, 1.0 mmol) and the resulting mixture was stirred 
for 16 h and subsequently washed with DCM (3 × 50 mL). Aqueous KOH was added (0.6 mL, 5 M) and the 
aqueous solution was extracted with EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the 
aqueous solution was extracted with EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the 
aqueous solution was extracted with EtOAc (50 mL). The combined organic layers were dried (Na2SO4). 1 
mL HCl in EtOAc (~2.3 M) was added and the mixture was concentrated. The product was obtained as a 
white solid (169 mg, 0.91 mmol, 91%) 1H NMR (CD3OD, 300 MHz) δ (ppm) 7.33–7.15 (m, 5H), 3.33–3.19 
(m, 1H), 2.82–2.60 (m, 2H), 2.06–1.75 (m, 2H), 1.34 (d, J = 6.6 Hz, 3H); 13C NMR (CD3OD, 75 MHz) δ (ppm) 
141.8, 129.7, 129.3, 127.4, 48.6, 37.7, 32.5, 18.5; IR (cm-1) 2890, 1516, 765, 745, 700; HRMS [ESI+ (m/z)]: 
calcd for C10H16N (M+H+) 150.12827, found 150.12989. 
 
4-Phenylbutan-2-amine hydrochloride (14) (entry 6) 
4-Methoxy-N-(4-phenylbutan-2-yl)aniline (8) (255 mg, 1.0 mmol) was dissolved in 
MeCN/H2O (1:1, 20 mL), aqueous H2SO4 (1M, 1 mL) was added followed by H5IO6 
(228 mg, 1.0 mmol) and the resulting mixture was stirred for 20 h and subsequently 
washed with DCM (3 × 50 mL). Aqueous KOH was added (0.6 mL, 5 M) and the aqueous solution was 
extracted with EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the aqueous solution was 
extracted with EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the aqueous solution was 
extracted with EtOAc (50 mL). The combined organic layers were dried (Na2SO4). 1 mL HCl in EtOAc (~2.3 
M) was added and the mixture was concentrated. The product was obtained as a white solid (125 mg, 0.67 
mmol, 67%) 1H NMR (CD3OD, 300 MHz) δ (ppm) 7.33–7.13 (m, 5H), 3.33–3.20 (m, 1H), 2.82–2.61 (m, 2H), 
2.06–1.76 (m, 2H), 1.34 (d, J = 6.6 Hz, 3H); 13C NMR (CD3OD, 75 MHz) δ (ppm) 141.8, 129.6, 129.3, 127.3, 
48.6, 37.6, 32.5, 18.5. 
NMR data are in accordance with NMR data obtained from 14 (entry 5). 
 
(2S,3S)-3-Amino-2-methyl-3-(4-nitrophenyl)propan-1-ol hydrochloride (15) (entry 9) 
(2S,3S)-3-((4-Methoxyphenyl)amino)-2-methyl-3-(4-nitrophenyl)propan-1-ol (9) 
(316 mg, 1.0 mmol) was dissolved in MeCN/H2O (1:1, 20 mL), aqueous H2SO4 (1M, 1 
mL) was added followed by trichloroisocyanuric acid (116 mg, 0.5 mmol) and the 
resulting mixture was stirred for 18 h and subsequently washed with DCM (3 × 50 mL). Aqueous KOH was 
added (0.6 mL, 5 M) and the aqueous solution was extracted with EtOAc (50 mL). Aqueous KOH was 
added (0.3 mL, 5 M), and the aqueous solution was extracted with EtOAc (50 mL). Aqueous KOH was 
added (0.3 mL, 5 M), and the aqueous solution was extracted with EtOAc (50 mL). The combined organic 
layers were dried (Na2SO4). 1 mL HCl in EtOAc (~2.3 M) was added and the mixture was concentrated. 
The residue was taken up in EtOAc (50 mL) and concentrated. The residue was taken up in DCM (50 mL) 
and concentrated. The product was obtained as an off-white solid (249 mg, 1.0 mmol, 100 %) 1H NMR 
(CD3OD, 300 MHz) δ (ppm) 8.37–8.28 (m, 2H), 7.84–7.74 (m, 2H), 4.57 (d, J = 6.4 Hz, 1H), 3.47 (dd, J = 
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11.0, 4.8 Hz, 1H), 3.36 (dd, J = 11.0, 6.7 Hz, 1H), 2.52–2.33 (m, 1H), 1.07 (d, J = 7.0 Hz, 3H); 13C NMR 
(CD3OD, 75 MHz) δ (ppm) 149.4, 143.8, 130.3, 124.9, 64.3, 59.2, 39.8, 13.6. 
NMR spectral data are in accordance with data obtained from 15 (entry 10) (vide infra). 
 
(2S,3S)-3-Amino-2-methyl-3-(4-nitrophenyl)propan-1-ol hydrochloride (15) (entry 10) 
(2S,3S)-3-((4-Methoxyphenyl)amino)-2-methyl-3-(4-nitrophenyl)propan-1-ol (9) 
(316 mg, 1.0 mmol) was dissolved in MeCN/H2O (1:1, 20 mL), aqueous H2SO4 (1M, 1 
mL) was added followed by H5IO6 (228 mg, 1.0 mmol) and the resulting mixture was 
stirred for 18 h and subsequently washed with DCM (3 × 50 mL). Aqueous KOH was added (0.6 mL, 5 M) 
and the aqueous solution was extracted with EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and 
the aqueous solution was extracted with EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the 
aqueous solution was extracted with EtOAc (50 mL). The combined organic layers were dried (Na2SO4). 1 
mL HCl in EtOAc (~2.3 M) was added and the mixture was concentrated. The residue was taken up in 
EtOAc (50 mL) and concentrated. The product was obtained as a white solid (222 mg, 0.90 mmol, 90%) 1H 
NMR (CD3OD, 300 MHz) δ (ppm) 8.37–8.28 (m, 2H), 7.79–7.67 (m, 2H), 4.52 (d, J = 6.3 Hz, 1H), 3.45 (dd, J 
= 11.0, 4.7 Hz, 1H), 3.33 (dd, J = 10.3, 6.2 Hz, 1H), 2.45–2.28 (m, 1H), 1.04 (d, J = 7.0 Hz, 3H); 13C NMR 
(CD3OD, 75 MHz) δ (ppm) 149.6, 143.7, 130.2, 124.9, 64.4, 59.3, 39.8, 13.6; IR (cm-1) 3353, 2966, 2882, 
1529, 1346; HRMS [ESI+ (m/z)]: calcd for C10H15N2O3 (M–Cl-) 211.10827, found 211.10916. 
 
(4S)-4-Amino-4-phenylbutan-2-ol hydrochloride (16) (entry 11) 
(4S)-4-((4-Methoxyphenyl)amino)-4-phenylbutan-2-ol (10) (44 mg, 0.162 mmol) was 
dissolved in MeCN/H2O (1:1, 10 mL), aqueous H2SO4 (0.16 mL, 1M) was added 
followed by trichloroisocyanuric acid (19 mg, 0.081 mmol). The resulting mixture was 
stirred for 18 h and subsequently washed with DCM (3 × 25 mL). Aqueous KOH was added (0.3 mL, 5 M) 
and the aqueous solution was extracted with EtOAc (25 mL). Aqueous KOH was added (0.15 mL, 5 M), and 
the aqueous solution was extracted with EtOAc (25 mL). Aqueous KOH was added (0.15 mL, 5 M), and the 
aqueous solution was extracted with EtOAc (25 mL). The combined organic layers were dried (Na2SO4) 
and slightly concentrated. 0.16 mL HCl in EtOAc (~2.3 M) was added and the mixture was concentrated. 
The product was obtained as a white solid (24 mg, 0.119 mmol, 73%).1H NMR (CD3OD, 300 MHz) δ (ppm) 
7.53–7.34 (m, 5H, both diastereomers), 4.55–4.41 (m, 1H, both diastereomers), 3.88–3.74 (m, 2/3H, major 
diastereomer), 3.73–3.58 (m, 1/3H minor diastereomer), 2.20–1.91 (m, 2H, both diastereomers), 1.21 (d, J 
= 6.2 Hz, 4/3H, major diasteromer), 1.18 (d, J = 6.2 Hz, 2/3H, minor diastereomer); 13C NMR (CD3OD, 75 
MHz) δ (ppm) 138.5 (major diasteromer), 138.4 (minor diastereomer), 130.3 (major diastereomer), 130.1 
(minor diastereomer), 128.4 (minor diasteromer), 128.0 (major diastereomer), 66.2 (minor 
diastereomer), 64.8 (major diastereomer), 55.7 (minor diastereomer), 54.2 (major diastereomer), 43.8 
(minor diastereomer), 43.7 (major diastereomer), 24.5 (minor diastereomer), 23.4 (major diastereomer). 
NMR Spectral data are in accordance with data obtained from 16 (entry 12) (vide infra). 
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(4S)-4-Amino-4-phenylbutan-2-ol hydrochloride (16) (entry 12) 
(4S)-4-((4-Methoxyphenyl)amino)-4-phenylbutan-2-ol (10) (44 mg, 0.162 mmol) was 
dissolved in MeCN/H2O (1:1, 10 mL), aqueous H2SO4 (0.16 mL, 1M) was added 
followed by H5IO6 (37 mg, 0.162 mmol). The resulting mixture was stirred for 16 h and 
subsequently washed with DCM (3 × 25 mL). Aqueous KOH was added (0.3 mL, 5 M) and the aqueous 
solution was extracted with EtOAc (25 mL). Aqueous KOH was added (0.15 mL, 5 M), and the aqueous 
solution was extracted with EtOAc (25 mL). Aqueous KOH was added (0.15 mL, 5 M), and the aqueous 
solution was extracted with EtOAc (25 mL). The combined organic layers were dried (Na2SO4), 0.16 mL 
HCl in EtOAc (~2.3 M) was added and the mixture was concentrated. The product was obtained as a white 
solid (26 mg, 0.129 mmol, 80 %). 1H NMR (CD3OD, 300 MHz,) δ (ppm) 7.53–7.36 (m, 5H, both 
diastereomers), 4.53–4.42 (m, 1H, both diastereomers), 3.87–3.73 (m, 2/3H, major diastereomer), 3.73–
3.59 (m, 1/3H minor diastereomer), 2.17–1.93 (m, 2H, both diastereomers), 1.21 (d, J = 6.2 Hz, 4/3H, 
major diasteromer), 1.18 (d, J = 6.2 Hz, 2/3H, minor diastereomer); 13C NMR (CD3OD, 75 MHz): δ (ppm) 
138.5 (major diasteromer), 138.4 (minor diastereomer), 130.3 (major diastereomer 2C), 130.1 (minor 
diastereomer 2C), 128.4 (minor diastereomer), 128.0 (major diastereomer), 66.2 (minor diastereomer), 
64.8 (major diastereomer), 55.7 (minor diastereomer), 54.2 (major diastereomer), 43.8 (minor 
diastereomer), 43.7 (major diastereomer), 24.5 (minor diastereomer), 23.4 (major diastereomer); IR (cm-
1) 3278, 2963, 2441, 2218, 699; HRMS [ESI+ (m/z)]: calcd for C10H16NO (M–Cl-) 166.12319, found 
166.12382. 
 
(2S,3S)-2-Methyl-3-(methylamino)-3-(4-nitrophenyl)propan-1-ol hydrochloride (17) 
(2S,3S)-3-((4-Methoxyphenyl)(methyl)amino)-2-methyl-3-(4-
nitrophenyl)propan-1-ol (11) (0.33 g, 1.0 mmol) was dissolved in MeCN/H2O (1:1, 
20 mL), aqueous H2SO4 (1 mL, 1M) was added followed by trichloroisocyanuric 
acid (116 mg, 0.5 mmol) and the resulting mixture was stirred for 21 h and 
subsequently washed with DCM (3 × 50 mL). Aqueous KOH was added (0.6 mL, 5 M) and the aqueous 
solution was extracted with EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the aqueous 
solution was extracted with EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the aqueous 
solution was extracted with EtOAc (50 mL). The combined organic layers were dried (Na2SO4) and 
concentrated. The residue was dissolved in 20 mL EtOAc, 1 mL HCl in EtOAc (~2.3 M) was added and the 
mixture was concentrated. The product was obtained as an off-white solid (247 mg, 0.95 mmol, 95%) 1H 
NMR (CD3OD, 300 MHz,) δ (ppm) 8.39–8.32 (m, 2H), 7.81–7.73 (m, 2H), 4.48 (d, J = 4.5 Hz, 1H), 3.54 (dd, J 
= 10.8, 4.7 Hz, 1H), 3.28 (dd, J = 10.8, 9.1 Hz, 2H), 2.58 (s, 3H), 2.69–2.49 (m, 1H), 0.90 (d, J = 7.0 Hz, 3H); 
13C NMR (CD3OD, 75 MHz): δ (ppm) 149.9, 140.0, 131.4, 125.0, 68.8, 64.2, 38.2, 33.0, 13.8; IR (cm-1) 3360, 
2967, 1522, 1349; HRMS [ESI+ (m/z)]: calcd for C11H17N2O3 (M+H+) 225.12392, found 225.12475. 
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(3S,4R)-3-Hydroxy-4-((4-methoxyphenyl)amino)-4-phenylbutan-2-one (18) 
Benzaldehyde (8.2 mL, 8.6 g, 81 mmol) was dissolved in DMSO (480 mL). p-
Anisidine (10.0 g, 81 mmol) and L-proline (1.84 g, 0.016 mmol) were added. The 
resulting mixture was stirred for 2 h followed by addition of hydroxyacetone (18 
mL, 90% pure). The reaction mixture was stirred for 17 h, poured out in water 
(500 mL) and extracted with a 1:1 mixture of EtOAc/heptane (2 × 500 mL, 1 × 100 mL). The combined 
organic layers were washed with water (3 × 500 mL) and saturated aqueous NaHCO3 (200 mL). The 
organic layer was dried (Na2SO4) and concentrated. The residue was purified by column chromatography 
(EtOAc/heptane 1/3 → 1/1). The fractions containing the product were concentrated until the product 
precipitated. The suspension was left standing for 1 h and filtered off. The residue was washed with 
heptane (100 mL), dried, dissolved in EtOAc (50 mL) and concentrated. The product was obtained as an 
off-white solid (8.72 g, 30.6 mmol, 38%). 1H NMR (CDCl3, 300 MHz) δ (ppm) 7.40–7.22 (m, 5H), 6.72–6.65 
(m, 2H), 6.54–6.47 (m, 2H), 4.89 (d, J = 2.6 Hz, 1H), 4.41 (d, J = 1.8 Hz, 1H), 4.37 (bs, 1H), 3.78 (bs, 1H), 3.68 
(s, 3H), 2.31 (s, 3H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 207.4, 152.4, 140.1, 139.3, 128.6, 127.5, 127.0, 
115.1, 114.8, 80.7, 59.1, 55.6, 25.2. d.r. (NMR) >19:1 (one stereoisomer visible) HPLC ee > 99% (Chiralpak 
AD-H (250 × 4.6 mm), flow 1.0 mL/min, heptane/2-propanol 80/20, retention times: minor diastereomer 
9.1 min, major diastereomer 13.6 min). 
NMR spectral data are in accordance with previously reported data11 
 
(1R,2S)-1-((4-Methoxyphenyl)amino)-1-phenylbutane-2,3-diol (19) 
Under an atmosphere of argon, (3S,4R)-3-hydroxy-4-((4-methoxyphenyl)amino)-
4-phenylbutan-2-one (18) was dissolved in DCM/MeOH (40 mL/40 mL). NaBH4 
(2.65 g, 70 mmol) was added. The mixture was stirred for 1 h and quenched with 
aqueous HCl (20 mL, 5 M). Subsequently, aqueous NaOH (50 mL) was added. The 
mixture was extracted with EtOAc (2 × 100 mL). The combined organic layers were dried (Na2SO4) and 
concentrated. The residue was taken up in DCM and concentrated. The product was obtained as a white 
solidifying oil (2.03 g, 7.1 mmol, quant.)). 1H NMR (CDCl3, 300 MHz) δ (ppm) 7.36–7.20 (m, 5H, both 
diastereomers), 6.76–6.49 (m, 4H (both diastereomers), 4.54 (d, J = 4.3 Hz, 1H, major diastereomer), 4.43 
(d, J = 3.9 Hz, 1/5H, minor diastereomer), 4.00–3.50 (m, 2H, both diastereomers), 3.68 (s, 3H, both 
diastereomers), 1.37–1.15 (m, 3H, both diastereomers); 13C NMR (CDCl3, 75 MHz) δ (ppm) 152.6, 140.7, 
128.8, 128.7, 127.5, 127.1, 115.9, 115.8, 114.7, 78.7, 77.2 68.5, 67.6, 61.5, 59.8, 55.6, 20.2, 18.8. IR (cm-1) 
3419, 2966, 2932, 1513, 1028, 810; HRMS [ESI+ (m/z)]: calcd for C17H21NO3Na (M+Na+) 310.14191, found 
310.14250; Rf 0.33 (EtOAc/heptane 1:1). 
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N-((1R,2S)-2,3-Bis((tert-butyldimethylsilyl)oxy)-1-phenylbutyl)-4-methoxyaniline (22) 
A flask was loaded with tert-butyldimethylsilyl chloride (2.62 g, 17.4 mmol) 
and placed under argon. DMF (20 mL), (1R,2S)-1-((4-methoxyphenyl)amino)-
1-phenylbutane-2,3-diol (19) (1.00 g, 3.48 mmol) and imidazole (2.37 g, 34.8 
mmol) were added and the mixture was heated to 80 °C for 16 h and 
subsequently allowed to cool to rt. Saturated aqueous NH4Cl (50 mL) was 
added and the resulting mixture was extracted with diethyl ether (100 mL). The organic layer was washed 
with water (100 mL), saturated aqueous NaHCO3, dried (Na2SO4) and concentrated. The residue was 
purified by column chromatography (EtOAc/heptane 1:2). The product was obtained as a colorless oil 
(1.60 g, 3.10 mmol, 89%). 1H NMR (CDCl3, 300 MHz) δ (ppm) 7.36–7.13 (m, 5H), 6.75–6.63 (m, 2H), 6.45–
6.34 (m, 2H), 4.74–4.50 (m, 2H), 3.97–3.70 (m, 2H), 3.69 (2 × s, 3H), 1.19 (d, J = 6.2 Hz, 3H), 0.96–-0.52 (2 
× TBS, 30H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 128.3, 128.2, 127.5, 126.8, 126.4, 114.9, 114.7, 114.2, 
113.5, 82.9, 80.5, 70.8, 69.4, 58.5, 55.8, 55.7, 54.7, 26.2, 26.0, 25.9, 25.7, 20.0, 18.3, 18.0, 17.8, -2.9, -3.7, -
4.2, -5.0, -5.5 (complex NMRs of mixture of diastereomers), IR (cm-1) 3430, 2953, 2929, 2896, 2856, 1512, 
834; HRMS [ESI+ (m/z)]: calcd for C29H50NO3Si2 (M+H+) 516.33292, found 516.33212; Rf (EtOAc/heptane 
1/9) 0.68. 
 
(1R,2S)-2,3-bis((tert-Butyldimethylsilyl)oxy)-1-phenylbutan-1-amine (23) 
To a suspension of N-((1R,2S)-2,3-bis((tert-butyldimethylsilyl)oxy)-1-phenylbutyl)-
4-methoxyaniline (22) (41 mg, 0.079 mmol) in a mixture of MeCN/H2O (6 mL, 1:1) 
was added aqueous H2SO4 and trichloroisocyanuric acid (9.3 mg, 0.040 mmol). The 
mixture was stirred for 20.5 h and H2O (2 mL) and saturated aqueous Na2CO3 (1 mL) 
were added. The mixture was stirred or 30 min and H2O was added (10 mL). The 
aqueous mixture was extracted with DCM (2 × 10 mL). The combined organics were dried (Na2SO4) and 
concentrated. The product was obtained as a slightly coloured film (25 mg, 0.061 mmol, 77%) 1H NMR 
(CDCl3, 300 MHz) δ (ppm) 7.51–7.16 (m, 5H), 3.99–3.58 (m, 2H), 1.35–0.69 (m, 21H), 0.18–-0.34 (m, 12H); 
IR (cm-1) 2955, 2929, 2896, 2857, 1255, 1099, 834, 777; HRMS [ESI+ (m/z)]: calcd for C22H44NO2Si2 (M+H+) 
410.29106, found 410.29124. 
 
4-((4-Phenylbutan-2-yl)amino)phenol (24) 
Under an atmosphere of argon, acetic acid (0.57 mL, 0.60 g, 10 mmol) was 
dissolved in DCM (30 mL). Benzylacetone (1.48 g, 1.5 mL, 10 mmol), 4-
aminophenol (1.09 g, 10 mmol) and Na(OAc)3BH (2.97 g, 14 mmol) were 
added. The resulting mixture was stirred for 18 h and quenched with saturated 
aqueous NaHCO3. After separation, the aqueous layer was extracted with DCM 
(30 mL). The combined organic layers were dried (Na2SO4) and concentrated. Diisopropyl ether (10 mL) 
was added to the residue upon which the product crystallised. After filtration, the crystals were washed 
with diisopropyl ether (20 mL). The product was obtained as a white solid (1.33 g, 5.51 mmol, 55%). 1H 
NMR (CDCl3, 300 MHz) δ (ppm) 7.35–7.14 (m, 5H), 6.75–6.61 (m, 2H), 6.55–6.35 (m, 2H), 4.40–3.00 (bs, 
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2H) 3.48–3.30 (m, 1H), 2.72 (t, J = 7.8 Hz, 2H), 1.93–1.65 (m, 2H), 1.20 (d, J = 6.3 Hz, 3H); 13C NMR (CDCl3, 
75 MHz) δ (ppm) 147.5, 142.0, 141.6, 128.4, 128.4, 125.8, 116.2, 115.1, 49.1, 38.8, 32.4, 20.8. 
NMR Spectral data are in accordance with previously reported data.20  
 
2-Methoxy-N-(4-phenylbutan-2-yl)aniline (25) 
Under an atmosphere of argon, acetic acid (1.26 mL, 1.32 g, 22 mmol) was dissolved 
in DCM (30 mL). Benzylacetone (1.5 mL, 1.48 g, 10 mmol), o-anisidine (2.5 mL, 2.71 
g, 22 mmol) and Na(OAc)3BH (5.93 g, 28 mmol) were added. The resulting mixture 
was stirred for 18 h. Aqueous HCl (1M, 100 mL) was added. After separation, the 
aqueous layer was extracted with DCM (50 mL). The combined organic layers were 
washed with aqueous NaOH (1M, 50 mL). The organic layer was dried (Na2SO4) and concentrated. The 
residue was purified by column chromatography (EtOAc/heptane 1/9). The product was obtained as a 
colorless oil (2.40 g, 9.40 mmol, 94%). 1H NMR (CDCl3, 300 MHz) δ (ppm) 7.31–7.15 (m, 5H), 6.88–6.80 (m, 
1H), 6.77 (dd, J = 7.9, 1.4 Hz, 1H), 6.63 (ddd, J = 7.9, 7.5, 1.6 Hz, 1H), 6.52 (dd, J = 8.0, 1.3 Hz, 1H), 4.15–4.00 
(m, 1H), 3.85 (s, 3H), 3.58–3.41 (m, 1H), 2.74 (t, J = 7.9 Hz, 2H), 2.02–1.73 (m, 2H), 1.24 (d, J = 6.3 Hz, 3H); 
13C NMR (CDCl3, 75 MHz) δ (ppm) 146.8, 142.1, 137.4, 128.4, 128.3, 125.8, 121.3, 115.8, 110.1, 109.5, 55.4, 
47.5, 38.8, 32.5, 20.9; IR (cm-1), 3419, 3024, 2960, 1511, 1220, 1029, 735; HRMS [ESI+ (m/z)]: calcd for 
C17H22NO (M+H+) 256.17014, found 256.16907; Rf (EtOAc/heptane 1/9) 0.55.  
 
2-((4-Phenylbutan-2-yl)amino)phenol (26) 
Under an atmosphere of argon, acetic acid (0.57 mL, 0.60 mL, 10 mmol) was 
dissolved in DCM (30 mL). Benzylacetone (1.5 mL, 1.48 g, 10 mmol), o-aminophenol 
(1.09 g, 10 mmol) and Na(OAc)3BH (2.97 g, 14 mmol) were added. The resulting 
mixture was stirred for 20 h. Aqueous HCl (1M, 100 mL) was added and the DCM 
was evaporated. After filtration, the residue was taken up in methanol (10 mL) and 
DCM (50 mL). The organic mixture was washed with saturated aqueous NaHCO3. The organic layer was 
dried (Na2SO4 ) and concentrated. The residue was taken up in diisopropyl ether (40 mL) and a solution of 
HCl in EtOAc (~2.3 M, 8 mL) was added. After filtration, the residue was washed with diisopropyl ether 
and taken up in methanol (10 mL). Saturated aqueous NaHCO3 (50 mL) was added and the resulting 
mixture was extracted with DCM (100 mL). The organic layer was dried (Na2SO4) and concentrated. The 
product was obtained as a dark oil (1.46 g, 6.05 mmol, 61%). 1H NMR (CDCl3, 300 MHz) δ (ppm) 7.35–7.15 
(m, 5H), 7.05–6.35 (m, 4H), 3.60–3.25 (m, 1H), 2.75 (t, J = 7.9 Hz, 2H), 2.03–1.70 (m, 2H), 1.23 (d, J = 6.2 
Hz, 3H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 142.0, 128.4, 128.4, 125.8, 32.4, 22.8 (also some broad signals 
present, no chemical shifts reported); IR (cm-1), 3025, 2924, 1509, 738, 698; HRMS [ESI+ (m/z)]: calcd for 
C16H20NO (M+H+) 242.15449, found 242.15464; Rf (EtOAc/heptane 1/3) 0.46. 
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N-(4-Phenylbutan-2-yl)aniline (27) 
Under an atmosphere of argon, acetic acid (1.26 mL, 1.32 g, 22 mmol) was dissolved 
in DCM (30 mL). Benzylacetone (1.5 mL, 1.48 g, 10 mmol), aniline (2.0 mL, 2.05 g, 22 
mmol) and Na(OAc)3BH (5.93 g, 28 mmol) were added. The resulting mixture was 
stirred for 20 h. Aqueous HCl (1M, 100 mL) was added. After separation, the 
aqueous layer was extracted with DCM (50 mL). The combined organic layers were washed with aqueous 
NaOH (1M, 50 mL). The organic layer was dried (Na2SO4) and concentrated. The residue was purified by 
column chromatography (EtOAc/heptane 1/9). The product was obtained as a slightly yellow oil (2.36 g, 
10 mmol, 100%) 1H NMR (CDCl3, 300 MHz) δ (ppm) 7.35–7.12 (m, 7H), 6.69 (tt, J = 7.4, 1.1 Hz, 1H), 6.59–
6.52 (m, 2H), 3.59–3.45 (m, 1H), 3.43 (bs, 1H), 2.75 (t, J = 7.9 Hz, 2H), 2.00–1.70 (m, 2H), 1.24 (d, J = 6.2 Hz, 
3H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 147.5, 142.0, 129.3, 128.4, 128.4, 125.8, 116.9, 113.1, 47.9, 38.8, 
32.5, 20.8. 
NMR spectral data are in accordance with previously reported data.20 
 
Table 3: 
4-Phenylbutan-2-amine hydrochloride (14) (entry 3) 
4-((4-Phenylbutan-2-yl)amino)phenol (24) (241 mg, 1.0 mmol) was dissolved in 
MeCN/H2O (1:1, 20 mL), aqueous H2SO4 (1 mL, 1M) was added, followed by 
trichloroisocyanuric acid (116 mg, 0.5 mmol) and the resulting mixture was stirred for 
24 h and subsequently washed with DCM (3 × 50 mL). Aqueous KOH was added (0.6 mL, 5 M) and the 
aqueous solution was extracted with EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the 
aqueous solution was extracted with EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the 
aqueous solution was extracted with EtOAc (50 mL). The combined organic layers were dried (Na2SO4). 1 
mL HCl in EtOAc (~2.3 M) was added and the mixture was concentrated. The product was obtained as a 
white solid (138 mg, 0.74 mmol, 74%). 1H NMR (CD3OD, 300 MHz) δ (ppm) 7.33–7.13 (m, 5H), 3.35–3.19 
(m, 1H), 2.81–2.63 (m, 2H), 2.13–1.71 (m, 2H), 1.35 (d, J = 6.6 Hz, 3H); 13C NMR (CD3OD, 75 MHz) δ (ppm) 
141.8, 129.6, 129.3, 127.3, 48.6, 37.6, 32.5, 18.6. 
NMR data are in accordance with NMR data obtained from 14 (Table 2, entry 5). 
 
4-Phenylbutan-2-amine hydrochloride (14) (entry 4) 
4-((4-Phenylbutan-2-yl)amino)phenol (24) (241 mg, 1.0 mmol) was dissolved in 
MeCN/H2O (1:1, 20 mL), aqueous H2SO4 (1 mL, 1M), was added, followed by H5IO6 (228 
mg, 1.0 mmol) and the resulting mixture was stirred for 25 h and subsequently washed 
with DCM (3 × 50 mL). Aqueous KOH was added (0.6 mL, 5 M) and the aqueous solution was extracted 
with EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the aqueous solution was extracted with 
EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the aqueous solution was extracted with 
EtOAc (50 mL). The combined organic layers were dried (Na2SO4), 1 mL HCl in EtOAc (~2.3 M) was added 
and the mixture was concentrated. The product was obtained as a white solid (125 mg, 0.67 mmol, 67%). 
1H NMR (CD3OD, 300 MHz) δ (ppm) 7.36–7.13 (m, 5H), 3.33–3.19 (m, 1H), 2.82–2.57 (m, 2H), 2.09–1.75 
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(m, 2H), 1.34 (d, J = 6.6 Hz, 3H); 13C NMR (CD3OD, 75 MHz) δ (ppm) 141.8, 129.6, 129.3, 127.3, 48.6, 37.6, 
32.5, 18.5. 
NMR data are in accordance with NMR data obtained from 14 (Table 2, entry 5). 
 
4-Phenylbutan-2-amine hydrochloride (14) (entry 5) 
2-Methoxy-N-(4-phenylbutan-2-yl)aniline (25) (255 mg, 1.0 mmol) was dissolved in 
MeCN/H2O (1:1, 20 mL), aqueous H2SO4 (1 mL, 1M) was added, followed by 
trichloroisocyanuric acid (116 mg, 1.0 mmol) and the resulting mixture was stirred for 
18 h and subsequently washed with DCM (3 × 50 mL). Aqueous KOH was added (0.6 mL, 5 M) and the 
aqueous solution was extracted with EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the 
aqueous solution was extracted with EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the 
aqueous solution was extracted with EtOAc (50 mL). The combined organic layers were dried (Na2SO4), 1 
mL HCl in EtOAc (~2.3 M) was added and the mixture was concentrated. The product was obtained as a 
white solid (84 mg, 0.45 mmol, 45%).1H NMR (CD3OD, 300 MHz) δ (ppm) 7.35–7.12 (m, 5H), 3.35–3.20 
(m, 1H), 2.83–2.61 (m, 2H), 2.11–1.77 (m, 2H), 1.35 (d, J = 6.6 Hz, 3H); 13C NMR (CD3OD, 75 MHz) δ (ppm) 
141.8, 129.6, 129.3, 127.3, 48.6, 37.6, 32.5, 18.5. 
NMR data are in accordance with NMR data obtained from 14 (Table 2, entry 5). 
 
4-Phenylbutan-2-amine hydrochloride 14 (entry 6) 
2-Methoxy-N-(4-phenylbutan-2-yl)aniline (25) (0.26 g, 1.0 mmol) was dissolved in 
MeCN/H2O (1:1, 20 mL), aqueous H2SO4 (1 mL, 1M) was added, followed by H5IO6 (228 
mg, 1.0 mmol) and the resulting mixture was stirred for 18 h and subsequently washed 
with DCM (3 × 50 mL). Aqueous KOH was added (0.6 mL, 5 M) and the aqueous solution was extracted 
with EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the aqueous solution was extracted with 
EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the aqueous solution was extracted with 
EtOAc (50 mL). The combined organic layers were dried (Na2SO4), 1 mL HCl in EtOAc (~2.3 M) was added 
and the mixture was concentrated. The product was obtained as a white solid (78 mg, 0.42 mmol, 42%).1H 
NMR (CD3OD, 300 MHz) δ (ppm) 7.34–7.12 (m, 5H), 3.36–3.16 (m, 1H), 2.83–2.56 (m, 2H), 2.09–1.76 (m, 
2H), 1.35 (d, J = 6.6 Hz, 3H); 13C NMR (CD3OD, 75 MHz) δ (ppm) 141.8, 129.6, 129.3, 127.3, 48.6, 37.6, 32.5, 
18.5. 
NMR data are in accordance with NMR data obtained from 14 (Table 2, entry 5). 
 
4-Phenylbutan-2-amine hydrochloride (14) (entry 7) 
2-((4-Phenylbutan-2-yl)amino)phenol (26) (0.24 g, 1.0 mmol) was dissolved in 
MeCN/H2O (1:1, 20 mL), aqueous H2SO4 (1 mL, 1M) was added, followed by 
trichloroisocyanuric acid (116 mg, 0.5 mmol) and the resulting mixture was stirred for 
15 h and subsequently washed with DCM (3 × 50 mL). Aqueous KOH was added (0.6 mL, 5 M) and the 
aqueous solution was extracted with EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the 
aqueous solution was extracted with EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the 
aqueous solution was extracted with EtOAc (50 mL). The combined organic layers were dried (Na2SO4), 1 
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mL HCl in EtOAc (~2.3 M) was added and the mixture was concentrated. The product was obtained as a 
dark oil (115 mg, 0.62 mmol, 62%) 1H NMR (CD3OD, 300 MHz) δ (ppm) 7.36–7.07 (m, 5H), 3.35–3.18 (m, 
1H), 2.85–2.62 (m, 2H), 2.15–1.74 (m, 2H), 1.35 (d, J = 6.6 Hz, 3H); 13C NMR (CD3OD, 75 MHz) δ (ppm) 
141.8, 129.6, 129.3, 127.3, 48.6, 37.6, 32.5, 18.5. 
NMR data are in accordance with NMR data obtained from 14 (Table 2, entry 5). 
 
4-Phenylbutan-2-amine hydrochloride (14) (entry 8) 
2-((4-Phenylbutan-2-yl)amino)phenol (26) (0.24 g, 1.0 mmol) was dissolved in 
MeCN/H2O (1:1, 20 mL), aqueous H2SO4 (1 mL, 1M) was added, followed by H5IO6 (228 
mg, 1.0 mmol) and the resulting mixture was stirred for 15 h and subsequently washed 
with DCM (3 × 50 mL). Aqueous KOH was added (0.6 mL, 5 M) and the aqueous solution was extracted 
with EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the aqueous solution was extracted with 
EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the aqueous solution was extracted with 
EtOAc (50 mL). The combined organic layers were dried (Na2SO4), 1 mL HCl in EtOAc (~2.3 M) was added 
and the mixture was concentrated. The product was obtained as an off-white solid (59 mg, 0.32 mmol, 
32%) 1H NMR (CD3OD, 300 MHz) δ (ppm) 7.36–7.05 (m, 5H), 3.35–3.18 (m, 1H), 2.84–2.62 (m, 2H), 2.11–
1.75 (m, 2H), 1.35 (d, J = 6.6 Hz, 3H). 13C NMR (CD3OD, 75 MHz) δ (ppm) 141.8, 129.6, 129.3, 127.3, 48.6, 
37.6, 32.5, 18.5. 
NMR data are in accordance with NMR data obtained from 14 (Table 2, entry 5). 
 
4-Phenylbutan-2-amine hydrochloride (14) (entry 9) 
N-(4-Phenylbutan-2-yl)aniline (27) (225 mg, 1.0 mmol) was dissolved in MeCN/H2O 
(1:1, 20 mL), aqueous H2SO4 (1 mL, 1M) was added, followed by trichloroisocyanuric 
acid (116 mg, 1.0 mmol) and the resulting mixture was stirred for 18 h and 
subsequently washed with DCM (3 × 50 mL). Aqueous KOH was added (0.6 mL, 5 M) and the aqueous 
solution was extracted with EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the aqueous 
solution was extracted with EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the aqueous 
solution was extracted with EtOAc (50 mL). The combined organic layers were dried (Na2SO4). 1 mL HCl 
in EtOAc (~2.3 M) was added and the mixture was concentrated. The product was obtained as an off-
white wax/solid (5.1 mg, 0.027 mmol, 3%).1H NMR (CD3OD, 300 MHz) δ (ppm) 7.34–7.10 (m, 5H), 3.38–
3.19 (m, 1H), 2.82–2.61 (m, 2H), 2.04–1.74 (m, 2H), 1.34 (d, J = 6.6 Hz, 3H); 13C NMR (CD3OD, 75 MHz) δ 
(ppm) 141.8, 129.7, 129.3, 127.4, 48.6, 37.7, 32.5, 18.5. 
NMR data are in accordance with NMR data obtained from 14 (Table 2, entry 5). 
 
4-Phenylbutan-2-amine hydrochloride (14) (entry 10) 
N-(4-Phenylbutan-2-yl)aniline (27) (225 mg, 1.0 mmol) was dissolved in MeCN/H2O 
(1:1, 20 mL), aqueous H2SO4 (1 mL,1M) was added, followed by H5IO6 (228 mg, 1.0 
mmol) and the resulting mixture was stirred for 19 h and subsequently washed with 
DCM (3 × 50 mL). Aqueous KOH was added (0.6 mL, 5 M) and the aqueous solution was extracted with 
EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the aqueous solution was extracted with 
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EtOAc (50 mL). Aqueous KOH was added (0.3 mL, 5 M), and the aqueous solution was extracted with 
EtOAc (50 mL). The combined organic layers were dried (Na2SO4), 1 mL HCl in EtOAc (~2.3 M) was added 
and the mixture was concentrated. The product was obtained as a slightly brown oil (2.9 mg, 0.016 mmol, 
2%).1H NMR (CD3OD, 300 MHz) δ (ppm) 7.34–7.13 (m, 5H), 3.34–3.19 (m, 1H), 2.86–2.52 (m, 2H), 2.12–
1.56 (m, 2H), 1.34 (d, J = 6.6 Hz, 2H); 13C NMR (CD3OD, 75 MHz) δ (ppm) 141.8, 129.7, 129.3, 127.4, 48.6, 
37.7, 32.5, 18.5. 
NMR data are in accordance with NMR data obtained from 14 (Table 2, entry 5). 
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3 
LACCASE-MEDIATED DEPROTECTION OF p-
METHOXYPHENYL-(PMP)-PROTECTED 
AMINES 
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3.1 Introduction 
The para-methoxyphenyl (PMP) group is, as described in Chapter 2, increasingly used as a 
nitrogen protecting group for amines and imines.1 At the start of our research, the PMP 
protecting group was generally considered a crucial element in proline-catalysed asymmetric 
Mannich reactions for reaching high enantioselectivities. Industrial application of the PMP-
protecting group had, however, been thwarted by a lack of cheap and practical deprotection 
methods. In most cases, a large excess of ceric ammonium nitrate (CAN) was used for 
deprotection, which is expensive and highly toxic.2 Phenyl iodoacetate3 and also electrochemical 
deprotection4 have been proposed instead, but both approaches do not provide viable 
alternatives for industrial application. Recently however, we demonstrated that the cheap 
oxidants trichloroisocyanuric acid (TCCA) and periodic acid can be both efficiently applied for 
PMP deprotection of amines (Chapter 2).5 Parallel to this chemical PMP deprotection and due to 
the growing need for green and sustainable catalytic deprotection strategies, we also aimed to 
develop an oxidative enzymatic method for effective removal of the PMP group from amines.  
Since we previously showed (Section 2.2) that a rather large variety of oxidative reagents can be 
employed for PMP removal, we reasoned that this transformation might also be effectuated 
using oxidative enzymes. In view of the many applications of laccases (E.C. 1.10.3.2) in oxidative 
transformations,6 we envisioned that these enzymes are potential candidates for selective PMP 
removal as well. Laccases are multi-copper oxidases found in several trees and fungi, catalysing 
the oxidation of various types of compounds with concomitant reduction of oxygen to water, 
avoiding the formation of hazardous hydrogen peroxide.  
 
3.2 Screening of laccases and optimising reaction conditions 
Our investigation into the applicability of laccases for PMP group removal commenced with 
developing an HPLC assay to screen laccases by monitoring the conversion of starting material, 
i.e. the N-PMP protected amine, into the desired free amine. As a benchmark substrate, we chose 
the protected 1,3-amino alcohol 1 (Scheme 1).7 
 
  
Scheme 1 Deprotection of PMP group. 
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A thorough screen of reaction conditions was carried out in which co-solvents and the pH were 
varied. Two commercially available laccases were employed as such, namely laccase T (from 
Trametes versicolor) and laccase AB (from Agaricus bisporus).  
 
Table 1 Screening of reaction parameters. 
 
Conditions: A mixture of laccase T or AB (4 mg), benzoic acid (internal standard, 1 mg), PMP-amine 1 (1 
mg), buffer and co-solvent (1 mL) was shaken at rt. a Conversions were determined using HPLC (Inertsil 
ODS-3 column) on crude samples after filtration *values >100% are due to inaccuracy in assay. 
 
Because of the generally low solubility of organic substrates in aqueous solution, we decided to 
investigate the use of co-solvents from the start. We considered this especially important, since 
earlier studies revealed that laccases are often deactivated by organic solvents.8 Thus, a series of 
experiments were carried out in a buffer (50 mM, pH 5)/co-solvent mixture, thereby varying the 
co-solvent. The conversions of substrate 1 into the free amine 3, as determined by HPLC, are 
depicted in Table 1 (entries 1–8). These results led us to conclude that the laccase-mediated 
PMP deprotection proceeds smoothly in homogeneous systems, but we found biphasic systems 
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(e.g. with EtOAc, toluene, MTBE) also applicable (not shown in Table 1). Additionally, it must be 
noted that higher amounts of co-solvent, although rendering the substrate more soluble, 
significantly decreased the conversion through enzyme deactivation. Considering these initial 
results, we continued with evaluation of the pH dependence of the reaction in a buffer/MeCN 
mixture (4:1) using both laccases T and AB (Table 1, entries 9–24). Clearly, the conversions 
increased with lower pH values, albeit that highly acidic conditions (pH < 3) led to enzyme 
deactivation. Having concluded that 3 was the optimum pH value and laccase T the more suited 
enzyme, a series of industrially viable solvents were evaluated in varying ratios with the buffer 
solution (Table 1, entries 25–48). No real solvent limitations were identified in these 
experiments. We have therefore identified the combination of a water miscible solvent and 
acidic water (pH 3) as optimal. 
Subjection of protected amino alcohol 1 to laccase AB gave a maximum conversion of 38% 
(buffer pH 5/MeCN 4:1, Table 1, entry 13). To improve this conversion we envisaged the usage 
of so-called mediators, which are known to enlarge the scope of laccases.6g Mediators are usually 
small organic molecules, which act as ‘electron shuttles’ between the enzyme and the substrate 
to overcome a limited substrate scope. Hence, they might make the necessity of a fit of the 
substrate in the active site of the enzyme redundant. 
 
Scheme 2 Mediators act as ‘electron shuttles’. 
 
We investigated the influence of mediators (Fig. 1) on the efficiency of this particular reaction. 
Mechanistically, the mediator is, after being oxidised by laccase, responsible for the conversion 
of the substrate into its oxidised form. Since the reduced mediator can be reoxidised by the 
enzyme, both laccase and mediator can be used in a catalytic fashion using oxygen as the 
stoichiometric oxidant thereby producing water as the by-product (Scheme 2).   
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Figure 1 Tested mediators for laccase-catalysed deprotection. 
 
 
The best result was obtained with 2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS, 
5) (introduced as the corresponding diammonium salt) as the mediator leading to 81% 
conversion into 3, instead of 38% in entry 13, 19 h, rt, 0.1 equiv of ABTS). 
 
3.3 Preparative scale experiments 
To validate the screening results, we performed a series of preparative experiments using the 
initial substrate 1 as well as substrates 10, 13–16 with laccases T and AB (Table 2). Surprisingly, 
subjection of PMP-protected benzylamine 12 to these enzymes did not produce benzylamine 
(17) itself. Possibly, laccase-mediated formation of benzaldehyde had taken place (see Chapter 
2). In most other cases, however, the corresponding crude amines 2, 11, 18, 19 and 21 were 
isolated after workup in reasonable to good crude yields.  
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Table 2 Preparative deprotections using laccase T and AB.a 
 
a Conditions: PMP-protected amine (0.92 mmol), laccase (120 mg), THF/buffer mixture (1:4, pH 3, 200 
mL), rt, o.n. b Reaction conducted in the presence of ABTS.2NH3 (mediator) (10 mol%).  
 
In entries 9 and 10, the demethylated deprotected product 19 was recovered, indicating 
isomerisation of the intermediate quinimide 22 to iminium ion 23 and subsequent hydrolysis to 
the corresponding amine. The resulting p-hydroxyphenyl-protected ammonium ion 24 is again 
prone to laccase-mediated oxidation, so that eventually the unsubstituted amine 19 is formed 
(Scheme 3).  
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Scheme 3 Oxidative demethylation, followed by oxidative deprotection. 
 
Finally, realising that more concentrated reaction mixtures are desirable to render processes 
industrially viable, we repeated one of the deprotection experiments in a 10 mg/mL suspension 
to find that the desired product was isolated in a somewhat lower yield (58 vs 82% in entry 5). 
 
3.4 Conclusions 
In conclusion, the increasing use of the p-methoxyphenyl (PMP) group in organic synthesis 
requires cost-efficient, environmentally friendly and scalable deprotection procedures to render 
these processes industrially viable. We have developed a novel enzymatic oxidative deprotection 
procedure for N-PMP-protected amines involving laccases, which is effective at a pH below 4. 
Additionally, we have found that the use of ABTS leads to an increase in conversions in a specific 
example. The yields and purities of the products obtained with the ‘chemical’ deprotection 
(Chapter 2) are generally higher, which makes it the preferential method. However, when 
functional groups are present which do neither tolerate periodic acid nor trichloroisocyanuric 
acid, enzymatic deprotection followed by purification of the crude product may be the better 
option.  
 
3.5 Acknowledgement 
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3.6 Experimental section 
For general remarks, see section 2.8. Enzymes used for the experiments described in Tables 1 and 2 were 
purchased from Sigma-Aldrich as light brown powders (activity laccase T from Trametes versicolor: 13.6 
U/mg; activity laccase AB from Agaricus bisporus: 8.0 U/mg)  
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Synthetic procedures for compounds 1, 10, 13, 14 and 15 have been described in Chapter 2. 
 
(4S)-4-(3,4-Dimethoxyphenyl)-4-((4-methoxyphenyl)amino)butan-2-ol (16) 
Under argon: To a solution of (S)-4-(3,4-dimethoxyphenyl)-4-((4-methoxyphenyl)amino)butan-2-one 
(1.08 g, 3.28 mmol) (see Chapter 4, ((S)-1) in a mixture of MeOH and DCM (1:1, 
100 mL) was added NaBH4 (0.124 g, 3.28 mmol). The mixture was stirred for 1 h, 
quenched with saturated aqueous NaHCO3 (100 mL) and diluted with DCM (100 
mL). After separation, the aqueous layer was extracted with DCM (100 mL). The 
combined organic layers were dried (Na2SO4) and concentrated to give product 
16 as a white/colorless solid glass (1.10 g, 3.32 mmol, quant.) 1H NMR (CDCl3, 300 MHz) δ (ppm) 6.91–
6.77 (m, 3H, both diastereomers), 6.73–6.64 (m, 2H, both diastereomers), 6.60–6.47 (m, 2H, both 
diastereomers), 4.50 (dd, J = 7.3, 5.3 Hz, 2/3H, major diastereomer), 4.38 (dd, J = 9.0, 5.1 Hz, 1/3H, minor 
diastereomer), 4.09–3.93 (m, 1H, both diastereomers), 3.86–3.82 (m, 6H, both diastereomers), 3.69 (s, 1H, 
minor diastereomer), 3.69 (s, 2H, major diastereomer), 2.01–1.71 (m, 2H), 1.24 (d, J = 6.3 Hz, 2H, major 
diastereomer), 1.22 (d, J = 6.6 Hz, 1H, minor diastereomer). 
1H NMR spectral data are in accordance with data in Chapter 4: Compound 2 
 
Procedure for the laccase-mediated PMP-deprotection. To a solution of the substrate (0.92 mmol) in THF 
(40 mL) and phosphate buffer (160 mL, pH 3, 50 mM) was added laccase AB or T (120 mg) and if stated 
ABTS (10 mol%). The resulting suspension was stirred in an open flask (except entry 6) o.n. at rt, acidified 
to pH 1 with 5 N HCl and optionally filtrated over Celite. The filtrate was washed with DCM (3 × 100 mL). 
The resulting aqueous phase was subsequently brought to pH ~12 via addition of 5 N aqueous NaOH or 
KOH and extracted with EtOAc (4 × 75 mL). Before each extraction, the mixture was adjusted to pH ~12 
with 5 N aqueous NaOH or KOH. The combined organic fractions were dried, filtered and concentrated 
after addition of HCl/EtOAc (2.3 M, 1 mL). 
 
1-Phenylethanamine hydrochloride (18) (entry 3) 
The product was obtained using laccase T as a dark oil (62 mg, 0.39 mmol, 43%). 1H NMR 
(CD3OD, 300 MHz) δ (ppm) 7.52–7.36 (m, 5H), 4.46 (q, J = 6.9 Hz, 1H), 1.64 (d, J = 6.9 Hz, 
3H). 
1H NMR spectral data are in accordance with data previously obtained (See Chapter 2, compound 13). 
 
1-Phenylethanamine hydrochloride (18) (entry 4)  
The product was obtained using laccase AB as a dark oil (64 mg, 0.41 mmol, 44%). 1H NMR 
(CD3OD, 300 MHz) δ (ppm) 7.61–7.32 (m, 5H), 4.47 (q, J = 6.9 Hz, 1H), 1.65 (d, J = 6.9 Hz, 
3H). 
1H NMR spectral data are in accordance with data previously obtained (See Chapter 2, compound 13) 
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(2S,3S)-3-Amino-2-methyl-3-phenylpropan-1-ol hydrochloride (2) (entry 5)  
The product was obtained using laccase T as a dark oil (152 mg, 0.75 mmol, 82%). 1H 
NMR (CD3OD, 300 MHz,) δ (ppm) 7.53–7.35 (m, 5H), 4.32 (d, J = 6.7 Hz, 1H), 3.46–3.32 
(m, 2H), 2.41–2.20 (m, 1H), 1.04 (d, J = 6.9 Hz, 3H). 
1H NMR spectral data are in accordance with previously obtained data (Chapter 2, compound 5.HCl)  
 
(2S,3S)-3-Amino-2-methyl-3-phenylpropan-1-ol hydrochloride (2) (entry 6) 
The product was obtained using laccase AB as a dark oil (137 mg, 0.68 mmol, 74%). 1H 
NMR (CD3OD, 300 MHz) δ (ppm) 7.56–7.28 (m, 5H), 4.31 (d, J = 6.7 Hz, 1H), 3.44–3.32 (m, 
2H), 2.38–2.22 (m, 1H), 1.04 (d, J = 6.9 Hz, 3H). 
1H NMR spectral data are in accordance with previously obtained data (Chapter 2, compound 5.HCl)  
 
(2S,3S)-3-Amino-2-methyl-3-(4-nitrophenyl)propan-1-ol hydrochloride (entry 7) 
The product was obtained using laccase T as an off-white solid (138 mg, 0.56 mmol, 
61%). 1H NMR (CD3OD, 300 MHz) δ (ppm) 8.38–8.25 (m, 2H), 7.83–7.72 (m, 2H), 4.55 
(d, J = 6.4 Hz, 1H), 3.46 (dd, J = 11.0, 4.8 Hz, 1H), 3.35 (dd, J = 11.0, 6.7 Hz, 1H), 2.46–
2.32 (m, 1H), 1.06 (d, J = 7.0 Hz, 3H). 
1H NMR spectral data are in accordance with previously obtained data (Chapter 2, compound 15)  
 
(2S,3S)-3-Amino-2-methyl-3-(4-nitrophenyl)propan-1-ol hydrochloride (19) (entry 8)  
The product was obtained using laccase AB as an off-white solid/oil (213 mg, 0.86 
mmol, 94%). 1H NMR (CD3OD, 300 MHz,) δ (ppm) 8.41–8.22 (m, 2H), 7.87–7.68 (m, 
2H), 4.57 (d, J = 6.3 Hz, 1H), 3.47 (dd, J = 11.0, 4.8 Hz, 1H), 3.36 (dd, J = 11.0, 6.7 Hz, 
1H), 2.56–2.31 (m, 1H), 1.06 (d, J = 7.0 Hz, 3H). 
1H NMR spectral data are in accordance with previously obtained data (Chapter 2, compound 15) 
 
(2S,3S)-2-Methyl-3-(methylamino)-3-(4-nitrophenyl)propan-1-ol hydrochloride (19) (entry 9) 
The product was obtained using laccase T as a dark solidifying oil (194 mg, 0.79 
mmol, 86%). 1H NMR (CD3OD, 300 MHz) δ (ppm) 8.40–8.25 (m, 2H), 7.83–7.73 
(m, 2H), 4.55 (d, J = 6.3 Hz, 1H), 3.46 (dd, J = 11.0, 4.8 Hz, 1H), 3.35 (dd, J = 11.0, 
6.7 Hz, 1H), 2.46–2.32 (m, 1H), 1.06 (d, J = 7.0 Hz, 3H). 
1H NMR spectral data are in accordance with previously obtained data (Chapter 2, compound 15) 
 
(2S,3S)-2-Methyl-3-(methylamino)-3-(4-nitrophenyl)propan-1-ol hydrochloride (19) (entry 10)  
The product was obtained using laccase AB as a colorless oil (106 mg, 0.43 mmol, 
47%). 1H NMR (CD3OD, 300 MHz,) δ (ppm) 8.38–8.28 (m, 2H), 7.79–7.73 (m, 2H), 
7.72–7.67 (m, 1H), 4.54 (d, J = 6.3 Hz, 1H), 3.46 (dd, J = 11.0, 4.8 Hz, 1H), 3.35 (dd, 
J = 11.0, 6.8 Hz, 1H), 2.45–2.32 (m, 1H), 1.05 (d, J = 7.0 Hz, 3H). 
1H NMR spectral data are in accordance with previously obtained data (Chapter 2, compound 15) 
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(4S)-4-Amino-4-(3,4-dimethoxyphenyl)butan-2-ol (21) (entry 11) 
The product was obtained using laccase T as a dark oil (mixture of 
diastereomers) (119 mg, 0.45 mmol, 49%) 1H NMR (CD3OD, 300 MHz) δ (ppm) 
7.15–6.95 (m, 3H, both diasteromers), 4.65–4.38 (m, both diastereomers), (3.88 
(s, minor diastereomer) + 3.87 (s, major diastereomer), 3H), 3.83 (s, 3H, both 
diastereomers), 3.92–3.52 (m, 1H, both diastereomers), 2.20–1.75 (m, 2H, both diastereomers), (1.22 (d, J 
= 6.1 Hz, major diastereomer) + 1.18 (d, J = 6.2 Hz, minor diastereomer), 3H).13C NMR (for major isomer) 
(CD3OD, 75 MHz): δ (ppm) 151.0, 150.9, 130.9, 120.9, 113.1, 111.8, 64.8, 56.7, 56.5, 54.0, 43.7, 23.3. IR 
(cm-1) 3348, 2966, 2935, 1520, 1262, 1145, 1021; HRMS [ESI+ (m/z)]: calcd for C12H20NO3 (M+H+) 
226.14432, found 226.14462. 
 
(4S)-4-Amino-4-(3,4-dimethoxyphenyl)butan-2-ol (entry 12) 
The product was obtained using laccase AB as a dark oil (mixture of 
diastereomers) (119 mg, 0.45 mmol, 49%). 1H NMR (CD3OD, 300 MHz) δ (ppm) 
7.15–6.95 (m, 3H, both diastereomers), (4.64–4.54 (m, minor diastereomer) + 
4.48–4.39 (m, major diastereomer), 1H) (3.88 (s, minor diastereomer) + 3.87 (s, 
major diastereomer), 3H), 3.83 (s, 3H, both diastereomers), 3.90–3.56 (m, 1H, both diastereomers), 2.30–
1.65 (m, 2H, both diastereomers), (1.22 (d, J = 6.2 Hz, major diasteromer) + 1.19 (d, J = 6.2 Hz, minor 
diastereomer), 3H).13C NMR (for major isomer) (CD3OD, 75 MHz): δ (ppm) 151.0, 150.9, 130.9, 120.9, 
113.1, 111.8, 64.8, 56.7, 56.5, 54.0, 43.7, 23.4. IR (cm-1) 3365, 2965, 2936, 1520, 1264, 1144, 1023; HRMS 
[ESI+ (m/z)]: calcd for C12H20NO3 (M+H+) 226.14432, found 226.14460. 
 
4-Phenylbutan-2-amine hydrochloride (11) (entry 13) 
The product was obtained using laccase T as a dark oil (68 mg, 0.37 mmol, 40%). 1H 
NMR (CD3OD, 300 MHz,) δ (ppm) 7.40–7.11 (m, 5H), 3.35–3.21 (m, 1H), 2.83–2.57 
(m, 2H), 2.13–1.67 (m, 2H), 1.39 (d, J = 6.6 Hz, 3H). 
1H NMR spectral data are in accordance with previously obtained data (Chapter 2, compound 14)  
 
4-Phenylbutan-2-amine hydrochloride (11) (entry 14) 
The product was obtained using laccase AB as a slightly colored solidifying oil (37 
mg, 0.20 mmol, 22%). 1H NMR (CD3OD, 300 MHz,) δ (ppm) 7.34–7.10 (m, 5H), 3.29–
3.21 (m, 1H), 2.82–2.57 (m, 2H), 2.06–1.75 (m, 2H), 1.34 (d, J = 6.6 Hz, 3H). 
1H NMR spectral data are in accordance with previously obtained data (Chapter 2, compound 14)  
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        4 
STEREOSELECTIVE SYNTHESIS OF N-PMP-
PROTECTED 1,3-AMINO ALCOHOLS 
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4.1 Introduction 
With the growing number of enantio- and diastereomerically pure pharmaceutical compounds, 
the need for stereoselective synthetic methodologies is increasing.1,2 Since the 1,3-amino alcohol 
moiety is often encountered in drugs and drug-like molecules, general procedures are desired to 
selectively prepare all possible diastereomers of such compounds. Examples of drugs containing 
this structural motif are depicted in Figure 1. Ritonavir and lopinavir are both drugs with anti-
HIV properties.3 4-Hydroxyleucine derivatives show activity in the treatment of fat metabolism 
and obesity.4  
 
Figure 1 Examples of pharmaceutically relevant 1,3-amino alcohols.  
 
Other pharmaceutically active 1,3-amino alcohols are used for the treatment of psychiatric 
disorders such as depression (e.g. fluoxetine and duloxetine) and ADHD (e.g. atomoxetine) 
(Figure 2). Zhang et al.5 described an elegant rhodium-catalysed hydrogenation of the ketone 
precursor as the key step in the synthesis of the former compounds.  
 
Figure 2 Psychoactive 1,3-amino alcohols. 
 
Additionally, the 1,3-amino alcohol pattern is found in antibiotics as a building block of 
negamycin,6 clavalanine7 and biphenomycins A and B (Figure 3).8 
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Figure 3 1,3-Amino alcohols as important structural elements of antiobiotics. 
 
Various natural products also contain 1,3-amino alcohol moieties. Selected examples include 
lythracaea alkaloids,9 sedum alkaloids,10 paliclavine,11 and dysiherbaine.12. On a different note, 
an excellent review of Keay and co-workers extensively describes the application of 1,3-amino 
alcohols as chiral transfer agents in asymmetric transformations.13 
Despite its abundance in synthetically relevant targets, relatively few stereoselective methods 
are available for the construction of the 1,3-amino alcohol moiety. Undoubtedly, the most 
straightforward route would involve stereoselective reduction of Mannich products of which the 
ketone function is reduced by employing hydride donors. While several methods for the 
reduction of α-chiral amino ketones have been reported,14,15,16 only a small number of reports on 
the reduction of β-amino ketones, with the amine and ketone separated by only a methylene 
group, have been disclosed. Dias and co-workers reported a diastereoselective reduction of 
acyclic N-aryl-β-amino ketones, using LiEt3BH or Zn(BH4)2.17 Berkes et al. published a 
diastereoselective reduction of β-amino ketones using MnCl2.18 The group of Truong described 
that both syn- and anti-1,3-amino alcohols could be prepared through treatment of β-amino 
ketones with SmI2 in methanol, with the nitrogen-protecting group as the stereodirecting unit.19 
A recent paper of the Davis group described a diastereoselective reduction of acyclic N-sulfinyl 
β-amino ketones. Both anti- and syn-amino alcohols could be prepared in moderate to excellent 
selectivity by using LiEt3BH or Li(tBuO)3AlH. They applied their newly developed methodology 
in a formal total synthesis of (–)-pinidinol and (+)-epipinidinol.20 
As an alternative, amino alcohols can be prepared through ruthenium-catalysed hydrogenation 
of β-amino ketones, although these methodologies are generally reported for the synthesis of 
targets without α-chirality.21 Rhodium-catalysed examples have also been published, however, 
none of them dealing with chiral amines.5,22 As a third method, Ellman and co-workers reported 
a diastereoselective reduction of N-sulfonyl protected 1,3-hydroxyimines.23 Menche et al. 
described a syn-selective reductive amination of β-hydroxyketones with p-anisidine and 
polymethylhydrosiloxane as the reducing agent in the presence of Ti(OiPr)4. They employed 
their method in the synthesis of the hydroxylamine core of ritonavir/lopinavir (Fig. 1).24 The list 
of stereoselective methods to transform β-amino ketones into the corresponding alcohols is 
completed by biocatalytic reductions with enzymes or baker’s yeast. Only a few examples have 
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been published involving β-amino ketones, which are mostly rather substrate specific and 
therefore not generally applicable.25 In 2010, Bäckvall et al. published a method for the synthesis 
of syn- and anti-1,3-amino alcohols via dynamic kinetic resolution of N-Boc-protected 1,3-amino 
ketones.26 
We envisaged that enantioselective access to N-PMP-protected β-amino ketones via the proline-
catalysed Mannich reaction and the recently discovered cheap and efficient methods for the 
removal of the PMP protecting group (vide Chapters 2 and 3) could provide a new general entry 
into the synthesis of 1,3-amino alcohols. In this chapter, our results in converting the N-PMP-
protected β-amino ketones into syn- and anti-1,3-amino alcohols in a diastereoselective manner 
are described.  
 
4.2 Hydride reductions 
As described in Section 4.1, a straightforward way to convert ketones into alcohols proceeds 
through reduction with a borohydride reagent. We chose to screen reaction conditions on amino 
ketone 1, because it was available as a single enantiomer and readily synthesised on large scale 
(see Chapter 7). The formation of both possible alcohols was monitored using HPLC. 
 
Scheme 1 Reduction of β-amino ketone 1. 
 
With NaBH4 as reductant, amino alcohol 2 was formed in a 1:3 ratio of diastereomers (entry 1, 
Table 1). In case of Zn(BH4)2 the desired amino alcohols were formed in a reversed 5:1 ratio. The 
relative configurations were tentatively assigned based on chelation-controlled reduction, with 
Zn2+ acting as a chelator between the ketone and amine functions, thereby favouring syn-product 
formation (Scheme 2, pathway a). Consequently, it was assumed that Felkin–Anh-controlled 
NaBH4 reduction (Scheme 2, pathway b) produced predominantly the anti-product. The small 
difference in steric demand of the Ar and NHPMP substituents in the latter model accounts for 
the observed low diastereoselectivity. 
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Scheme 2 Chelation- and Felkin–Anh controlled reduction. 
 
We subsequently tested a series of boro- and aluminiumhydrides, but unfortunately in none of 
these cases a sufficiently high diastereoselectivity was observed (Table 1). 
 
Table 1 Screening of various reductants for the reduction of (S)-1. 
 
 
Apparently, the influence of the existing chiral center was too small to induce chirality at the 
second chiral center, which prompted us to investigate other approaches.  
 
4.3 Iridium-catalysed transfer hydrogenation: anti-amino alcohols 
Both hydrogenation and transfer hydrogenation have found a plethora of applications in 
stereoselective reduction of alkynes, alkenes, imines and ketones. Surprisingly, no literature 
precedence on the diastereoselective (transfer) hydrogenation of chiral β-amino ketones existed 
at the start of our research, while on the other hand β-hydroxy ketones have shown to be 
suitable hydrogenation substrates.27,28 In transfer hydrogenations, 2-propanol or a mixture of 
formic acid/triethylamine is used as the source of hydrogen, which is reversibly transferred to 
the substrate molecule. Due to this reversibility, a careful analysis of the reaction progress and 
selectivity is required. We started our investigations on N-PMP-protected β-amino ketone 1. 
Using the well-established Ru/TsDPEN complex as the catalyst, we observed a clean conversion 
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into the desired 1,3-amino alcohols with a moderate diastereomeric excess (60%), which 
irrespective of the existing chiral center depended on the catalyst chirality (Figure 4).  
 
 
Scheme 2 Ru/(R,R)-TsDPEN-catalysed transfer hydrogenation of 1. 
 
Encouraged by these initial results we explored the use of iridium-based catalysts. We prepared 
efficient asymmetric transfer hydrogenation (ATH) catalysts 5 by heating a solution of an 
iridium precursor (i.e. [IrCp*Cl2]2) and an amino acid amide in the presence of an inorganic base 
(e.g. K2CO3) (Scheme 3) according to a modified protocol disclosed by Verzijl.29 
 
Scheme 3 Synthesis of Ir-based amino acid amide catalysts 5. 
 
The inorganic base was removed by filtration to suppress possible elimination of the N-PMP 
group prior to reduction. Preferably, α,α-disubstituted amino acids were employed to avoid the 
risk of catalyst racemisation. To our satisfaction, exposure of benchmark substrate 1 to these 
catalysts resulted in very high diastereoselectivities. When D-α-Me-phenylglycine amide was 
used as the ligand, conversion of (S)-1 into the corresponding (R,S)-amino alcohol (R,S)-2 
proceeded with a diastereomeric ratio of 96:4, while the (R)-amino ketone led to a 1:1 formation 
of amino alcohols. This implies that the existing chiral center has a large impact on the 
stereochemical outcome of the transfer hydrogenation. The influence of the preexisting chirality 
in terms of a match and mismatch with the ligand was confirmed by employing achiral Aib-NH2 
as the ligand. In the presence of the achiral catalyst, a diastereomeric ratio of 84:16 was 
observed for the products. A limited ligand screening (Table 2) showed that the 
diastereostereoselectivity could be increased to 100:0 (entry 7). 
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Table 2 Screening of Ir-based amino acid amide catalysts for ATH of amino ketone 1. 
 
 
Although we obtained better results with α-benzylphenylglycinamide as the ligand, we explored 
the substrate scope of the stereoselective ATH with the D-α-methylphenylglycinamide-based 
catalyst because of its larger availability at the time. Substrates were prepared via the 
asymmetric proline-catalysed Mannich reaction (See Section 4.7). It should be noted that in 
some instances, Mannich ketones were prone to partial racemisation over time. We hypothesise 
that racemisation occurs via catalysis by impurities in the Mannich ketone samples, because 
ketones 6–9 were oils and purified by troublesome column chromatography, whereas 1 was 
purified through crystallisation and the resulting crystals appeared more stable.  
 
Table 3 Preparative asymmetric transfer hydrogenation of β-amino ketones. 
 
Conditions: ketone (1.0 equiv), (IrCp*Cl2)2 (0.02 equiv), D-α-Me-phenylglycine-NH2 (0.20 
equiv), K2CO3 (3 equiv), 2-propanol, rt, 1.5–20 h. a determined by HPLC. b isolated yield. 
cabsolute configuration = (R,R):(S,R). 
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The results shown in Table 3 led us to conclude that the asymmetric transfer hydrogenation of 
β-amino ketones with an iridium based catalyst is widely applicable. In all examples we 
observed a reasonable to good diastereoselectivity, with the best selectivities obtained for R1 = 
Ar.  
With a method for the anti-selective preparation of 1,3-amino alcohols in hand, we realised that 
extensive screening of other metal/ligand combinations could possibly deliver 1,3-amino 
alcohols with syn-selectivity. However, at the time we simultaneously explored the option of 
hydrogenation instead of transfer hydrogenation, which is outlined in Section 4.4. 
 
4.4 Rhodium-catalysed hydrogenation: syn-amino alcohols 
Since with asymmetric transfer hydrogenation, only the anti-1,3-amino alcohols were accessible, 
we resorted to hydrogenation with molecular hydrogen for the synthesis of the syn-congeners. 
We discovered that hydrogenation of β-amino ketones in the presence of the catalyst derived 
from monovalent Rh(I) and a C2-symmetric ligand such as (R)-BINAP (15), (Scheme 4), 
produced the desired syn-1,3-amino alcohols in excellent diastereoselectivity.  
 
Scheme 4 Formation of Rh-based (R)-BINAP catalyst 16. 
 
Again we observed a strong effect of the existing chiral center on the diastereoselectivity. Upon 
hydrogenation of (S)-1 with Rh/(R)-BINAP, pure (S,S)-2 was obtained, whereas with Rh/(S)-
BINAP the ratio (R,S) vs (S,S) was 70:30. DCM appeared to be the most suitable solvent with 
respect to solubility of the starting material, diastereoselectivity and reaction rate. To 
investigate the scope and limitations, we subsequently hydrogenated a number of aromatic, 
aliphatic and carboxylic β-amino ketones on preparative scale (Table 4). 
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Table 4 Preparative asymmetric hydrogenation of β-amino ketones. 
 
 
a Conditions: substrate (1.0 equiv), Rh(COD)2BF4 (0.05 or 0.30 equiv), (R)-BINAP (0.05 or 0.030 equiv). b 
determined by HPLC. c isolated yields. d absolute configuration = (R,R):(S,R). 
 
Unfortunately, the reactions proceeded rather slowly, which prompted us to use relatively high 
catalyst loadings. Gratefully, in all cases near-exclusive formation of the desired syn-
stereoisomer was observed. 
Finally, to verify the assigned stereochemical outcome, we prepared (S,S)-2 on a larger scale and 
X-ray crystallographic analysis of the product proved that Rh/(R)-BINAP hydrogenation of (S)-1 
indeed led to formation of the syn-product ((S,S)-2) (Figure 5).30 
 
Figure 5 Crystal structure representation of (S,S)-2.  
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4.5 Conclusions 
In conclusion, we have developed two complementary methods for the hydrogenation of β-
amino ketones to the corresponding 1,3-amino alcohols. The anti-products can be obtained 
through asymmetric transfer hydrogenation, in which 2-propanol is employed as the hydrogen 
donor and an Ir/α-substituted-amino acid amide complex as the catalyst. Syn-products are 
accessible by hydrogenation under increased hydrogen pressure in the presence of a Rh-based 
BINAP catalyst. In combination with the proline-catalysed Mannich reaction, these methods have 
now proven to be powerful tools for the enantio- and diastereoselective synthesis of all four 
diastereomers of 1,3-amino alcohols.  
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4.7 Experimental section 
Amino acid amides were obtained from DSM, Geleen, The Netherlands. 
For general remarks, see section 2.8. 
 
(S)-4-(3,4-Dimethoxyphenyl)-4-((4-methoxyphenyl)amino)butan-2-one ((S)-1) 
To a mixture of DMSO (45 mL) and acetone (180 mL) was added 3,4-
dimethoxybenzaldehyde (10.5 g, 63.2 mmol), p-anisidine (7.78 g, 63.2 mmol) and 
L-proline. The resulting reaction mixture was stirred for 23 h. The reaction 
mixture was quenched with 100 mL potassium phosphate buffer (0.5 M, pH 7, 100 
mL). Subsequently, a total of 150 mL of potassium phosphate buffer (0.5 M, pH 7) 
was added in portions. The reaction mixture was cooled to 0 °C and the flask was 
scratched with a spatula, which induced precipitation. After stirring for 20 min, the suspension was 
filtered off and the residue was washed with water (0 °C, 50 mL). The product was dried in vacuo. The 
product was obtained as an off-white powder (12.7 g). The product was recrystallised from EtOAc and 
obtained as off-white crystals (10.2 g, 31.0 mmol, 49%).1H NMR (CDCl3, 300 MHz) δ (ppm) 6.92–6.86 (m, 
2H), 6.84–6.77 (m, 1H), 6.73–6.65 (m, 2H), 6.57–6.48 (m, 2H), 4.69 (t, J = 6.5 Hz, 1H), 3.85 (s, 6H), 3.70 (s, 
3H), 2.89 (d, J = 6.5 Hz, 2H), 2.11 (s, 3H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 207.4, 152.4, 149.2, 148.1, 
141.0, 135.4, 118.2, 115.4, 114.7, 111.3, 109.5, 55.9 (2C), 55.7, 55.2, 51.4, 30.8; HRMS [ESI+ (m/z)]: calcd 
for C19H23NO4Na (M+Na+) 352.15248, found 352.15249; HPLC: ee: >99%, Chiralpak AD-H (250 × 4.6 mm), 
flow 1.0 mL/min, n-heptane/2-propanol 80/20, retention time: major enantiomer 19.0 min, minor 
enantiomer: 15.8 min. 
NMR spectral data are in accordance with data in Chapter 7 (Ch.7, compound ent-7)  
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(S)-4-(4-Fluorophenyl)-4-((4-methoxyphenyl)amino)butan-2-one (6) 
p-Anisidine (2.00 g, 16.2 mmol) was dissolved in DMSO (20 mL) and 4-
fluorobenzaldehyde (1.74 mL, 2.00 g, 16.2 mmol) and L-proline (373 mg, 3.24 
mmol) were added. After 2 h of stirring, acetone was added (80 mL). The 
resulting mixture was stirred for 22 h and quenched with saturated aqueous 
NaHCO3 (100 mL). It was subsequently extracted with a mixture of EtOAc and 
heptane (1:1, 2 × 100 mL) The combined organic layers were dried (Na2SO4) and concentrated. The 
residue was purified using column chromatography (1st column: EtOAc/heptane 1/9 → 1/4 → 1/3, 2nd 
column: EtOAc/heptane 1/9 → 1/4). Yield: 1.40 g (4.87 mmol, 30%) of an orange oil. 1H NMR (CDCl3, 300 
MHz) δ (ppm) 7.38–7.29 (m, 2H), 7.05–6.95 (m), 6.72–6.65 (m, 2H), 6.53–6.46 (m, 2H), 4.74 (t, J = 6.5 Hz, 
1H), 4.15 (bs, 1H), 3.70 (s, 3H), 2.89 (d, J = 6.5 Hz, 2H), 2.11 (s, 3H); 13C NMR (CDCl3, 75 MHz): δ (ppm) 
206.9, 161.91 (d, J = 245.4 Hz), 152.5, 140.7, 138.4, 127.90 (d, J = 8.0 Hz), 115.59 (d, J = 21.5 Hz), 115.4, 
114.7, 55.6, 54.6, 51.3, 30.7; IR (cm-1): 3383, 3003, 2833, 1710, 1509, 1235, 820; HRMS [ESI+ (m/z)]: calcd 
for C17H18FNO2Na (M+Na+) 310.12193, found 310.12059; HPLC: ee: 91%, Chiralpak AD-H (250 × 4.6 mm), 
flow 1.0 mL/min, n-heptane/2-propanol 80/20, retention time: major enantiomer 14.6 min,; minor 
enantiomer: 9.9 min. Rf 0.26 (EtOAc/heptane 1/2). 
 
(S)-4-((4-Methoxyphenyl)amino)-4-(o-tolyl)butan-2-one (7)  
p-Anisidine (2.00 g, 16.2 mmol) was dissolved in DMSO (20 mL) and o-
tolualdehyde (1.88 mL, 2.00 g, 16.2 mmol) and L-proline (373 mg, 3.24 mmol) 
were added. After 2 h of stirring, acetone was added (80 mL). The resulting 
mixture was stirred for 19 h and quenched with saturated aqueous NaHCO3 (100 
mL). It was subsequently extracted with a mixture of EtOAc and heptane (1:1, 2 × 100 mL). The combined 
organic layers were dried (Na2SO4) and concentrated. The residue was purified using column 
chromatography (EtOAc/heptane 1/9 → 1/4). Yield 2.34 g (8.26 mmol, 51%) of an orange oil. 1H NMR 
(CDCl3, 300 MHz) δ (ppm) 7.41–7.33 (m, 1H), 7.19–7.12 (m, 3H), 6.73–6.65 (m, 2H), 6.50–6.40 (m, 2H), 
4.96 (dd, J = 7.9, 5.3 Hz, 1H), 4.07 (bs, 1H), 3.69 (s, 3H), 2.87 (dd, J = 15.7, 5.1 Hz, 1H), 2.80 (dd, J = 15.9, 7.9 
Hz, 1H), 2.45 (s, 3H), 2.14 (s, 3H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 207.3, 152.3, 141.0, 140.4, 134.7, 
130.8, 127.1, 126.6, 125.2, 115.0, 114.8, 55.7, 51.6, 49.8, 30.5, 19.1, 10.0; IR (cm-1) 3383, 3022, 2947, 2831, 
1708, 1510, 1237; HRMS [ESI+ (m/z)]: calcd for C18H21NO2Na (M+Na+) 306.14700, found 306.14873; 
HPLC: ee: 96%, Chiralpak AD-H (250 × 4.6 mm), flow 1.0 mL/min, n-heptane/2-propanol 80/20, retention 
time: major enantiomer 11.9 min, minor enantiomer: 7.7 min.; Rf 0.33 (EtOAc/heptane 1/2). 
 
(R)-4-((4-Methoxyphenyl)amino)-6-methylheptan-2-one (8)  
p-Anisidine (2.00 g, 16.2 mmol) was dissolved in DMSO (20 mL) and 
isovaleraldehyde (1.74 mL, 2.00 g, 16.2 mmol) and L-proline (373 mg, 3.24 
mmol) were added. After 2 h of stirring, acetone was added (80 mL). The 
resulting mixture was stirred for 18 h and quenched with saturated aqueous 
NaHCO3 (100 mL). It was subsequently extracted with a mixture of EtOAc and heptane (1:1, 2 × 100 mL). 
The combined organic layers were dried (Na2SO4) and concentrated. The residue was purified using 
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column chromatography (EtOAc/heptane 1/9 → 1/4). Yield: 2.16 g (8.66 mmol, 53%) of a yellow oil. 1H 
NMR (CDCl3, 300 MHz,) δ (ppm) 6.80–6.73 (m, 2H), 6.62–6.54 (m, 2H), 3.85–3.75 (m, 1H), 3.73 (s, 3H), 
2.65 (dd, J = 16.1, 5.0 Hz, 1H), 2.54 (dd, J = 16.2, 6.5 Hz, 1H), 2.12 (s, 3H), 1.83–1.65 (m, 1H), 1.47 (ddd, J = 
14.2, 8.2, 6.1 Hz, 1H), 1.32 (ddd, J = 13.7, 8.0, 5.7 Hz, 1H), 0.92 (d, J = 6.6 Hz, 3H), 0.90 (d, J = 6.5 Hz, 3H); 13C 
NMR (CDCl3, 75 MHz) δ (ppm) 208.4, 152.2, 141.3, 115.0, 114.9, 55.7, 49.1, 48.1, 44.7, 31.0, 25.0, 22.9, 
22.3; HPLC: ee: 84%, Chiralpak AD-H (250 × 4.6 mm), flow 1.0 mL/min, n-heptane/2-propanol 80/20, 
retention time: major enantiomer 5.8 min, minor enantiomer: 6.5 min. 
Spectral data are in accordance with literature values.31 
 
(E)-Ethyl 2-((4-methoxyphenyl)imino)acetate (9a) 
Under an atmosphere of argon, ethyl glyoxylate (10 mL, ~50% in toluene) was dissolved in 
anhydrous toluene (250 mL). Molsieves (4Å, 50 g) and p-anisidine (5.54 g, 45 mmol) were 
added. The mixture was stirred for 22 h and filtered over celite. The filtrate was 
concentrated. The product was obtained as a dark yellow oil (9.28 g, 44.8 mmol, quant.) 1H NMR (CDCl3, 
300 MHz) δ (ppm) 7.94 (s, 1H), 7.40–7.33 (m, 2H), 6.98–6.89 (m, 2H), 4.41 (q, J = 7.1 Hz, 2H), 3.84 (s, 3H), 
1.40 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 75 MHz): δ (ppm) 163.6, 160.5, 148.0, 141.4, 123.6, 114.5, 61.9, 
55.5, 14.2. 
Spectral data are in accordance with literature values.32 
 
(S)-Ethyl 2-((4-methoxyphenyl)amino)-4-oxopentanoate (9)  
(E)-Ethyl 2-((4-methoxyphenyl)imino)acetate (9a) (3.36 g, 16.2 mmol) was 
dissolved in DMSO (20 mL) and acetone (80 mL) and L-proline were added. The 
resulting mixture was stirred for 18 h and quenched with aqueous NaHCO3. The 
resulting mixture was extracted with a mixture of EtOAc and heptane (1:1, 2 × 200 mL). The combined 
organic layers were dried (Na2SO4) and concentrated. The residue was taken up in diisopropyl ether (20 
mL) and washed with water (2 × 50 mL) and brine (50 mL). The organic layer was dried (Na2SO4) and 
concentrated. The product could be obtained as an orange oil in pure form without further purification 
(3.16 g, 11.9 mmol, 73%). 1H NMR (CDCl3, 300 MHz) δ (ppm) 6.83–6.71 (m, 2H), 6.70–6.57 (m, 2H), 4.33 (t, 
J = 5.6 Hz, 1H), 4.17 (q, J = 7.2 Hz, 2H), 3.74 (s, 3H), 2.96 (d, J = 5.6 Hz, 2H), 2.18 (s, 3H), 1.23 (t, J = 7.0 Hz, 
3H); 13C NMR (CDCl3, 75 MHz): δ (ppm) 205.8, 173.0, 153.1, 140.5, 115.8, 114.8, 61.4, 55.7, 54.3, 45.8, 30.4, 
14.1; HPLC: ee: >99%, Chiralpak AD-H (250 × 4.6 mm), flow 1.0 mL/min, n-heptane/2-propanol/ethanol 
80/10/10, retention time: major enantiomer 16.8 min; minor enantiomer: 16.0 min. 
Spectral data are in accordance with literature values.33 
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(2R,4S)-4-(3,4-Dimethoxyphenyl)-4-((4-methoxyphenyl)amino)butan-2-ol ((R,S)-2) 
D-α-Methylphenylglycinamide (4.12 mg, 0.025 mmol), K2CO3 (50 mg, 0.361 mmol) 
and IrCp*Cl2 (2 mg, 2.51 μmol) were taken up in MeCN (dry, 5 mL). The mixture 
was stirred for 30 min at 70 °C and cooled to 0 °C. The solution was filtered and 
concentrated. (S)-4-(3,4-Dimethoxyphenyl)-4-((4-methoxyphenyl)amino)butan-
2-one ((S)-1) (41 mg, 0.125 mmol) was added to the catalyst together with dry 2-
propanol (10 mL). The resulting reaction mixture was stirred for 20 h under argon, poured out in a 
mixture of saturated aqueous NaHCO3 (20 mL) and DCM (20 mL). The aqueous layer was extracted with 
DCM (2 × 20 mL). The combined organic layers were dried (Na2SO4) and concentrated. The residue was 
purified by column chromatography (EtOAc in heptane, 1/9 → 3/7). The product was obtained as an off-
white sticky oil (quant. yield). 1H NMR (CDCl3, 300 MHz) δ (ppm) 7.04–6.43 (m, 7H), 4.49 (t, J = 6.1 Hz, 1H), 
4.18–3.95 (m, 1H), 3.84 (s, 6H), 3.69 (s, 3H), 2.01–1.78 (m, 2H), 1.25 (d, J = 6.2 Hz, 3H); 13C NMR (CDCl3, 75 
MHz) δ (ppm) 152.1, 149.1, 147.8, 141.4, 136.5, 118.1, 115.1, 114.7, 111.2, 109.4, 65.3, 56.2, 55.8 (2C), 
55.7, 46.7, 23.7. IR (cm-1) 3383, 2933, 2832, 1511, 1234; HRMS [ESI+ (m/z)]: calcd for C19H25NO4 (M+H+) 
332.18618, found 332.18626; HPLC: d.r.: 96.4 Chiralpak AD-H (250 × 4.6 mm), flow 1.0 mL/min, 
heptane/2-propanol 80/20, retention time: major diastereomer 15.7 min, minor diastereomer: 24.0 min. 
Rf 0.17 (EtOAc/heptane 1:1). 
 
(2R,4S)-4-(4-Fluorophenyl)-4-((4-methoxyphenyl)amino)butan-2-ol ((R,S)-10) 
D-α-Methylphenylglycinamide (8.24 mg, 0.050 mmol), K2CO3 (100 mg, 0.723 
mmol) and IrCp*Cl2 (4 mg, 5.02 μmol) were taken up in MeCN (dry, 5 mL). The 
mixture was stirred for 30 min at 70 °C and cooled to 0 °C. The solution was 
filtered and concentrated. The residue was taken up in 4 mL dry 2-propanol. (S)-
4-(4-Fluorophenyl)-4-((4-methoxyphenyl)amino)butan-2-one (6) (36 mg, 0.125 mmol) was dissolved in 
dry 2-propanol (8 mL), followed by addition of 2 mL of the catalyst mixture. The resulting reaction 
mixture was stirred under argon for 2 h and poured out in a mixture of a half-saturated aqueous NaHCO3 
(20 mL) and DCM (20 mL). The aqueous layer was extracted with DCM (2 × 20 mL). The combined organic 
layers were dried (Na2SO4) and concentrated. The residue was purified by column chromatography 
(EtOAc/n-heptane, 1/9 → 3/7). The product was obtained as an off-white solid (32 mg, 0.111 mmol, 88%). 
1H NMR (CDCl3, 300 MHz) δ (ppm) 7.36–7.18 (m, 2H), 7.09–6.89 (m, 2H), 6.68 (d, J = 8.6 Hz, 2H), 6.47 (d, J 
= 8.7 Hz, 2H), 4.56 (dd, J = 6.9, 5.1 Hz, 0.9H), 4.43 (dd, J = 8.8, 5.0 Hz, 0.1H), 4.10–3.90 (dt, J = 19.0, 9.5 Hz, 
1H), 3.69 (s, 3H), 1.98–1.76 (m, 2H), 1.24 (d, J = 6.2 Hz, 3H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 161.69 (d, J 
= 244.5 Hz), 152.11 (s), 141.16 (s), 139.51 (s), 127.71 (d, J = 7.9 Hz), 115.41 (d, J = 21.3 Hz), 114.91 (s), 
114.76 (s), 65.24 (s), 55.70 (s), 55.58 (s), 46.74 (s), 23.81 (s); IR (cm-1) 3381, 2969, 1510, 1235; HRMS 
[ESI+ (m/z)]: calcd for C17H21FNO2 (M+H+) 290.15563, found 290.15600 HPLC d.r. 95:5 Chiralpak AD-H 
(250 × 4.6 mm), flow 1.0 mL/min, n-heptane/2-propanol 80/20, retention time: major diastereomer 13.7 
min, minor diastereomer: 24.1 min. Rf 0.17 (EtOAc/heptane 1/2). 
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(2R,4S)-4-((4-Methoxyphenyl)amino)-4-(o-tolyl)butan-2-ol ((R,S)-11) 
D-α-Methylphenylglycinamide (8.24 mg, 0.050 mmol), K2CO3 (100 mg, 0.723 
mmol) and IrCp*Cl2 (4 mg, 5.02 μmol) were taken up in MeCN (dry, 5 mL). The 
mixture was stirred for 30 min at 70 °C and cooled to 0 °C. The solution was 
filtered and concentrated. The residue was taken up in 4 mL dry 2-propanol. (S)-
4-((4-Methoxyphenyl)amino)-4-(o-tolyl)butan-2-one (7) (35 mg, 0.125 mmol) 
was dissolved in dry 2-propanol (8 mL), followed by addition of 2 mL of the catalyst mixture. The resulting 
reaction mixture was stirred for 1.5 h under argon and quenched with half-saturated aqueous NaHCO3 (30 
mL) and DCM (30 mL). After separation, the aqueous layer was extracted with DCM (2 × 10 mL). The 
combined organic layers were dried (Na2SO4) and concentrated. The residue was purified by column 
chromatography (EtOAc/heptane, 1/9 → 3/7) The product was obtained as a yellow oil (27 mg, 0.095 
mmol, 76%).1H NMR (CDCl3, 300 MHz) δ (ppm) 7.50–7.33 (m, 1H), 7.22–7.06 (m, 3H), 6.68 (d, J = 8.6 Hz, 
2H), 6.45 (d, J = 8.0 Hz, 2H), 4.94–4.72 (m, 1H), 4.20–4.00 (m, 1H), 3.68 (s, 3H), 2.43 (s, 3H), 1.92–1.72 (m, 
2H), 1.26 (d, J = 6.1 Hz, 3H); 13C NMR (CDCl3, 75 MHz): δ (ppm) 152.1, 141.5, 141.3, 134.5, 130.7, 126.6, 
126.4, 125.2, 114.8, 65.5, 55.7, 52.3, 45.0, 23.8, 19.1; IR (cm-1) 3391, 2966, 1511, 1235, 1040, 819; HRMS 
[ESI+ (m/z)]: calcd for C18H24NO2 (M+H+) 286.18070, found 286.18151; HPLC d.r. 97:3 Chiralpak AD-H 
(250 × 4.6 mm), flow 1.0 mL/min, heptane/2-propanol 80/20, retention time: major diastereomer 14.7 
min; minor diastereomer: 23.2 min; Rf 0.17 (EtOAc/heptane 1:1). 
 
(2R,4R)-4-((4-Methoxyphenyl)amino)-6-methylheptan-2-ol ((R,R)-12) 
Under an atmosphere of argon, D-α-methylphenylglycinamide (8.24 mg, 0.050 
mmol), K2CO3 (100 mg, 0.723 mmol) and IrCp*Cl2 (4 mg, 5.02 μmol) were taken 
up in MeCN (dry, 5 mL). The mixture was stirred for 30 min at 70°C and cooled to 
0°C. The solution was filtered and concentrated. The residue was taken up in 4 
mL dry 2-propanol. (R)-4-((4-Methoxyphenyl)amino)-6-methylheptan-2-one (8) (33 mg, 0.125 mmol) 
was placed under argon and dissolved in dry 2-propanol (8 mL). 2 mL of the catalyst solution was added 
and the mixture was stirred for 18 h. The reaction mixture was poured out in a mixture of a an aqueous 
half-saturated solution of NaHCO3 (20 mL) and DCM (20 mL). After separation, the aqueous phase was 
extracted with DCM (2 × 20 mL). The combined organic layers were dried (Na2SO4) and concentrated. The 
residue was purified by column chromatography (EtOAc/heptane 1/9 → 1/4). The product was obtained 
as a yellow oil (31 mg, 0.123 mmol, 99%). 1H NMR (CDCl3, 300 MHz) δ (ppm) 6.82–6.61 (m, 4H, both 
diastereomers), 4.14–4.02 (m, 1H, both diastereomers), 3.75 (s, 3/5H, minor diastereomer), 3.74 (s, 
12/5H, major diastereomer), 3.59 (qd, J = 7.0, 3.5 Hz, 4/5H, major diastereomer), 3.52–3.41 (m, 1/5H, 
minor diastereomer), 3.40–2.75 (bs, 2H, both diastereomers), 1.83–1.58 (m, 2H, both diastereomers), 
1.56–1.24 (m, 3H,both diastereomers), 1.21 (d, J = 6.3 Hz, 12/5H, major diastereomer), 1.20 (d, J = 6.2 Hz, 
3/5H, minor diastereomer), 0.92 (d, J = 6.6 Hz, 12/5H), 0.87 (d, J = 6.6 Hz, 3/5H), 0.88 (d, J = 6.5 Hz, 
12/5H), 0.84 (d, J = 6.6 Hz, 3/5H); 13C NMR (CDCl3, 75 MHz): δ (ppm) 153.3 (minor diastereomer), 152.5 
(major diasteromer), 141.8 (major diastereomer), 140.7 (minor diastereomer), 117.1 (minor 
diastereomer), 115.5 (major diastereomer), 114.9 (major diastereomer), 114.8 (minor diastereomer), 
68.6 (minor diastereomer), 65.3 (major diastereomer), 55.7 (major diastereomer), 55.6 (minor 
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diastereomer), 54.9 (minor diastereomer), 50.4 (major diastereomer), 45.6 (minor diastereomer), 44.9 
(major diastereomer), 43.2 (minor diastereomer), 42.9 (major diastereomer), 25.0 (major diastereomer), 
24.9 (minor diastereomer), 24.0 (both diastereomers), 23.3 (minor diastereomer), 23.0 (major 
diastereomer), 22.5 (major diastereomer), 22.0 (minor diastereomer). IR (cm-1, film from DCM) 3367, 
2955, 1510, 1236; HRMS [ESI+ (m/z)]: calcd for C12H26N1O2 (M+H+) 252.19635, found 252.19628; HPLC: 
d.r. 76:24 (Chiralpak AD-H (250 × 4.6 mm), flow 0.3 mL/min, n-heptane/2-propanol/ethanol 80/15/5, 
retention time: major diastereomer 20.7 min; minor diastereomer 21.7 min; Rf 0.29 (EtOAc/heptane 1/2). 
 
(2S,4R)-Ethyl 4-hydroxy-2-((4-methoxyphenyl)amino)pentanoate ((R,S)-13) 
Under an atmosphere of argon, D-α-methylphenylglycinamide (8.24 mg, 0.050 
mmol), K2CO3 (100 mg, 0.723 mmol) and IrCp*Cl2 (4 mg, 5.02 μmol) were taken 
up in MeCN (dry, 5 mL). The mixture was stirred for 30 min at 70°C and cooled to 
0°C. The solution was filtered and concentrated. The residue was taken up in 4 
mL dry 2-propanol. (R)-4-((4-Methoxyphenyl)amino)-6-methylheptan-2-one (9) (33 mg, 0.12 mmol) was 
placed under argon and dissolved in dry 2-propanol (8 mL). 2 mL of the catalyst solution was added and 
the mixture was stirred for 18 h. The reaction mixture was poured out in a mixture of a an aqueous half-
saturated solution of NaHCO3 (20 mL) and DCM (20 mL). After separation, the aqueous phase was 
extracted with DCM (2 × 20 mL). The combined organic layers were dried (Na2SO4) and concentrated. The 
residue was purified by column chromatography (EtOAc/heptane 1/9 → 1/4 → 1/2). The product was 
obtained as a yellow oil (33 mg, 0.12 mmol, 100%) 1H NMR (CDCl3, 300 MHz) δ 6.82–6.63 (m, 4H, both 
diastereomers), 4.25–3.99 (m, 2H), 4.16 (q, J = 7.0 Hz, 2H, both diastereomers, 3.74 (s, 0.18 × 3H, minor 
diastereomer), 3.73 (s, 0.82 × 3H, major diastereomer), 2.00–1.68 (m, 2H, both diastereomers), 1.25 (d, J = 
6.3 Hz, 3H, both diastereomers), 1.23 (t, J = 7.1 Hz, 0.82 × 3H, major diastereomer), 1.22 (t, J = 7.1 Hz, 0.18 
× 3H); 13C NMR (CDCl3, 75 MHz): δ (ppm) 174.4 (major diastereomer), 173.7 (minor diastereomer), 154.0 
(minor diastereomer), 153.2 (major diastereomer), 140.9 (major diastereomer), 140.2 (minor 
diastereomer), 117.4 (minor diastereomer), 115.9 (major diastereomer), 114.8 (major diastereomer), 
114.8 (minor diastereomer) , 67.6 (minor diastereomer), 65.2 (major diastereomer), 61.2 (minor 
diastereomer), 61.2 (major diastereomer), 59.2 (minor diastereomer), 56.2 (major diastereomer), 55.6 
(major diastereomer), 55.6 (minor diastereomer), 41.2 (both diastereomers), 23.8 (major diastereomer), 
23.6 (minor diastereomer), 14.2 (both diastereomers); IR (cm-1) 3368, 2968, 1728, 1513, 1238; HRMS 
[ESI+ (m/z)]: calcd for C14H22N1O4 (M+H+) 268.15488, found 268.15511 HPLC: d.r. 79:21 Chiralpak AD-H 
(250 × 4.6 mm), flow 1.0 mL/min, heptane/2-propanol/ethanol 80/10/10, retention time: major 
diastereomer 11.2 min; minor diastereomer: 14.6 min; Rf 0.12 (EtOAc/heptane 1/2). 
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(2S,4S)-4-(3,4-Dimethoxyphenyl)-4-((4-methoxyphenyl)amino)butan-2-ol ((S,S)-2) 
Rh(COD)2BF4 (16.24 mg, 0.040 mmol) and (R)-BINAP (25 mg, 0.040) were taken 
up in 2 mL DCM and heated to 50°C for 30 min. The catalyst solution was added to 
a solution of (S)-4-(3,4-dimethoxyphenyl)-4-((4-methoxyphenyl)amino)butan-2-
one ((S)-1) (41 mg, 0.125 mmol) in DCM (10 mL) in an autoclave. Hydrogen 
pressure was applied (25 bar) and the mixture was heated to 50°C and stirred for 
19 h. The mixture was diluted with DCM (20 mL) and aqueous NaHCO3 (20 mL). 
After separation, the aqueous layer was extracted with DCM (2 × 20 mL). The combined organic layers 
were dried (Na2SO4) and concentrated. The residue was purified by column chromatography 
(EtOAc/heptane 1/9 → 3/7).Yield: 32 mg (77%) of a white solid. 1H NMR (CDCl3, 300 MHz) δ (ppm) 6.89–
6.75 (m, 3H), 6.69 (d, J = 8.6 Hz, 2H), 6.57 (d, J = 8.6 Hz, 2H), 4.39 (dd, J = 8.5, 5.1 Hz, 1H), 4.18–3.94 (m, 
1H), 3.84 (s, 6H), 3.70 (s, 3H), 1.98–1.74 (m, 2H), 1.23 (d, J = 6.1 Hz, 3H); 13C NMR (CDCl3, 75 MHz): δ 
(ppm) 152.9, 149.2, 141.0, 136.5, 125.9, 118.1, 116.6, 114.6, 111.2, 109.3, 68.0, 59.9, 55.9 (2C), 55.7, 46.9, 
24.3; IR (cm-1) 3367, 2934, 2834, 1511, 1234, 1028; HRMS [ESI+ (m/z)]: calcd for C19H25NO4Na (M+Na+) 
354.16813, found 354.16781; HPLC d.r. >99:1 Chiralpak AD-H (250 × 4.6 mm), flow 1.0 mL/min, 
heptane/2-propanol 80/20, retention time: major diastereomer 23.8 min; minor diastereomer: n/a. (see 
(R,S)-2) Rf 0.21 (EtOAc/heptane 1/1). 
 
(2S,4S)-4-(4-Fluorophenyl)-4-((4-methoxyphenyl)amino)butan-2-ol ((S,S)-10) 
Rh(COD)2BF4 (15.2 mg, 0.037 mmol) and (R)-BINAP (23.35 mg, 0.037 mmol) 
were taken up in 2 mL DCM. 0.33 mL of the catalyst solution was added to a tube, 
containing (S)-4-(4-fluorophenyl)-4-((4-methoxyphenyl)amino)butan-2-one (6) 
(36 mg, 0.125 mmol) in DCM (5 mL). Hydrogen pressure was applied (25 bar) and 
the mixture was stirred at 300K for 44 h. The reaction mixture was concentrated 
and the crude product was purified by column chromatography (heptane → 22% EtOAc in heptane). Yield: 
27 mg (76%) of an off-white solid). 1H NMR (CDCl3, 300 MHz) δ (ppm) 7.31–7.22 (m, 2H), 7.03–6.93 (m, 
2H), 6.72–6.65 (m, 2H), 6.57–6.50 (m, 2H), 4.44 (dd, J = 9.0, 5.0 Hz, 1H), 4.09–3.94 (m, 1H), 3.69 (s, 3H), 
1.95–1.72 (m, 2H), 1.23 (d, J = 6.2 Hz, 3H); 13C NMR (CDCl3, 75 MHz): δ (ppm) 161.84 (d, J = 245.5 Hz), 
160.2, 153.0, 140.3, 139.3, 127.73 (d, J = 7.9 Hz), 116.6, 115.51 (d, J = 21.4 Hz), 114.7. IR (cm-1) 3366, 2966, 
2931, 1510, 1234; HRMS [ESI+ (m/z)]: calcd for C17H21F1N1O2 (M+H+) 299.15563, found 290.15677; HPLC: 
d.r. >99:1 (syn/anti) Chiralpak AD-H (250 × 4.6 mm), flow 1.0 mL/min, heptane /2-propanol 80/20, 
retention time: major diastereomer 23.5 min; minor diastereomer: n/a. (see (R,S)-10); Rf 0.38 
(EtOAc/heptane 1/1). 
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(2S,4S)-4-((4-Methoxyphenyl)amino)-4-(o-tolyl)butan-2-ol ((S,S)-11) 
Rh(COD)2BF4 (15.2 mg, 0.037 mmol) and (R)-BINAP (23.35 mg, 0.037 mmol) 
were taken up in 2 mL DCM. Catalyst solution (0.33 mL) was added to a tube, 
containing (S)-4-((4-methoxyphenyl)amino)-4-(o-tolyl)butan-2-one (7) (36 mg, 
0.125 mmol) in DCM (5 mL). Hydrogen pressure was applied (25 bar) and the 
mixture was stirred at 300 K for 44 h. The reaction mixture was concentrated and 
purified by column chromatography (heptane → 30% EtOAc in heptane). Yield: 29 mg (81%) of colorless 
wax. 1H NMR (CDCl3, 300 MHz) δ (ppm) 7.37–7.27 (m, 1H), 7.19–7.09 (m, 3H), 6.73–6.65 (m, 2H), 6.56–
6.47 (m, 2H), 4.75–4.63 (m, 1H), 4.11 (dd, J = 12.2, 6.1 Hz, 1H), 3.69 (s, 3H), 2.38 (s, 3H), 1.85–1.74 (m, 2H), 
1.24 (d, J = 6.2 Hz, 3H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 152.8, 141.7, 140.8, 134.5, 130.7, 126.7, 126.6, 
124.6, 116.2, 114.7, 68.6, 56.0, 55.6, 45.9, 24.2, 19.2; IR (cm-1) 3671, 2985, 2900, 1406, 1393, 1066, 1055; 
HRMS [ESI+ (m/z)]: calcd for C18H24NO2 (M+H+) 286.18070, found 286.18105; HPLC: d.r. > 99:1 Chiralpak 
AD-H (250 × 4.6 mm), flow 1.0 mL/min, n-heptane/2-propanol 80/20, retention time: major diastereomer 
22.9 min, minor diastereomer: n/a. (see (R,S)-11); Rf 0.45 (EtOAc/heptane 1/1). 
 
(2S,4R)-4-((4-Methoxyphenyl)amino)-6-methylheptan-2-ol ((S,R)-12) 
Rh(COD)2BF4 (16.24 mg, 0.040 mmol) and (R)-BINAP (25 mg, 0.040) were taken 
up in 2 mL DCM and heated to 50°C for 30 min. The catalyst solution was added to 
a solution of (R)-4-((4-methoxyphenyl)amino)-6-methylheptan-2-one (8) (41 mg, 
0.125 mmol) in DCM (10 mL) in an autoclave. Hydrogen pressure was applied (25 
bar) and the mixture was heated to 50 °C and stirred for 15 h. The mixture was diluted with DCM (20 mL) 
and an aqueous solution of NaHCO3 (20 mL). After separation, the aqueous layer was extracted with DCM 
(2 × 20 mL). The combined organic layers were dried (Na2SO4) and concentrated. The product was 
purified by column chromatography (EtOAc/heptane 1/9 → 3/7) and obtained as a brown oil. Yield: 77%. 
1H NMR (CDCl3, 300 MHz) δ (ppm) 6.84–6.75 (m, 2H), 6.74–6.64 (m, 2H), 4.13–4.00 (m, 1H), 3.76 (s, 3H), 
3.53–3.39 (m, 1H), 1.78–1.16 (m, 5H), 1.20 (d, J = 6.2 Hz, 3H), 0.94–0.76 (m, 6H); 13C NMR (CDCl3, 75 MHz) 
δ (ppm) 153.3, 140.7, 117.2, 114.8, 68.7, 55.7, 54.9, 45.7, 43.2, 24.9, 24.0, 23.3, 22.1; IR (cm-1) 3367, 2954, 
2929, 1510, 1236; HRMS [ESI+ (m/z)]: calcd for C12H26NO2 (M+H+) 252.19635, found 252.19470; Rf 0.50 
(EtOAc/heptane 1/1) HPLC: d.r. 98:2 Chiralpak AD-H (250 × 4.6 mm), flow 0.3 mL/min, heptane/2-
propanol/ethanol 80/15/5, retention time: major diastereomer 21.7 min, minor diastereomer: 20.7 min. 
 
(2S,4S)-Ethyl 4-hydroxy-2-((4-methoxyphenyl)amino)pentanoate ((S,S)-13) 
Rh(COD)2BF4 (16.24 mg, 0.040 mmol) and (R)-BINAP (25 mg, 0.040) were taken up in 2 mL DCM and 
heated to 50°C for 30 min. The catalyst solution was added to a solution of (S)-
ethyl 2-((4-methoxyphenyl)amino)-4-oxopentanoate (9) (33 mg, 0.125 mmol) in 
DCM (10 mL) in an autoclave. Hydrogen pressure was applied (25 bar) and the 
mixture was heated to 50 °C and stirred for 17 h. The mixture was diluted with 
DCM (20 mL) and aqueous NaHCO3 (20 mL). After separation, the aqueous layer was extracted with DCM 
(2 × 20 mL). The combined organic layers were dried (Na2SO4) and concentrated. The product was 
purified by column chromatography (EtOAc/heptane 1/9 → 3/7) and obtained as an off-white solid. Yield: 
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19 mg (0.070 mmol, 56%) 1H NMR (CDCl3, 300 MHz) δ (ppm) 6.81–6.69 (m, 4H), 4.22–4.04 (m, 4H), 3.74 
(s, 3H), 1.94 (ddd, J = 14.2, 4.3, 2.5 Hz, 1H), 1.78 (dt, J = 14.3 Hz, 9.5 Hz, 1H, ), 1.23 (d, J = 6.3 Hz, 3H), 1.22 
(t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 173.7, 154.0, 140.2, 117.5, 114.8, 67.7, 61.3, 59.3, 
55.6, 41.2, 23.6, 14.1; IR (cm-1) 3367, 2967, 2932, 1728, 1511, 1236; HRMS [ESI+ (m/z)]: calcd for 
C14H22NO4 (M+H+) 268.15488, found 268.15450; HPLC: d.r. >99:1 Chiralpak AD-H (250 × 4.6 mm), flow 
1.0 mL/min, heptane/2-propanol/ethanol 80/10/10, retention time: major diastereomer 14.5 min, minor 
diastereomer: n/a. (see (R,S)-13), Rf 0.30 (EtOAc/heptane 1/1). 
 
Larger scale synthesis of (S,S)-2 
(2S,4S)-4-(3,4-Dimethoxyphenyl)-4-((4-methoxyphenyl)amino)butan-2-ol (S,S)-2 
Rh(COD)2BF4 (31 mg, 0.076 mmol) and (R)-BINAP (47 mg, 0.076 mmol) were 
dissolved in DCM (5 mL). (S)-4-(3,4-dimethoxyphenyl)-4-((4-
methoxyphenyl)amino)butan-2-one (S)-1 (500 mg, 1.52 mmol) was added and 
the mixture was put under H2 (autoclave, 25 bar) and stirred for 3 days. After 
release of the H2 pressure, the reaction mixture was diluted with DCM (50 mL) 
and washed with saturated aqueous NaHCO3. The organic layer was dried (Na2SO4) and concentrated. The 
residue was purified by column chromatography (silica eluted with EtOAc/heptane 1/2 → 1/1), which 
yielded an off-white solid (211 mg, 0.64 mmol, 42%). 1H NMR (CDCl3, 300 MHz,) δ (ppm) 6.86–6.76 (m, 
3H), 6.73–6.66 (m, 2H), 6.61–6.53 (m, 2H), 4.39 (dd, J = 8.9, 4.9 Hz, 1H), 4.11–3.99 (m, 1H), 3.84 (s, 3H), 
3.84 (s, 3H), 3.70 (s, 3H), 1.96–1.76 (m, 2H), 1.23 (d, J = 6.2 Hz, 3H). 1H NMR data in accordance with data 
obtained from (S,S)-2. 
 
Suitable crystals for X-ray analysis were grown from EtOAc. The resulting crystals were analysed by X-ray 
analysis (Table 5). 
 
Table 5 Crystal data and structure refinements for (S,S)-2. 
Crystal colour  
Crystal shape  
Crystal size  
Empirical formula   
Formula weight  
Temperature  
Radiation / Wavelength   
Crystal system, space group   
Unit cell dimensions,  a 
528 reflections,   b 
2.340 < θ < 27.500  c  
   α 
   β 
   γ 
Volume     
Z, Calculated density    
Absorption coefficient   
Diffractometer / scan  
 
F(000)      
translucent colourless   
regular rod        
0.50 × 0.29 × 0.25 mm 
C19H25NO4   
331.40  
208(2) K  
MoKa (graphite mon.) / 0.71073 Å 
Orthorhombic, P 21 21 21  
5.8467(2) Å 
17.0069(5) Å 
17.3740(9) Å  
90°   
90°                                                                                               
90°                                                                                               
1727.57(12) Å3  
4, 1.274 Mg/m3  
0.089 mm-1  
Nonius KappaCCD with area detector f and w scan  
712 
2.34 to 27.50°.  
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θ range for data collection   
Index ranges   
Reflections collected / unique   
Reflections observed   
Completeness to 2θ = 27.50   
Absorption correction  
 
Refinement method          
Computing   
Data / restraints / parameters  
Goodness-of-fit on F2       
SHELXL-97 weight parameters  
Final R indices [I>2σ (I)]  
R indices (all data)    
Largest diff. peak and hole   
 
-7<=h<=7, -22<=k<=22, -22<=l<=22 
37079 / 3975 [R(int) = 0.0237] 
3510 ([Io>2σ(Io)]) 
100.0% 
SADABS multiscan correction (Sheldrick, 1996) 
Full-matrix least-squares on F2 
 
 
SHELXL-97 (Sheldrick, 1997) 
3975 / 0 / 222 
1.079 
0.0365, 0.4031 
R1 = 0.0358, wR2 = 0.0793  
R1 = 0.0445, wR2 = 0.0841  
0.199 and -0.210 e.A-3 
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5 
A PICTET–SPENGLER ENTRY  
INTO 3,4-DISUBSTITUTED 
TETRAHYDROISOQUINOLINES 
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5.1 Introduction 
5.1.1 General introduction 
The tetrahydroisoquinoline skeleton is frequently encountered in naturally occurring alkaloids 
such as salsolinol (1),1 which plays a role in Parkinson’s disease, addiction and physiological 
regulatory functions, and michellamine B (2),2 an alkaloid that shows anti-HIV-1 properties. The 
tetrahydroisoquinoline motif is also present in other drug or drug-like molecules, e.g. the ACE-
inhibitor quinapril (3).3 
 
Figure 1 Salsolinol (1), michellamine B (2) and quinapril (3). 
 
Consequently, many synthetic methods to prepare members of this biologically relevant class of 
molecules have been developed over the years.4 An important strategy proceeds through a 
Pictet-Spengler5 condensation of β-arylethylamines (4) with an aldehyde or a ketone or a 
synthetic equivalent thereof (Scheme 1). 
 
Scheme 1 The original Pictet–Spengler reaction. 
 
In the Pictet-Spengler reaction, a β-arylethylamine 6 is converted into a hemiaminal upon 
treatment with the carbonyl compound 7. This hemiaminal is then dehydrated under acidic 
conditions to form the iminium ion 8, which undergoes a 6-endo-trig cyclisation to form the six-
membered ring structure (Scheme 2). The Pictet–Spengler reaction, which in fact is an 
electrophilic aromatic substitution, usually proceeds most effectively when electron rich β-
arylethylamines are employed.6 
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Scheme 2 The Pictet–Spengler reaction. 
 
5.1.2 Stereoselective Pictet–Spengler approaches to tetrahydroisoquinolines 
Although many asymmetric stereoselective routes have been developed throughout the years, 
only a few give access to enantio- and diastereomerically pure 3,4-disubstituted 
tetrahydroisoquinolines.7 As has been described in this thesis, the proline-catalysed Mannich 
reaction is an outstanding tool to prepare α,β-disubstituted amines 12 from enolisable 
aldehydes (13) and imines (14). We envisaged to take advantage of the excellent control of 
chirality in this reaction for the synthesis of enantio- and diastereomerically pure 3,4-
disubstituted tetrahydroisoquinolines 10, by transforming the Mannich bases 12 into these 
valuable target compounds (Scheme 3). 
 
Scheme 3 Retrosynthesis of 3,4-disubstituted tetrahydroisoquinolines. 
 
5.2 Non-activated phenylacetaldehyde as the Mannich donor 
We set out preparing the Mannich product of phenylacetaldehyde and an acceptor imine. 
Phenylacetaldehyde is commercially available and has been described as suitable donor 
aldehyde in the proline-catalysed Mannich reaction. While various examples of aldehydes as 
Mannich donors appeared in the literature starting from 2000, the first example of employing 
phenylacetaldehyde (15) in the proline-catalysed Mannich reaction was reported by the group 
of Janey in 2006.8 They observed that the reaction of phenylacetaldehyde (15) with the N-PMP 
imine of ethyl glyoxylate (16) in the presence of L-proline and with THF as the solvent led to the 
formation of α-aryl-β-amino aldehyde 17 in a stereoselective manner. Acetic acid was added in 
the reduction step to prevent lactonisation and epimerisation. As a final step, the ethyl ester was 
transformed into amide 19 (Scheme 4). 
 
To our delight, while we were performing our research, Pietruszka and co-workers reported the 
discovery of a new catalyst ((S)-indoline-3-carboxylic acid), which also accepts 
phenylacetaldehyde as the Mannich donor.9 Unlike proline, its use leads to anti-selective 
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formation of the desired β-amino aldehydes (18) (Scheme 4), which can obviously be converted 
into the corresponding alcohols. 
 
Scheme 4 Syn- and anti-selective formation of 2-phenyl-3-amino aldehydes 17 and 18. 
 
Following the reaction protocol of the Janey group, unfortunately we did not observe any 
conversion into the desired β-amino aldehyde. Interestingly, after adding a small amount of 
water to the reaction mixture, the desired product started to form promptly.10 Upon subsequent 
reduction and amidation, the hydroxy amide 19 was indeed obtained fully stereoselectively in 
41% yield. 
 
Initially, the N-PMP protected amino alcohol 19 was subjected to Pictet–Spengler conditions 
(paraformaldehyde, formic acid, 80 °C), which as anticipated would lead to the corresponding 
iminium ion 21. Not entirely unexpectedly, iminium ion 21, which is possibly in equilibrium 
with aminal 22, was subsequently reduced by formic acid, following the Eschweiler–Clarke 
pathway. To our surprise, the methylated intermediate 24 underwent lactonisation, despite the 
presence of the relatively unreactive pyrrolidine amide, to form 25 as the major product 
(Scheme 5). 
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Scheme 5 Eschweiler–Clarke N-methylation followed by lactonisation. 
 
Possibly, lactonisation takes place prior to reduction, which leads to the formation of a trans-
substituted lactone 23 and consequently renders the resulting iminium ion inaccessible for 
attack by the phenyl ring. To prevent the lactonisation, the primary alcohol was protected as a 
tert-butyldiphenylsilyl (TBDPS) ether. Subsequently, the PMP group was removed through 
oxidation with periodic acid (See Chapter 2) giving rise to amine 26. 
 
Scheme 6 Synthesis of amine 27 and unsuccessful Pictet–Spengler cyclisation.  
 
We attempted to prepare the tetrahydroisoquinolines through treatment with either 
paraformaldehyde or ethyl glyoxylate under acidic conditions, but in neither of these cases, the 
desired products were isolated (Scheme 6). Because we were not able to prepare the cyclised 
products with unactivated phenylacetaldehydes, we decided to investigate the employment of 
more electron rich aromatic analogues. 
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5.3 Activated phenylacetaldehydes as the Mannich donors 
Unlike phenylacetaldehyde, which was used as the Mannich donor in the preceding section, its 
electron-rich congener 29 was not commercially available. We attempted to oxidise precursor 
28 to the aldehyde employing pyridinium chlorochromate (PCC) as the oxidant, but observed 
that the desired product was accompanied by the formation of veratraldehyde. This 
phenomenon has previously been described in detail by Kumar and Fernandes.11 We speculate 
that after formation of the chromate ester, formaldehyde is released, giving rise to a stabilised 
cation, which is subsequently attacked by HCrO3-. After deprotonation, veratraldehyde is formed. 
Swern oxidation also appeared unsuccessful in our hands, but treatment with Dess–Martin 
periodinane (DMP) furnished 29 in 67% yield. 
 
As a next step, the modified conditions of the Janey group were applied to prepare amino alcohol 
30. To prevent lactonisation, the primary alcohol was protected with a TBDPS group afterwards. 
The resulted protected amino alcohol 31 was then treated with 1 equiv of trifluoroacetic acid 
(TFA) and 1 equiv of ethyl glyoxylate. LRMS (ESI) analysis of the crude reaction mixture showed 
the formation of a major product with a mass of 709 (M+1), while we expected to find a mass of 
711 (M+1) (Scheme 7).  
 
Scheme 7 Synthesis and subsequent Pictet–Spengler cyclisation of 31, followed by oxidation. 
 
Although the mass spectrum of the crude reaction mixture showed a predominance of the side 
product, after workup and purification we unexpectedly obtained 32 as the main product (with 
a mass of 711) in 81% yield and a 3:1 ratio of diastereoisomers (Figure 2). We analysed the side 
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product (with a mass of 709), but neither 1H and 13C NMR spectroscopy nor IR spectroscopy 
enabled us to elucidate its structure. According to the 1H NMR spectrum (Figure 3), only one of 
the diastereoisomers was converted into the side product with the lower mass.  
 
Figure 2 1H NMR Spectrum of 32 (M = 711). 
 
Figure 3 1H NMR Spectrum of 34 (M = 709). 
 
 
Upon treatment of 28 with paraformaldehyde, we found similar behaviour: a new product was 
formed, but LRMS showed a mass of 637 instead of 639 (Scheme 7). 
 
These results in our view clearly indicate an oxidative process. Additionally, the 1H NMR signal 
of one the ethyl esters seems distorted. We hypothesise that in the presence of oxygen the N-
oxide is formed, which under ESI conditions eliminates to form the product with (M+1) of 709, 
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although we have not been able to find direct evidence. To impede spontaneous oxidation of the 
amine, we removed the electron-rich PMP group via treatment with periodic acid. The free 
amine was then treated with ethyl glyoxylate and TFA. We were pleased to find that the cyclic 
product 34 was readily formed as a 3:1 mixture of diastereoisomers (Scheme 8). Moreover, 1H 
NMR analysis showed that the attack of the aromatic ring had occurred regioselectively. 
 
 
Scheme 8 Oxidative removal of PMP-protecting group followed by Pictet–Spengler cyclisation. 
 
As a next step we investigated the use of other aldehydes besides ethyl glyoxylate. 
Tetrahydroisoquinoline 35 was obtained in moderate yield when paraformaldehyde was 
employed (Scheme 8). Employing benzaldehyde, we were not able to isolate any of the desired 
cyclised product at all.  
 
We subsequently prepared a second amino alcohol to further evaluate the scope of our route. 
Aldehyde 37 was prepared by ozonolysis of commercially available safrole (36). Subsequent 
Mannich reaction followed by reduction with NaBH4 afforded amino alcohol 38 as a single 
stereoisomer. After TBDPS protection and PMP removal, the corresponding amine 40 was 
subjected to Pictet-Spengler conditions. Whereas cyclisation in the presence of ethyl glyoxylate 
led to formation of the desired product 41 in a 4:1 diastereomeric ratio, albeit in rather low 
yield, cyclisation with formaldehyde did not lead to the the desired compound (Scheme 9). 
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Scheme 9 Synthesis of tetrahydroisoquinoline 41. 
 
To account for the low yield of 41, we analysed the major side product by 1H and 13C NMR and 
found that the α-keto ester 44 had been formed as well. A plausible mechanistic explanation 
involves initial formation of iminium ion 42, which could isomerise to the more stable 
trisubstituted iminium ion 43 if not attacked sufficiently fast by the electron-rich aromatic ring. 
During workup, the imine was then hydrolysed to the corresponding ketone (Scheme 10).  
 
 
Scheme 10 Side-product formation during Pictet–Spengler reaction of 40. 
 
5.4 Conclusions and outlook 
In conclusion, we have shown that the products of the Mannich reaction of ethyl glyoxylate-
derived imines and electron-rich phenylacetaldehydes are suitable precursors for the Brønsted 
acid-catalysed Pictet-Spengler reaction with activated aldehydes. Considering the fact that 
organocatalysts are available to produce all four isomers of the starting amino alcohol, we have 
demonstrated the proof-of-principle of a promising new route to 3,4-substituted 
tetrahydroisoquinolines. Unfortunately, within the timeframe of this research, we did not have 
the opportunity to fully explore the scope of this methodology. Moreover, some limitations of 
this route have already emerged. The aromatic rings of the amino aldehydes should be 
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sufficiently activated to capture the initially formed iminium ion and not all aldehydes, employed 
as acceptors in the Pictet–Spengler reaction always give rise to the formation of the desired 
product. Future research could inter alia include the synthesis of 1,3-amino alcohols starting 
from indole-, thiophene-, or furan-containing aldehydes to evaluate whether the scope of the 
methodology extends beyond the use of electron-rich aromatic phenylacetaldehydes. 
Furthermore, in this study we have only tested a limited number of conditions to effect the 
Pictet-Spengler reaction. We believe that the use of other (Lewis- or Brønsted) acids and other 
aldehydes or synthetic equivalents might lead to further extension of this method. 
 
5.5 Experimental section 
For general remarks, see section 2.8. 
 
(2S,3S)-4-Hydroxy-2-((4-methoxyphenyl)amino)-3-phenyl-1-(pyrrolidin-1-yl)butan-1-one (17) 
To a solution of (E)-ethyl 2-((4-methoxyphenyl)imino)acetate (See Chapter 4) (4.0 g, 
19.3 mmol) in anhydrous THF (50 mL) were added water (2.5 mL) and L-proline (378 
mg, 3.28 mmol). After stirring at rt for 15 min, the reaction mixture was cooled to –5 °C, 
and freshly distilled phenylacetaldehyde (2.26 mL, 19.3 mmol) was added. The 
resulting mixture was stirred for 18 h before addition of acetic acid (3.8 mL). After 
careful addition of NaBH4 (825 mg, 21.8 mmol), the resulting mixture was stirred at –5 
°C for 2 h and subsequently quenched with concentrated aqueous NaHCO3. The aqueous solution was 
extracted with EtOAc (100 mL). The organic layer was dried (Na2SO4) and concentrated. The residue was 
dissolved in THF (50 mL) and pyrrolidine (1.7 mL, 1.45 g, 20.4 mmol) and Na2CO3 (354 mg, 3.34 mmol) 
were added. The resulting mixture was heated to 50 °C and stirred for 2 h. After quenching with saturated 
aqueous NaHCO3 (100 mL), the mixture was extracted with EtOAc (100 mL). The organic layer was dried 
(Na2SO4) and concentrated. The residue was purified via column chromatography (EtOAc/heptane 3/1 → 
EtOAc), and the product was obtained as a white solid (2.80 g, 7.90 mmol, 41%). 1H NMR (CDCl3, 300 MHz) 
δ (ppm) 7.36–7.22 (m, 5H), 6.79–6.72 (m, 2H), 6.67–6.60 (m, 2H), 4.59–4.43 (m, 1H), 4.37–4.15 (m, 1H), 
4.17–3.90 (m, 2H), 3.73 (s, 3H), 3.53–3.25 (m, 4H), 3.08–2.88 (m, 2H), 1.89–1.60 (m, 4H); 13C NMR (CDCl3, 
75 MHz) δ (ppm) 171.0, 152.8, 141.1, 138.8, 128.6, 128.5, 127.3, 115.9, 114.9, 63.2, 59.8, 55.7, 49.6, 46.5, 
46.0, 26.0, 23.9. 
NMR spectral data are in accordance with literature values.8 
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(2S,3S)-4-((tert-Butyldiphenylsilyl)oxy)-2-((4-methoxyphenyl)amino)-3-phenyl-1-(pyrrolidin-1-
yl)butan-1-one (22) 
Under an atmosphere of argon, (2S,3S)-4-hydroxy-2-((4-
methoxyphenyl)amino)-3-phenyl-1-(pyrrolidin-1-yl)butan-1-one (21) (1.00 g, 
2.82 mmol) was dissolved in dry DCM (25 mL) and cooled to 0 °C. tert-
Butyl(chloro)diphenylsilane (1.46 mL, 1.55 g, 5.64 mmol) was added followed 
by imidazole (384 mg, 5.64 mmol). The resulting mixture was stirred for 5 min 
and then allowed to come to rt. After 30 min, saturated aqueous NaHCO3 (25 
mL) was added. After separation, the organic layer was dried (Na2SO4) and concentrated. The residue was 
purified via column chromatography (EtOAc/heptane 1/9 → 1/3 → 1/1), which yielded the product as a 
white solid (1.57 g, 2.65 mmol, 94%). 1H NMR (CDCl3, 300 MHz) δ (ppm) 7.66–7.59 (m, 2H), 7.57–7.50 (m, 
2H), 7.46–7.27 (m, 6H), 7.26–7.19 (m, 3H), 7.12–7.04 (m, 2H), 6.73 (s, 4H), 4.76 (dd, J = 8.6, 3.8 Hz, 1H), 
4.26 (dd, J = 10.1, 8.8 Hz, 1H), 4.06 (bs, 1H), 3.88 (dd, J = 10.1, 4.5 Hz, 1H), 3.55–3.30 (m, 4H), 3.18 (dt, J = 
8.6, 4.3 Hz, 1H), 1.94–1.72 (m, 4H), 1.14–1.06 (s, 9H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 171.0, 152.7, 
142.5, 137.6, 135.6, 135.5, 133.5, 133.0, 129.7, 129.7, 129.0, 128.0, 127.7, 127.6, 127.1, 116.2, 114.8, 64.2, 
57.8, 55.8, 50.4, 46.4, 45.8, 26.9 (3C), 26.1, 24.0, 19.2; IR (cm-1) 3069, 2952, 2931, 2874, 2858, 2832, 1643, 
1512, 1428, 1112, 701; HRMS [ESI+ (m/z)]: calcd for C37H45N2O3Si (M+H+) 593.31994, found 593.31800; 
HPLC: ee > 99% Chiralpak AD-H (250 × 4.6 mm), flow 1.0 mL/min, 2-propanol/heptane 20/80, retention 
time: major enantiomer 25.0 min, minor enantiomer: 28.5 min. 
 
(2S,3S)-2-Amino-4-((tert-butyldiphenylsilyl)oxy)-3-phenyl-1-(pyrrolidin-1-yl)butan-1-one (23) 
(2S,3S)-4-((tert-Butyldiphenylsilyl)oxy)-2-((4-methoxyphenyl)amino)-3-phenyl-
1-(pyrrolidin-1-yl)butan-1-one (22) (0.30 g, 0.51 mmol) was dissolved in 
MeCN/H2O (30 mL/15 mL). Aqueous H2SO4 was added (1M, 0.51 mL) followed by 
H5IO6 (116 mg, 0.51 mmol). The mixture was stirred for 15 h and water (50 mL) 
and saturated aqueous Na2CO3 (3 mL) were added. The aqueous mixture was 
extracted with EtOAc (2 × 50 mL). The combined organic layers were dried (Na2SO4) and concentrated. 
The residue was purified via column chromatography (MeOH/DCM 1/99 → 2/98 → 5/95). After 
concentration of the pure product containing fractions, the residue was dissolved in DCM, filtered and 
concentrated. The product was obtained as a brown sticky oil (181 mg, 0.37 mmol, 73%). 1H NMR (CDCl3, 
300 MHz) δ (ppm) 7.56–7.49 (m, 2H), 7.42–7.26 (m, 10H), 7.25–7.18 (m, 3H), 4.15 (d, J = 7.5 Hz, 1H), 3.95 
(dd, J = 10.1, 5.7 Hz, 1H), 3.82 (dd, J = 10.1, 4.5 Hz, 1H), 3.63–3.33 (m, 4H), 3.13 (dt, J = 7.4, 5.1 Hz, 1H), 
1.98–1.69 (m, 4H), 1.04–0.96 (m, 9H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 172.6, 138.8, 135.5, 135.4, 133.3, 
132.9, 129.6, 129.5, 129.3, 128.2, 127.6, 127.5, 127.0, 64.9, 53.2, 52.5, 46.4, 45.8, 26.8, 25.9, 24.1, 19.1; IR 
(cm-1): 2929, 2856, 1640, 1427, 1108, 701; HRMS [ESI+ (m/z)]: calcd for C30H39N2O2Si (M+H+) 487.27808, 
found 487.27664; Rf 0.43 (MeOH/DCM 1/9). 
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2-(3,4-Dimethoxyphenyl)acetaldehyde (26) 
2-(3,4-Dimethoxyphenyl)ethanol (2.00 g, 11.0 mmol) was dissolved in DCM (50 mL). 
Dess–Martin periodinane (4.67 g, 11.0 mmol) was added and the resulting mixture was 
stirred at rt for 1.5 h, filtered over celite and washed with a 1:1 mixture of saturated 
aqueous NaHCO3 and 10% aqueous Na2S2O3 (100 mL). The aqueous layer was extracted 
with DCM (50 mL) and the combined organic layers were dried (Na2SO4) and 
concentrated. The residue was purified via column chromatography (EtOAc/heptane 1/2). The product 
was obtained as a yellow liquid (1.68 g, 9.32 mmol, 85%).1H NMR (CDCl3, 300 MHz) δ (ppm) 9.72 (t, J = 2.5 
Hz, 1H), 6.86 (d, J = 8.1 Hz, 1H), 6.76 (ddt, J = 8.1, 2.0, 0.5 Hz, 1H), 6.70 (d, J = 2.0 Hz, 1H), 3.87 (s, 6H), 3.62 
(d, J = 2.4 Hz, 2H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 199.4, 149.3, 148.4, 124.1, 121.8, 112.6, 111.6, 55.9 
(2C), 50.1; HRMS [EI+ (m/z)]: calcd for C10H12O3 (M+) 180.07864, found 180.07880. 
NMR data are in accordance with literature values.12 
 
(2S,3S)-Ethyl 3-(3,4-dimethoxyphenyl)-4-hydroxy-2-((4-methoxyphenyl)amino)butanoate (27) 
To a solution of (E)-Ethyl 2 ((4-methoxyphenyl)imino)acetate (16) (1.38 g, 6.66 
mmol) in anhydrous THF (20 mL) were added, water (1 mL) and L-proline (130 mg, 
1.13). The mixture was stirred for 15 min, cooled to –5 °C. After addition of 2-(3,4-
dimethoxyphenyl)acetaldehyde (26) (1.2 g, 6.66 mmol), the resulting mixture was 
stirred for 17.5 h. Acetic acid (1.3 mL) was added and after 10 min of stirring, NaBH4 
(0.28 g, 7.33 mmol) was added in portions. The reaction was stirred for 2 h and 
poured out in a saturated aqueous solution of NaHCO3 (50 mL). The aqueous solution was extracted with 
EtOAc (2 × 50 mL). The combined organic layers were dried (Na2SO4) and concentrated. The residue was 
purified via column chromatography (EtOAc/heptane 1/3 → 1/2 → 1/1 → 2/1). The product was obtained 
as a yellow sticky wax (1.74 g, 4.47 mmol, 67%). 1H NMR (CDCl3, 300 MHz) δ (ppm) 6.86–6.72 (m, 5H), 
6.69–6.62 (m, 2H), 4.42 (bs, 1H), 4.21–3.91 (m, 3H), 3.87 (s, 3H), 3.84 (s, 3H) 3.73 (s, 3H), 3.35 (dt, J = 7.6, 
5.5 Hz, 1H), 1.95 (bs, 1H), 1.23 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 173.5, 153.1, 149.0, 
148.6, 141.4, 129.7, 120.7, 116.1, 114.8, 111.8, 111.3, 63.9, 61.2, 60.2, 55.8 (2C), 55.7, 50.0, 14.3; IR (cm-1): 
3372, 2956, 2834, 1729, 1512, 1237, 1026; HRMS [ESI+ (m/z)]: calcd for C21H28N1O6 (M+H+) 390.19166, 
found 390.19232; HPLC: ee > 99% Chiralpak AD-H (250 × 4.6 mm), flow 1.0 mL/min, 2-propanol/heptane 
20/80, retention time: major enantiomer 25.6 min, minor enantiomer: 51.4 min. Rf 0.27 (EtOAc/heptane 
1/1).  
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(2S,3S)-Ethyl 4-((tert-butyldiphenylsilyl)oxy)-3-(3,4-dimethoxyphenyl)-2-((4-methoxyphenyl)a- 
mino)butanoate (28) 
(2S,3S)-Ethyl 3-(3,4-dimethoxyphenyl)-4-hydroxy-2-((4-methoxyphenyl)ami- 
no)butanoate (1.50 g, 3.85 mmol) (27) was dissolved in DCM (25 mL) and 
cooled to 0 °C. tert-Butylchlorodiphenylsilane (2.00 mL, 2.12 g, 7.7 mmol) and 
imidazole (524 mg, 7.7 mmol) were added. The resulting mixture was allowed 
to come to rt, stirred for 1.5 h and quenched with saturated aqueous NaHCO3. 
After separation, the aqueous layer was extracted with DCM (50 mL). The 
combined organic layers were dried (Na2SO4) and concentrated. The residue was purified via column 
chromatography (EtOAc/heptane 1/4). This yielded a colorless oil (2.30 g, 3.66 mmol, 95%) 1H NMR 
(CDCl3, 300 MHz) δ (ppm) 7.69–7.58 (m, 4H), 7.45–7.27 (m, 6H), 6.74 (d, J = 8.2 Hz, 5H), 6.74 (s, 4H), 6.62 
(dd, J = 8.2, 1.9 Hz, 1H), 6.57 (d, J = 1.9 Hz, 1H), 4.67 (dd, J = 7.7, 3.6 Hz, 1H), 4.20 (t, J = 9.8 Hz, 1H), 4.11 (q, 
J = 7.1 Hz, 2H), 3.87–3.73 (m, 1H), 3.84 (s, 3H), 3.77 (s, 3H), 3.74 (s, 3H), 3.35 (dt, J = 9.0, 4.4 Hz, 1H), 1.21 
(t, J = 7.1 Hz, 1H), 1.12–1.08 (s, 9H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 173.8, 152.9, 148.7, 148.3, 142.1, 
135.7, 135.6, 133.4, 129.8, 129.7, 129.6, 127.7, 127.6, 120.7, 116.1, 114.8, 111.9, 111.0, 64.1, 60.9, 59.1, 
55.8 (2C), 55.7, 50.3, 26.9, 19.2, 14.3; IR (cm-1) 3373, 2931, 2856, 1734, 1511, 1237, 1109, 1028, 703; 
HRMS [ESI+ (m/z)]: calcd for C37H46NO6Si (M+H+) 628.30944, found 628.30744; Rf 0.65 (EtOAc/heptane 
1/1). 
 
(2S,3S)-Ethyl 2-amino-4-((tert-butyldiphenylsilyl)oxy)-3-(3,4-dimethoxyphenyl)butanoate (33) 
(2S,3S)-Ethyl 4-((tert-butyldiphenylsilyl)oxy)-3-(3,4-dimethoxyphenyl)-2-((4-
methoxyphenyl)amino)butanoate (28) (1.71 g, 2.72 mmol) was dissolved in a 
mixture of MeCN and water (150 mL/75 mL). Aqueous H2SO4 was added (1M, 2.7 
mL) followed by addition of H5IO6 (0.62 g, 2.72 mmol). The resulting mixture was 
stirred for 17 h. Saturated Na2CO3 (20 mL) and water (100 mL) were added. The 
aqueous solution was extracted with EtOAc (2 × 300 mL). The combined organic layers were dried 
(Na2SO4) and concentrated. The residue was purified via column chromatography (EtOAc/heptane 1/2 → 
1/1). The product was obtained as a dark oil (1.09 g, 2.09 mmol, 77%). 1H NMR (CDCl3, 300 MHz) δ (ppm) 
7.67–7.56 (m, 4H), 7.46–7.31 (m, 6H), 6.78–6.71 (m, 1H), 6.70–6.63 (m, 2H), 4.17–4.02 (m, 4H), 3.83 (s, 
3H), 3.82 (dd, J = 10 Hz, 5.5 Hz, 2H), 3.78 (s, 3H), 3.25 (dt, J = 8.4, 5.3 Hz, 1H), 1.25 (q, 3H), 1.05 (s, 9H); 13C 
NMR (CDCl3, 75 MHz) δ (ppm) 175.2, 148.6, 148.1, 135.6, 135.6, 133.6, 133.5, 130.5, 129.6, 127.6, 120.9, 
112.1, 111.0, 64.6, 60.8, 55.8, 55.8 55.0, 50.8, 26.9, 19.2, 14.3; IR (cm-1) 2930, 2857, 1734, 1516, 1110, 704; 
HRMS [ESI+ (m/z)]: calcd for C30H40NO5Si (M+H+) 522.26757, found 522.26700; Rf 0.23 (EtOAc/heptane 
1/1). 
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(3S,4S)-Diethyl 4-(((tert-butyldiphenylsilyl)oxy)methyl)-6,7-dimethoxy-1,2,3,4-
tetrahydroisoquinoline-1,3-dicarboxylate (34) 
(2S,3S)-Ethyl 2-amino-4-((tert-butyldiphenylsilyl)oxy)-3-(3,4-
dimethoxyphenyl)butanoate (33) (50 mg, 0.096 mmol) was dissolved in dry DCM 
and put under an atmosphere of argon. Ethylglyoxylate (50% wt% in toluene, 19 
μL, 0.096 mmol) and TFA (7.4 μL, 0.096 mmol) were added and the resulting 
mixture was stirred at rt for 2 h. Aqueous saturated NaHCO3 (10 mL) and DCM 
(10 mL) were added and the layers were separated. The aqueous phase was extracted with DCM (10 mL). 
The combined organic layers were dried (Na2SO4) and concentrated. The residue was purified via column 
chromatography (EtOAc/heptane 1/5 → 1/3). The product was obtained as a mixture of diastereomers 
(31.5 mg, 0.052 mmol, 54%). 1H NMR (CDCl3, 300 MHz) δ (ppm) 7.73–7.32 (m, 10H, both diastereomers), 
6.83 (s, 3/4H, major diastereomer), 6.76 (s, 1/4H, minor diastereomer), 6.48 (s, 1/4H, minor 
diastereomer), 6.18 (s, 3/4H, major diastereomer), 4.99 (s, 3/4H, major diastereomer), 4.64 (s, 1/4H, 
minor diastereomer), 4.34 (d, J = 2.4 Hz, 3/4H, major diastereomer), 4.31–3.82 (m, 6H, both diastereomers 
+ 1/4H, minor diastereomer), 3.82 (s, 1/4H, minor diastereomer), 3.79 (s, 3/4H, major diastereomer), 
3.68 (s, 3/4H, major diastereomer), 3.67 (s, 1/4H, minor diastereomer), 3.16 (dd, J = 10.3, 5.8 Hz, 1H, both 
diastereomers), 1.24 (t, J = 7.1 Hz, 3H, both diastereomers), 1.18 (t, J = 7.1 Hz, 3H, both diastereomers), 
1.08 (s, 3/4 × 9H, major diastereomer), 1.01 (s, 1/4H, minor diastereomer); 13C NMR (CDCl3, 75 MHz) δ 
(ppm) 173.5, 173.4, 172.8, 171.9, 148.3, 148.1, 147.9, 147.3, 135.8, 135.6, 133.7, 133.4, 133.2, 129.7, 
129.7, 127.7, 127.6, 126.6, 125.3, 124.8, 123.4, 111.9, 111.2, 109.3, 109.1, 66.4, 66.1, 61.6, 61.4, 61.3, 60.9, 
60.8, 60.3, 57.9, 56.6, 55.7, 55.1, 53.8, 42.7, 42.1, 29.7, 26.9, 26.8, 19.2, 14.1, 14.1 (complex); IR (cm-1), 
2957, 2930, 1733, 1515, 1110, 704; HRMS [ESI+ (m/z)]: calcd for C34H44N1O7Si (M+H+) 606.28870, found 
606.28617; Rf 0.29 (minor diastereomer), 0.24 (major diastereomer) (EtOAc/heptane 1/2). 
 
(3S,4S)-Ethyl 4-(((tert-butyldiphenylsilyl)oxy)methyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquino- 
line-3-carboxylate (35) 
(2S,3S)-Ethyl 2-amino-4-((tert-butyldiphenylsilyl)oxy)-3-(3,4-dimethoxyphenyl)buta- 
noate (33) (50 mg, 0.096 mmol) was dissolved in dry DCM (5 mL) and put under an 
atmosphere of argon. Paraformaldehyde (2.9 mg, 0.096 mmol) and TFA (7.4 μL, 0.096 
mmol) were added and the resulting mixture was stirred at rt for 20 min. The mixture 
was then heated to 40 °C and stirred for 24 h. Saturated aqueous NaHCO3 (10 mL) and 
DCM (10 mL) were added. After separation, the aqueous layer was extracted with DCM (10 mL). The 
combined organic layers were dried (Na2SO4) and concentrated. The residue was purified via column 
chromatography (EtOAc/heptane (1/2 → 1/1). The product was obtained as a colorless oil (20 mg, 0.037 
mol, 39%). 1H NMR (CDCl3, 300 MHz) δ (ppm) 7.78–7.54 (m, 4H), 7.50–7.29 (m, 6H), 6.45 (s, 1H), 6.26 (s, 
1H), 4.25–4.04 (m, 4H), 3.97–3.74 (m, 3H), 3.80 (s, 3H), 3.68 (s, 3H), 3.28–3.16 (m, 1H), 1.24 (t, J = 7.1 Hz, 
3H), 1.05 (s, 9H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 173.7, 147.7, 147.4, 135.7 (2C), 135.6 (2C), 133.6, 
133.4, 129.7, 129.6, 127.6 (4C), 127.4, 124.9, 111.8, 108.7, 67.3, 60.8, 55.8, 55.4, 44.3, 41.7, 29.7, 26.9, 19.2, 
14.2; IR (cm-1), 2931, 2856, 1729, 1517, 1227, 1111, 704; HRMS [ESI+ (m/z)]: calcd for C31H40N1O5Si 
(M+H+) 534.26757, found 534.26836; Rf (EtOAc/heptane 1/1) 0.29. 
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2-(Benzo[d][1,3]dioxol-5-yl)acetaldehyde (37) 
Safrole (36) (5.0 mL, 5.48 g, 33.8 mmol) was dissolved in DCM (50 mL) in an oxygen flushed 
flask. The solution was flushed with oxygen for 10 min and cooled to –78 °C. An ozone stream 
was led through to the solution for 4 h. The reaction mixture was flushed with oxygen. 
Dimethylsulfide (3.2 mL) was added and the reaction mixture was placed under argon and 
stirred under reflux overnight. After cooling down, the reaction mixture was concentrated 
and the residue was purified via column chromatography (EtOAc/heptane 1/9). The product was 
obtained as a slightly yellow liquid (2.66 g, 16.2 mmol, 48%). 1H NMR (CDCl3, 300 MHz) δ (ppm) 9.71 (t, J = 
2.3 Hz, 1H), 6.82–6.78 (m, 1H), 6.71–6.63 (m, 2H), 5.96 (s, 2H), 3.59 (d, J = 2.3 Hz, 2H); 13C NMR (CDCl3, 75 
MHz) δ (ppm) 199.3, 148.2, 147.0, 125.3, 122.8, 109.9, 108.7, 101.1, 50.1; IR (cm-1), 3424, 2891, 1721, 
1489, 1245, 1037; HRMS [EI+ (m/z)]: calcd for C9H8O3 (M+) 164.04734, found 164.04801; Rf 
(EtOAc/heptane 1/1) 0.58. 
 
(2S,3S)-Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-4-hydroxy-2-((4-methoxyphenyl)amino)butanoate (38) 
To a solution of (E)-Ethyl 2-((4-methoxyphenyl)imino)acetate (16) (1.09 g, 5.26 
mmol) in anhydrous THF (20 mL) were added water (1 mL) and L-proline (130 mg, 
1.13 mmol). The mixture was stirred for 15 min and cooled to –5 °C. After addition of 
2-(benzo[d][1,3]dioxol-5-yl)acetaldehyde (37) (0.86 g, 5.26 mmol), the resulting 
mixture was stirred for 20.5 h. Acetic acid (1.0 mL) was added and NaBH4 (0.22 g, 
5.82 mmol) was added in portions. The reaction mixture was poured out in saturated 
aqueous NaHCO3 (50 mL). The aqueous solution was extracted with EtOAc (2 × 50 mL). The combined 
organic layers were dried (Na2SO4) and concentrated. The residue was purified via column 
chromatography (EtOAc/heptane 1/3 → 1/2 → 1/1). The product was obtained as a yellow oil (0.784 g , 
2.11 mmol, 40%). 1H NMR (CDCl3, 300 MHz) δ (ppm) 6.80–6.63 (m, 7H), 5.95 (d, J = 1.4 Hz, 1H), 5.95 (d, J = 
1.5 Hz, 1H), 4.40 (d, J = 5.1 Hz, 1H), 4.14 (q, J = 7.1 Hz, 3H), 4.05 (dd, J = 10.8, 7.8 Hz, 1H), 3.93 (dd, J = 10.8, 
5.7 Hz, 1H), 3.73 (s, 3H), 3.33 (dt, J = 7.6, 5.4 Hz, 1H), 1.23 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 75 MHz) δ 
(ppm) 173.4, 153.2, 147.9, 147.1, 141.4, 130.9, 121.9, 116.2, 114.8, 108.7, 108.4, 101.1, 63.8, 61.2, 60.2, 
55.7, 50.1, 14.3, 0.0; IR (cm-1), 3404, 2900, 1727, 1512, 1241, 1035; HRMS [ESI+ (m/z)]: calcd for 
C20H24NO6 (M+H+) 374.16036, found 374.15986; Rf (EtOAc/heptane 1/1) 0.47 HPLC: ee > 99% Chiralpak 
AD-H (250 × 4.6 mm), flow 1.0 mL/min, 2-propanol/heptane 20/80, retention time: major enantiomer 
18.5 min, minor enantiomer: 33.1 min. 
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(2S,3S)-Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-4-((tert-butyldiphenylsilyl)oxy)-2-((4-methoxyphenyl) 
amino)butanoate (39) 
(2S,3S)-Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-4-hydroxy-2-((4-methoxyphenyl) 
amino)butanoate (38) (694 mg, 1.86 mmol) was dissolved in anhydrous DCM 
(25 mL), placed under an atmosphere of argon and cooled to 0 °C. After 
addition of tert-butylchlorodiphenylsilane (0.96 mL, 1.02 g, 3.72 mmol) and 
imidazole (253 mg, 3.72 mml), the mixture was stirred for 5 min, allowed to 
come to rt and stirred for an additional 18h. Saturated aqueous NaHCO3 (50 
mL) was added. After separation, the aqueous layer was extracted with DCM (50 mL). The combined 
organic layers were dried (Na2SO4) and concentrated. The residue was purified via column 
chromatography (EtOAc/heptane 1/4 + EtOAc/heptane 1/9 → 1/6). The product was obtained as a yellow 
wax (875 mg, 1.43 mmol, 77%). 1H NMR (CDCl3, 300 MHz) δ (ppm) 7.71–7.58 (m, 4H), 7.47–7.28 (m, 6H), 
6.76 (s, 4H), 6.68 (d, J = 7.9 Hz, 1H), 6.59 (d, J = 1.6 Hz, 1H), 6.51 (dd, J = 8.0, 1.7 Hz, 1H), 5.91 (d, J = 1.4 Hz, 
1H), 5.90 (d, J = 1.4 Hz, 1H), 4.67 (dd, J = 8.0, 3.3 Hz, 1H), 4.18 (t, J = 9.9 Hz, 1H), 4.12 (q, J = 7.1 Hz, 1H), 
3.76 (dd, J = 9.4, 5.3 Hz, 1H), 3.75 (s, 3H), 3.34 (dt, J = 9.51, 4.35 Hz, 1H), 1.23 (t, J = 7.1 Hz, 3H), 1.11 (s, 
9H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 173.7, 152.9, 147.5, 146.8, 142.1, 135.6, 135.6, 133.4, 133.3, 130.9, 
129.7, 129.6, 127.7, 127.7, 121.8, 116.2, 114.7, 108.8, 108.1, 100.9, 64.0, 61.0, 59.1, 55.7, 50.3, 26.9, 19.2, 
14.3; IR (cm-1), 2930, 2879, 1737, 1512, 1237, 1038; HRMS [ESI+ (m/z)]: calcd for C36H42NO6Si (M+H+) 
612.27814, found 612.27726; Rf (EtOAc/heptane 1/4) 0.29. 
 
(2S,3S)-Ethyl 2-amino-3-(benzo[d][1,3]dioxol-5-yl)-4-((tert-butyldiphenylsilyl)oxy)butanoate (40) 
To a solution of (2S,3S)-ethyl 3-(benzo[d][1,3]dioxol-5-yl)-4-((tert-
butyldiphenylsilyl)oxy)-2-((4-methoxyphenyl)amino)butanoate (39) (759 mg, 1.24 
mmol) in MeCN/H2O (90 ml/45 mL) was added aqueous H2SO4 (1M, 1.24 mL) and 
periodic acid (283 mg, 1.24 mmol). The resulting mixture was stirred for 16 h and 
saturated aqueous Na2CO3 (10 mL) and water (50 mL) were added. The aqueous 
mixture was extracted with EtOAc (2 × 150 mL). The combined organic layers were 
dried (Na2SO4) and concentrated. The residue was purified via column chromatography (EtOAc/heptane 
1/2). The product was obtained as a brown oil (474 mg, 0.94 mmol, 76%). 1H NMR (CDCl3, 300 MHz) δ 
(ppm) 7.67–7.59 (m, 4H), 7.45–7.32 (m, 6H), 6.68 (d, J = 8.0 Hz, 1H), 6.64 (d, J = 1.7 Hz, 1H), 6.55 (dd, J = 
8.0, 1.7 Hz, 1H), 5.89 (s, 2H), 4.17–3.99 (m, 1H), 3.78 (dd, J = 10.0, 5.4 Hz, 1H), 3.24 (dt, J = 8.8, 5.1 Hz, 1H), 
1.24 (t, J = 7.1 Hz, 3H), 1.05 (s, 9H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 175.2, 147.4, 146.6, 135.6, 133.5, 
131.5, 129.7, 127.6, 122.0, 109.1, 108.0, 100.8, 64.5, 60.8, 54.8, 50.7, 35.4, 31.9, 26.9, 19.2, 14.3; IR (cm-1), 
2931, 2856, 1733, 1488, 1249, 1110, 704; HRMS [ESI+ (m/z)]: calcd for C29H36NO5Si (M+H+) 506.23627, 
found 506.23675; Rf (EtOAc/heptane 1/1) 0.57.  
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(7S,8S)-Diethyl 8-(((tert-butyldiphenylsilyl)oxy)methyl)-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-
g]isoquinoline-5,7-dicarboxylate (41) 
To a solution of (2S,3S)-ethyl 2-amino-3-(benzo[d][1,3]dioxol-5-yl)-4-((tert-
butyldiphenylsilyl)oxy)butanoate (40) (50 mg, 0.099 mmol) in dry DCM (5 mL) 
was added ethyl glyoxylate (~50 wt% solution in toluene, 19 μL, 0.096 mmol) 
and TFA (7.4 μL, 11 mg, 0.096 mmol). The mixture was stirred for 20 h and 
quenched with saturated aqueous NaHCO3. After addition of DCM (10 mL), the 
layers were separated. The aqueous phase was extracted with DCM (10 mL) and the combined organic 
layers were dried (Na2SO4) and concentrated. The residue was purified via column chromatography 
(EtOAc/heptane 1/9 → 1/6 → 1/3). Yield: 10 mg (0.017 mmol, 18%). Yield of side product 44: 17 mg 
(0.034 mmol, 35%). Characterisation for 41: 1H NMR (CDCl3, 300 MHz) δ (ppm) 7.72–7.30 (m, 10H, 
bothdiastereomer), 6.79 (s, 4/5H, major diastereomer), 6.70 (s, 1/5H), 6.46 (s, 1/5H, minor 
diastereomer), 6.23 (s, 4/5H, major diastereomer), 5.90 (d, J = 1.4 Hz, 1/5H, minor diastereomer), 5.89 (d, 
J = 1.4 Hz, 1/5H, minor diastereomer), 5.87 (d, J = 1.4 Hz, 4/5H, major diastereomer), 5.83 (d, J = 1.4 Hz, 
4/5H, major diastereomer) , 4.95 (s, 4/5H, major diastereomer), 4.58 (s, 1/5H, minor diastereomer), 4.35–
4.00 (m, 4H+1/5H, both + minor diastereomer), 4.34 (d, J = 2.5 Hz, 4/5H, major diastereomer), 4.00–3.69 
(m, 2H, both diastereomers), 3.21–3.11 (m, 1H, both diastereomers), 1.18 (t, J = 7.1 Hz, 1H, both 
diastereomers), 1.07 (m, 36/5H, major diastereomer), 1.01 (s, 9/5H, minor diastereomer);  13C NMR 
(CDCl3, 75 MHz) δ (ppm) 173.4, 172.7, 146.7, 135.7, 135.6, 133.5, 133.4, 129.8, 129.7, 127.7, 126.6, 124.7, 
109.2, 108.7, 106.7, 106.4, 100.9, 77.2, 66.2, 61.6, 60.9, 57.0, 53.7, 43.1, 29.7, 26.9, 26.8, 14.2, 14.1 
(complex mixture of diastereomers); IR (cm-1), 2929, 1736, 1485, 1208, 1111, 1038, 705; HRMS [ESI+ 
(m/z)]: calcd for C33H40NO7Si (M+H+) 590.25740, found 590.25616; Rf (EtOAc/heptane 1/1) 0.74. 
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6.1 Introduction 
β-2,3-Disubstituted amino acids are privileged structural elements,1 which are frequently 
encountered in biologically active substances such as cocaine (1), taxol® (2), penicillin V (3), 
dolastatin 11 (4) and dioctatin A (5) (Figure 1). 
 
Figure 1 Biologically active β-amino acids: cocaine (1), taxol (2), penicillin V (3), dolastatin 11 (4) and 
dioctatin A (5). 
 
Cocaine has been isolated from the coca plant (Erythroxylaceae family) and has a plethora of 
pharmacological effects, including influence on the central nervous system, body temperature, 
sympathetic nervous system and nerve conduction.2 It was initially recognised as a potent 
therapeutic agent, but is nowadays mostly associated with drug abuse. Taxol®, a tubulin-
targeting cytoskeletal drug, initially isolated from the Taxus brevofolia,3 is currently on the 
market as a drug (Paclitaxel) against ovarian cancer. Paclitaxel inhibits the disassembly of 
microtubules. As a consequence, the increased concentration of microtubules instigates cell 
death.4 Unfortunately, the biological availability of paclitaxel is limited and although total 
syntheses of paclitaxel have been reported,5 it can be more economically synthesised in a semi-
synthetic manner, starting from a suitably protected variant of the less scarce 10-
deacetylbaccatin III (7) and a protected derivative of the N-benzoyl-β-2,3-disubstituted amino 
acid side chain 6 (Fig. 1).6  
 
β-Lactam antibiotics such as penicillin V are cyclised β-2,3-disubstituted amino acids, which are 
used in the treatment of bacterial infections.7 The marine depsipeptide dolastatin 11 (4) was 
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isolated from the mollusk Dolabella auricularia and has been studied for its cytotoxic effects.8 
Dioctatin A (5) is a naturally occurring tripeptide, consisting of two β-amino acids and a 
dehydroamino acid, which inhibits the aflatoxin production of fungi (see: Section 6.3). On 
account of the great importance of β-2,3-disubstituted amino acids, numerous synthetic 
methods for their preparation have been developed throughout the years.1,9 
 
Barbas et al. recognised that the 1,3-amino aldehydes obtained from the proline-catalysed 
Mannich reaction could be further elaborated into the corresponding 1,3-amino acids, but 
ignored the removal of the N-PMP-group.10 Furthermore, isolation and purification of the 
intermediate β-amino aldehydes may lead to undesired epimerisation. Janey and co-workers 
developed a three-step protocol to synthesise an N-Boc-protected amino amide, starting from an 
N-PMP-protected amino alcohol.11 In this chapter we describe a general method to convert N-
PMP-protected 1,3-amino alcohols into protecting group-free β-2,3-disubstituted amino acids in 
a one-pot procedure. 
 
6.2 Synthesis of β-2,3-disubstituted amino acids 
As described in Chapter 1, proline, amongst other catalysts, effectively catalyses the Mannich 
reaction between PMP-protected imines and aldehydes. β-Amino aldehydes are formed with 
high diastereo- and enantioselectivity and are best immediately transformed into the 
corresponding 1,3-amino alcohols to prevent epimerisation during purification. Chapter 2 
describes the oxidative deprotection of N-PMP-protected amines with usage of periodic acid. 
Alsters et al. disclosed a method to convert alcohols into the corresponding ketones or 
carboxylic acids, employing catalytic sodium dichromate with sodium periodate as the 
stoichiometric oxidant.12 Since both methodologies in fact make use of the same oxidant, we 
envisioned combining these two synthetic methods, with the aim to convert N-PMP-protected 
amino alcohols directly into the corresponding protecting group-free β-2,3-disubstituted amino 
acids.  
  
When preparing the amino alcohols 16–21, it appeared crucial to monitor the initial conversion 
of imines 10–13 into the amino aldehydes by HPLC analysis in order to obtain good yields. We 
observed that the retro-Mannich reaction was favoured at higher temperatures; above –10 °C, 
the initially formed Mannich product relapsed to the starting materials in the presence of the 
catalyst. The starting aldehydes 8–9 might eventually undergo a self-aldol reaction, leading to 
hydroxy aldehydes 15 (Table 1).13 The low temperature that was required rendered initial HPLC 
monitoring of the conversion troublesome. However, by preparing HPLC samples at low 
temperatures (–20 to –10 °C) and immediately injecting them on the HPLC column, the 
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conversion of the imine into the amino aldehyde could be adequately monitored in time. Upon 
quenching of the reaction with NaBH4, the β-amino aldehydes 14 were irreversibly transformed 
into the 1,3-amino alcohols 16–21.  
 
Table 1 Synthesis of 1,3-amino alcohols. 
 
 
As becomes clear from the results in Table 1, amino alcohols with aromatic R2 groups were 
synthesised in good yields and complete selectivities (entries 1–4). Additionally, we prepared 
amino alcohol 21 starting from two aliphatic aldehydes. However, since the imine of p-anisidine 
and hexanal (13, R2 = n-pentyl) was considered less stable and therefore more difficult to purify, 
we prepared the imine in situ without workup afterwards (entry 6). The imine formation could 
be monitored by HPLC, but we were not able to push the equilibrium further than ca. 70% by 
adding dehydrating agents. When the imine formation stopped proceeding, the donor aldehyde 
was added and product formation was again monitored by HPLC. The desired product 21 could 
be isolated after reduction and purification in 14% yield and complete selectivity. We then 
synthesised the Mannich adduct of propionaldehyde (8) and N-PMP ethyl glyoxylate (12). 
Barbas et al.14 previously reported that aldehyde 14 (R1 = Me, R2 = CO2Et) was isolated without 
any diastereoselectivity, but we showed that by direct reduction of the aldehyde, the alcohol 
could be obtained in complete selectivity albeit in 16% yield (entry 5). With the enantio- and 
diastereomerically pure amino alcohols 16–21 in hand, we intended to convert these products 
in a one-pot process into the corresponding free β-2,3-disubstituted amino acids. 
 
In Chapter 2 we described a method to mildly remove the PMP-group from an amine. This 
deprotection method was further extended to the synthesis of -2,3-disubstituted amino acids 
via a one-pot deprotection-oxidation sequence (Table 2). First, the reduced Mannich adducts 
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were treated with periodic acid to effect PMP removal and upon completion, a catalytic amount 
of sodium dichromate and an additional 5 equiv of periodic acid were added to the aqueous 
solution, resulting in oxidation of the alcohol to the carboxylic acid. The crude mixture was 
purified using ion-exchange chromatography to yield the corresponding -2,3-disubstituted 
amino acids. Given the vast number of N-PMP-1,3-amino alcohols that are accessible via the 
asymmetric Mannich reaction, the latter pathway represents a facile and efficient entry into a 
large variety of -amino acids. This was shown by transforming a series of 1,3-amino alcohols 
into the amino acids 23–27 as depicted in Table 2.  
 
Table 2 Formation of -2,3-disubstituted amino acids. 
 
Following the aforementioned procedure, we obtained β-2,3-disubstituted amino acids 23–27 in 
good yields. Starting from 20 (R1 = Me, R2 = CO2Et), the corresponding amino acid could also be 
prepared according to mass spectroscopic analysis of the reaction mixture. Purification 
however, was more troublesome due to the base labile ester functionality in the molecule. Since 
ion-exchange chromatography requires elution of the product with a 2 M NH4OH solution, we 
assumed this purification method to be incompatible with the ethyl ester functionality.  
  
6.3 Synthesis of a dioctatin A building block 
Aflatoxins (e.g. aflaxtoxin B1 (28),15 Figure 2), strongly carcinogenic substances that belong to the 
class of mycotoxins, are mainly produced by strains of Aspergillus flavus and Aspergillus 
parasiticus and affect crops such as maize and peanuts. 
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Figure 2 Aflatoxin B1. 
 
To prevent its malevolent consequences, effective methods to reduce the aflatoxin 
contamination of crops are desired. Research has previously been directed towards the 
synthesis of anti-fungal agents, but no compounds have been discovered which are sufficiently 
active and safe at the same time. On the other hand, Sakuda et al. discovered that dioctatin A (5) 
inhibits the aflatoxin production,16,17 without inhibiting the growth of the aflatoxin-producing 
microorganism. Dioctatin A (5) is a tripeptide consisting of dehydro-α-amino acid 31, and two β-
amino acids (2R,3S)-29 and 30 (Scheme 1).  
 
Scheme 1 Retrosynthesis of dioctatin A (5). 
 
The retrosynthesis depicted in Scheme 1 leads to a seemingly short route to dioctatin A. 
However, it does not start from commercially available amino acids. β-2,3-Disubstituted amino 
acid (2R,3S)-29 was prepared by Sakuda starting from 2-octenoic acid ethyl ester in only 6% 
overall yield. Moreover, a laborious low-yielding chromatographic separation of the two 
diastereoisomers was included in the route, which rendered it less applicable for scale-up. 
Additionally, Sakuda claims that the stereochemical configuration of the 2-position of amino acid 
29 is R (as depicted in Scheme 1),17 although no substantial proof was provided. In his synthetic 
route, amino acid 29 was initially produced as a mixture of diastereoisomers (epimers at the 2-
position), which were separated by chromatography. Two tripeptides, prepared from either 
(2R,3S)-29 or from (2S,3S)-29, were tested for anti-aflatoxin production activity. The peptide 
with the highest activity was concluded to be the naturally occurring stereoisomer after 
comparison of their analytical data. However, the absolute configuration of the 2-position 
remained unproven. The development of a straightforward and efficient protocol for the 
synthesis of β-2,3-disubstituted amino acids from N-PMP-protected 1,3-amino alcohols (Section 
6.2) prompted us to pursue a synthesis of building block (2R,3S)-29. Synthesis of the preceding 
1,3-amino alcohol via proline catalysis would lead to a syn-configuration of the substituents; i.e. 
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(2R,3S)-29 (using D-proline) or 26 ((2S,3R-configuration)) (using L-proline), and comparison of 
the 1H NMR data of the resulting β-2,3-disubstituted amino acids with those of the epimers 
prepared by Sakuda, would deliver the stereochemical proof. 
 
The D-proline-catalysed Mannich reaction produced the intermediate amino alcohol 32 with 
excellent selectivity, while the subsequent conversion into the β-2,3-disubstituted amino acid 
(2R,3S)-29 proceeded as expected (Scheme 2). We compared its 1H NMR data with the data from 
26 and with the data of the presumed (2R,3S)-diastereomer produced by Sakuda. The spectral 
data were identical which proves that C2 is indeed R-configured.  
 
Scheme 2 Synthesis of amino acid (2R, 3S)-29. 
 
Since our protocol requires no separation of stereoisomers and the overall yield (18%) is 
significantly higher than in the Sakuda route, it might contribute to a more efficient future 
synthesis of dioctatin A.  
 
6.4 Conclusion and outlook 
In conclusion, we have developed a new and efficient protocol for the synthesis of enantio- and 
diastereomerically pure β-2,3-disubstituted amino acids. After formation of N-PMP-protected 
1,3-amino alcohols via the asymmetric proline-catalysed Mannich reaction, these valuable 
compounds can be transformed in high yields into the corresponding protecting group-free 
amino acids by treatment with periodic acid and sodium dichromate in a one-pot two-step 
protocol. In addition, we have shown that the development of this new route paves the way for 
an easier and more scalable access into one of the key building blocks for the synthesis of the 
naturally occurring aflatoxin production inhibitor dioctatin A. Through comparison with 
literature data, we have additionally confirmed the tentatively assigned stereochemistry of the 
2-position of the N-terminal β-amino acid of dioctatin A.  
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6.6 Experimental section 
For general remarks, see section 2.8. 
 
(E)-4-Methoxy-N-(4-nitrobenzylidene)aniline (10) 
A solution of p-anisidine (30.0 g, 244 mmol) and 4-nitrobenzaldehyde (36.9 g, 
244 mmol) in 1,2-DCE (300 mL) was heated to 90 °C and stirred for 1 h under 
an atmosphere of argon. The solvent was then removed until crystallisation 
started. The mixture was cooled to 0 °C. The obtained crystals were filtered off 
and washed with cold EtOAc. The product was obtained as a yellow solid (41.2 
g, 0.16 mmol, 66%). 1H NMR (CDCl3, 300 MHz) δ (ppm) 8.58 (s, 1H), 8.32 (d, J = 6.3 Hz, 2H), 8.06 (d, J = 6.6 
Hz, 2H), 7.31 (d, J = 6.9 Hz, 2H), 6.96 (d, J = 6.9 Hz, 2H), 3.86 (s, 3H). 
Spectral data are in accordance with literature values.18 
 
(E)-4-(((4-Methoxyphenyl)imino)methyl)benzonitrile (11) 
A solution of p-anisidine (2.96 g, 24.0 mmol) and 4-cyanobenzaldehyde (3.48 g, 
24.0 mmol) in MeOH (120 mL) was stirred for 1h at rt under an atmosphere of 
argon. After concentration, the residue was recrystallised from EtOAc (50 mL). 
The product 10 (2.1 g, 8.89 mmol, 37%) was obtained as a yellow solid. 1H 
NMR (CDCl3, 300 MHz) δ (ppm) 8.52 (s, 1H), 7.99 (d, J = 8.1 Hz, 2H), 7.75 (d, J = 
8.4 Hz, 2H), 7.29 (d, J = 9.0 Hz, 2H), 6.95 (d, J = 9.0 Hz, 2H), 3.85 (s, 3H); 13C NMR (CDCl3 75 MHz) δ (ppm) 
159.1, 155.3, 143.7, 140.3, 132.5, 128.8, 122.5, 118.5, 114.5, 113.9, 55.5; IR (cm-1) 2955, 2837, 2220, 1586, 
1505, 1246, 1034, 838, 559; HRMS [ESI (m/z)] calcd for C15H13N2O (M+H)+ 237.10279, found 237.10304; 
Rf = 0.72 (EtOAc/heptane, 1:1); Mp 116–117 °C.  
 
(E)-Ethyl 2-((4-methoxyphenyl)imino)acetate (12) 
To a solution of p-anisidine (6.21 g, 50.4 mmol) in anhydrous toluene (100 mL) was 
added ethyl glyoxylate (~50 wt%) (10.3 g, 50.4 mmol). The resulting mixture was 
stirred for 5 min, filtered and concentrated at 40 °C. The product was obtained as a 
brown oil (9.99 g, 47.8 mmol, 95%). 1H NMR (CDCl3, 300 MHz) δ (ppm) 7.94 (s, 1H), 
7.36 (d, J = 9.0 Hz, 2H), 6.93 (d, J = 9.0 Hz, 2H), 4.41 (q, J = 7.2 Hz, 2H), 3.84 (s, 1H), 1.40 (t, J = 7.2 Hz, 3H). 
1H NMR data are in accordance with data in Chapter 4 (p 109). 
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(2S,3S)-3-(4-Methoxyphenylamino)-2-methyl-3-(4-nitrophenyl)propan-1-ol (16) 
(E)-4-Methoxy-N-(4-nitrobenzylidene)aniline (10) (300 mg, 1.17 mmol) and L-
proline (23 mg, 0.23 mmol) were dissolved in a mixture of NMP (19 mL) and 
water (1 mL). After cooling to –14 °C freshly distilled propionaldehyde (0.25 mL, 
3.5 mmol) was added. The mixture was stirred for 144 h and cooled to 0 °C 
before addition of NaBH4 (133 mg, 3.51 mmol). Saturated aqueous NaHCO3 (30 
mL) was added and the mixture was three times extracted with a 1:1 mixture of EtOAc and heptane. The 
combined organic layers were dried (Na2SO4), filtered and concentrated. The residue was purified via 
column chromatography (EtOAc/heptane, 0 → 75%). The product was obtained as a brown oil (201 mg, 
0.64 mmol, 54%). 1H NMR (CDCl3, 300 MHz) δ (ppm) 8.18 (d, J = 8.7 Hz, 2H), 7.51 (d, J = 9.0 Hz, 2H), 6.68 
(d, J = 9.0 Hz, 2H), 6.43 (d, J = 9.0 Hz. 2H), 4.65 (d, J = 3.9 Hz, 1H), 3.68 (s, 3H), 3.67 (d, J= 1.5 Hz, 1H), 3.65 
(d, J= 3.6 Hz, 1H), 2.24–2.19 (m, 1H), 0.92 (d, J = 7.2 Hz, 3H).  
Data are in accordance with data in Chapter 2 (Ch. 2, Compound 9) 
 
(S)-2-((S)-(4-Methoxyphenylamino)(4-nitrophenyl)methyl)hexan-1-ol (17) 
(E)-4-Methoxy-N-(4-nitrobenzylidene)aniline (10) (100 mg, 0.390 mmol) and L-
proline (7.73 mg, 0.078) were dissolved in NMP (9.5 mL) and water (0.5 mL). The 
reaction mixture was cooled to –16 °C before addition of freshly distiled hexanal 
(0.16 mL, 1.2 mmol) and stirred for 48 h. The mixture was cooled to 0 °C and 
NaBH4 (44 mg, 1.2 mmol) was added. Saturated aqueous NaHCO3 (10 mL) was 
added and the mixture was extracted with a mixture of EtOAc and heptane (1:1, 3 × 20 mL). The combined 
organic layers were dried (Na2SO4), filtered and concentrated. The residue was purified via column 
chromatography (EtOAc/heptane, 0 → 25%). The product was obtained as a brown oil (102 mg, 0.28 
mmol, 73%). 1H NMR (CDCl3, 300 MHz) δ (ppm) 8.17 (d, J = 8.7 Hz, 2H), 7.51 (d, J = 8.4 Hz, 2H), 6.67 (d, J = 
9.0 Hz, 2H), 6.42 (d, J = 9.0 Hz, 2H), 4.70 (m, 1H), 3.76–3.63 (m, 2H), 3.68 (s, 3H), 2.00 (m, 1H), 1.38–1.16 
(m, 6H), 0.83 (t, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 152.4, 150.2, 147.0, 140.7, 128.1, 123.6, 
114.9, 114.8, 63.6, 60.7, 55.7, 46.4, 29.9, 25.4, 22.7, 13.9; IR (cm-1) 2931, 1512, 1345, 610, 586; HRMS [ESI) 
(m/z) calcd for C20H27N2O4 (M+H)+ 359.19708, found 359.19548; HPLC ee >99%, Chiralpak AD-H (250 × 
4.6 mm), flow 1.0 mL/min, n-hexane/2-propanol 80/20, retention times 25.1 min (major isomer), 8.5 min 
(minor isomer); d.r. >19:1 (determined by 1H NMR); Rf = 0.49 (EtOAc/heptane, 1:1); [α]20D –58.4 (c 0.395, 
CHCl3).  
 
4-((1S,2S)-3-Hydroxy-1-(4-methoxyphenylamino)-2-methylpropyl)benzonitrile (18) 
A solution of L-proline (8.33 mg, 0.084 mmol) and (E)-4-(((4-
methoxyphenyl)imino)methyl)benzonitrile (11) (100 mg, 0.420 mmol) in a 
mixture of NMP (9.5 mL) and water (0.5 mL) was cooled to –16 °C. 
Propionaldehyde (0.09 mL, 1.27 mmol) was added and the resulting mixture was 
stirred for 72 h. The mixture was cooled to 0°C before NaBH4 (48 mg, 1.3 mmol) 
was added. Saturated aqueous NaHCO3 (10 mL) was added and the mixture was extracted with a mixture 
of EtOAc and heptane (1:1, 3 × 20 mL). The combined organic layers were dried (Na2SO4), filtered and 
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concentrated. The residue was purified via column chromatorgraphy (EtOAc/heptane, 0 → 25%). The 
product was obtained as a brown oil (45.1 mg, 0.152 mmol, 36%). 1H NMR (CDCl3, 300 MHz) δ (ppm) 7.60 
(d, J = 8.1 Hz, 2H), 7.45 (d, J = 8.4 Hz, 2H), 6.67 (d, J = 8.7 Hz, 2H), 6.42 (d, J = 8.7 Hz, 2H), 4.49 (d, J = 3.6 Hz, 
1H), 3.68 (s, 3H), 3.64 (m, 2H), 2.27–2.09 (m, 1H), 0.90 (d, J = 6.9 Hz, 3H); 13C NMR (CDCl3 75 MHz) δ 
(ppm) 152.2, 148.2, 140.7, 132.2, 127.9, 118.9, 114.8, 114.7, 110.6, 65.6, 60.6, 55.7, 41.3, 11.6); IR (cm-1) 
3403, 2931, 2227, 1512, 1235, 1035, 820; HRMS [ESI (m/z)] calcd for C18H21N2O2 (M+H)+ 297.16030, 
found 297.15862; HPLC ee >99%, Chiralpak AD-H (250 × 4.6 mm), flow 1.0 mL/min, n-hexane/2-propanol 
80/20, retention times 15.4 min (major enantiomer), 9.3 min (minor enantiomer); d.r. >19:1 (determined 
with 1H NMR); Rf = 0.31 (EtOAc/heptane, 1:1); [α]20D –50.9 (c 0.615, CHCl3). 
 
4-((1S,2S)-2-(Hydroxymethyl)-1-(4-methoxyphenylamino)hexyl) benzonitrile (19)  
A solution of L-proline (8.33 mg, 0.084 mmol) and (E)-4-(((4-
methoxyphenyl)imino)methyl)benzonitrile (11) (100 mg, 0.420 mmol) in a 
mixture of NMP (9.5 mL) and water (0.5 mL) was cooled to –16 °C. Freshly 
distilled hexanal (0.18 mL, 1.3 mmol) was added and the resulting mixture was 
stirred for 96 h. The reaction mixture was cooled to 0 °C and NaBH4 (48 mg, 1.3 
mmol) was added. Saturated aqueous NaHCO3 (10 mL) was added and the 
mixture was extracted with a mixture of EtOAc and heptane (1:1, 3 × 20 mL). The combined organic layers 
were dried (Na2SO4), filtered and concentrated. The residue was purified via column chromatography 
(EtOAc/heptane, 0 → 25%). The product was obtained as a brown oil (112.3 mg, 0.332 mmol, 79%). 1H 
NMR (CDCl3, 300 MHz) δ (ppm) 7.60 (d, J = 8.4 Hz, 2H), 7.45 (d, J = 8.1 Hz, 2H), 6.68 (d, J = 9.0 Hz, 2H), 6.42 
(d, J = 9.0 Hz, 2H), 4.64 (d, J = 3.9 Hz, 1H), 3.74–3.62 (m, 2H), 3.69 (s, 3H), 2.01–1.97 (m, 1H), 1.38–1.17 (m, 
6H), 0.83 (t, J = 6.6 Hz, 3H); 13C NMR (CDCl3 75 MHz) δ (ppm) 152.3, 148.0, 140.8, 132.2, 128.0, 118.9, 
114.8, 114.8, 110.7, 63.6, 60.8, 55.7, 46.3, 29.9, 25.4, 22.7, 13.9; IR (cm-1) 3389, 2929, 2227, 1512, 1237, 
1037, 820; HRMS [ESI (m/z)] calcd for C21H27N2O2 (M+H)+ 339.20725, found: 339.20686; HPLC ee >99%, 
Chiralpak AD-H (250 × 4.6 mm), flow 1.0 mL/min, n-hexane/2-propanol 80/20, retention times 21.6 min 
(major enantiomer), 8.4 min (minor enantiomer); d.r. >19:1 (determined with 1H NMR); Rf = 0.56 
(EtOAc/heptane, 1:1); [α]20D –28.8 (c 0.225, CHCl3).  
 
(2S,3S)-Ethyl 4-hydroxy-2-(4-methoxyphenylamino)-3-methylbutanoate (20) 
A solution of L-proline (191 mg, 1.93 mmol) and N-PMP ethylglyoxylate (12) (2.00 g, 
9.65 mmol) in NMP (95 mL) and water (5 mL) was cooled to –20 °C. After addition of 
freshly distilled propionaldehyde (2.08 mL, 28.9 mmol) the mixture was stirred for 24 
h at –20 °C. NaBH4 (1.1 g, 29 mmol) was added (with T < 0 °C). After addition of water (30 mL) and 
saturated aqueous NaHCO3 (120 mL), the mixture was extracted with EtOAc/heptane (1:1, 3 × 100 mL). 
The combined organic layers were dried (Na2SO4), filtered and concentrated. The residue was purified via 
column chromatography (EtOAc/heptane, 0 → 60%). The product was obtained as a brown oil (412 mg, 
1.54 mmol, 16%). 1H NMR (CDCl3, 300 MHz) δ (ppm) 6.77 (d, J = 9.0 Hz, 2H), 6.70 (d, J = 9.0 Hz, 2H), 4.23–
4.11 (m, 3H), 3.76 (dd, J = 10.8 Hz, J= 4.2 Hz, 1H), 3.74 (s, 3H), 3.66 (dd, J= 10.8 Hz, J= 7.2 Hz, 1H), 2.29–
2.19 (m, 1H), 1.24 (t, J = 6.9 Hz, 3H), 1.0 (d, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 173.9, 153.3, 
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141.4, 116.5, 114.8, 65.8, 61.1, 61.0, 55.7, 38.1, 14.2, 11.7; IR (cm-1) 2933, 1725, 1512, 1235, 1034, 822, 
609; HRMS [ESI (m/z)] calcd for C14H22NO4 (M+H)+ 268.15488, found: 268.15428. HPLC ee >99%, 
Chiralpak AD-H (250 × 4.6 mm), flow 1.0 mL/min, n-hexane/2-propanol 80/20, retention times 8.1 min 
(major enantiomer), 9.8 min (minor enantiomer); d.r. >19:1 (determined via 1H NMR); Rf = 0.35 
(EtOAc/heptane, 1:1); [α]20D –49.4 (c 1.085, CHCl3).  
 
(2S,3R)-3-(4-Methoxyphenylamino)-2-methyloctan-1-ol (21)  
A solution of p-anisidine (100 mg, 0.812 mmol) en hexanal (66 µL, 0.81 mmol) in 
NMP (5 mL) was stirred for 2.5 h. L-Proline (16.1 mg, 0.162 mmol) was added and the 
reaction mixture was cooled to –16 °C. After addition of freshly distilled 
propionaldehyde (180 µL, 2.44 mmol) the mixture was stirred for 16 h. After allowing 
the reaction mixture to warm to 0 °C, NaBH4 (92.2 mg, 2.44 mmol) was added. Saturated aqueous NaHCO3 
(10 mL) was added and the mixture was extracted with EtOAc/heptane (1:1, 3 × 20 mL). The combined 
organic layers were dried (Na2SO4), filtered and concentrated. The residue was purified via column 
chromatography (EtOAc/heptane, 0 → 25%). The product was obtained as a brown oil (31 mg, 14%). 1H 
NMR (CDCl3, 300 MHz) δ (ppm) 6.77 (d, J = 8.7 Hz, 2H), 6.65 (d, J = 8.7 Hz, 2H), 3.74 (s, 3H), 3.67 (d, J = 5.4 
Hz, 2H), 3.43 (m, 1H), 2.93 (m, 1H), 1.98 (m, 1H), 1.51 (m, 1H), 1.26 (m, 6H), 0.95 (d, J = 6.9 Hz, 3H), 0.85 
(m, 3H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 152.5, 142.1, 115.8, 114.9, 67.1, 57.9, 55.8, 37.1, 32.4, 31.9, 
26.5, 22.6, 14.0, 11.0; IR (cm-1) 2360, 2339, 1557, 1509, 667, 610, 511, 418; HRMS [ESI (m/z)] calcd for 
C16H28NO2 (M+H)+ 266.21200, found: 266.21167; HPLC ee >99%, Chiralpak AD-H (250 × 4.6 mm), flow 1.0 
mL/min, n-hexane/2-propanol 95/5, retention times 15.9 min (major enantiomer) and 14.2 min (minor 
enantiomer); d.r. >19:1 (determined via 1H NMR); Rf = 0.56 (EtOAc/heptane, 1:1); [α]20D –40.0 (c 0.445, 
CHCl3).  
 
(2S,3S)-3-Amino-2-methyl-3-(4-nitrophenyl)propanoic acid (23) 
Under an inert atmosphere: To a solution of (2S,3S)-3-((4-
methoxyphenyl)amino)-2-methyl-3-(4-nitrophenyl)propan-1-ol* (16) (7.00 g, 
22.1 mmol) in MeCN/water (1:1, 150 mL) were added H2SO4 (1M, 22.1 mL, 22.1 
mmol) and periodic acid (5.04 g, 22.1) and the resulting mixture was stirred for 3.5 h. Subsequently, 
Na2Cr2O7.2H2O (0.33 g, 1.1 mmol) and periodic acid (25.2 g, 110.5 mmol) were added. After stirring for 16 
h, the mixture was washed with DCM (3 × 80 mL). After purification via ion exchange chromatography 
(DOWEX 50W × 8) the product was obtained as white-brown crystals (3.841 g, 77% yield). 1H NMR (D2O, 
300 MHz)  (ppm) 8.33 (d, J = 8.4 Hz, 2H), 7.68 (d, J = 8.7 Hz, 2H), 4.92 (d, J = 8.4 Hz, 1H), 3.28 (m, 1H), 1.34 
(d, J = 7.2 Hz, 3H); 13C NMR (D2O, 75 MHz)  (ppm) 175.5, 147.7, 140.9, 128.1, 123.9, 55.5, 42.9, 12.5; IR 
(cm-1): 2941, 1575, 1515, 1398, 1346, 1108, 858, 698; HRMS [ESI (m/z)] : calcd for C10H13N2O4 (M+H)+: 
225.08753, found: 225.08874; []20
D
+16.8 (c 0.975, H2O). 
*ee and d.r. of this batch were not determined, for a stereoselective synthesis See Chapter 2. 
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(S)-2-((S)-Amino(4-nitrophenyl)methyl)hexanoic acid (24) 
To a solution of (S)-2-((S)-(4-methoxyphenylamino)(4-
nitrophenyl)methyl)hexan-1-ol (17) (0.10 g, 0.28 mmol) in MeCN/H2O (1:1, 5 mL) 
were added H2SO4 (1M, 0.28 mL) and periodic acid (63.8 mg, 0.28 mmol). After 
stirring for 3.5 h, Na2CrO7. 2H2O (42 mg, 0.14 mmol) and periodic acid (319 mg, 
1.40 mmol) were added and the mixture was stirred for an additional 19.5 h. The resulting reaction 
mixture was washed with DCM (3 × 10 mL). After purification via ion exchange chromatography, the 
product was obtained as a white powder (47.7 mg, 64%). 1H NMR (D2O, 300 MHz) δ (ppm) 8.21 (d, J = 8.7 
Hz, 2H), 7.53 (d, J = 9.0 Hz, 2H), 4.43 (d, J = 9.3 Hz, 1H), 2.79–2.71(m, 1H), 1.54 (m, 2H), 1.25 (m, 4H), 0.78 
(m, 3H); 13C NMR (D2O, 75 MHz): δ (ppm) 129.1, 124.9, 57.4, 53.8, 29.5, 29.2, 22.5, 13.7. (quarternary 
carbons invisible due to low solubility of product in D2O; IR (cm-1) 2359, 2332, 1522, 1347, 668, 415; 
HRMS [ESI (m/z)] calcd for C13H19N2O4 (M+H)+ 267.13448, found: 267.13381; [α]20D +11.5 (c 0.38, DMSO).  
 
(S)-2-((S)-Amino(4-cyanophenyl)methyl)hexanoic acid (25) 
To a solution of 4-((1S,2S)-2-(hydroxymethyl)-1-(4-methoxyphenylamino)hexyl) 
benzonitrile (19) (0.1 g, 0.3 mmol) in MeCN/H2O (1:1, 5 mL) were added H2SO4 
(1M, 0.3 mL, 0.3 mmol) and periodic acid (63.4 mg, 0.30 mmol). After stirring for 
3.5 h, Na2Cr2O7. 2H2O (45 mg, 0.15 mmol) and periodic acid (342 mg, 1.50 mmol) 
were added and the mixture was stirred for an additional 19.5 h. The resulting reaction mixture was 
washed with DCM (3 × 10 mL). After purification via ion exchange chromatography, the product was 
obtained as a brown powder (55.4 mg, 75%). 1H NMR (D2O, 300 MHz) δ (ppm) 7.73 (d, J = 8.1 Hz, 2H), 
7.45 (d, J = 8.4 Hz, 2H), 4.30 (d, J = 9.3 Hz, 1H), 2.72–2.64 (m, 1H), 1.52 (m, 2H), 1.22 (m, 4H), 0.78 (m, 3H); 
13C NMR (D2O, 75 MHz) δ (ppm) 133.7, 128.6, 57.7, 54.3, 29.6, 29.2, 22.5, 13.7 (quarternary carbons 
invisible due to low solubility of product in D2O; IR (cm-1) 3748, 2360, 2339, 1558, 1540, 1507, 668, 418; 
[α]20D –1.8 (c 0.375, DMSO). 
 
(2S,3R)-3-Amino-2-methyloctanoic acid (26) 
To a solution of (2S,3R)-3-(4-methoxyphenylamino)-2-methyloctan-1-ol (21) (400 mg, 
1.50 mmol) in MeCN/H2O (1:1, 20 mL) were added H2SO4 (1M, 1.5 mL, 1.5 mmol) and 
periodic acid (342 mg, 1.50 mmol). After stirring for 16 h, Na2Cr2O7. 2H2O (22 mg, 
0.075 mmol) and periodic acid (1.71 g, 7.50 mmol) were added. The mixture was 
stirred for an additional 3 h and washed with DCM (3 × 50 mL). After purification via ion exchange 
chromatography, the product was obtained as a white powder (252 mg, 97%). 1H NMR (D2O, 300 MHz) δ 
(ppm) 3.43 (m, 1H), 2.60 (m, 1H), 1.66–1.64 (m, 2H), 1.35 (m, 6H), 1.18 (d, J = 7.2 Hz, 3H), 0.89 (br s, 3H); 
13C NMR (DMSO-d6, 75 MHz) δ (ppm) 176.7, 52.0, 31.1, 30.1, 24.8, 21.9, 13.9, 11.7; IR (cm-1) 2927, 2867, 
1564, 1400, 1364, 1263, 1167, 1107, 734, 703; HRMS [ESI (m/z)] calcd for C9H20NO2 (M+H)+ 174.14940, 
found 174.14928. 
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(2S,3S)-3-Amino-2-methyl-3-phenylpropanoic acid (27) 
Under an inert atmosphere: To a solution of (2S,3S)-3-((4-methoxyphenyl)amino)-2-
methyl-3-phenylpropan-1-ol (22)* (5.99 g, 22.1 mmol) in 1:1 acetonitrile/water (150 
mL) were added H2SO4 (1M, 22.1 mL, 22.1 mmol) and periodic acid (5.04 g, 22.1 mmol) 
and the resulting mixture was stirred for 1h. Subsequently, Na2Cr2O7·2H2O (0.33 g, 1.1 
mmol) and periodic acid (25.2 g, 110.5 mmol) were added. After stirring for 16 h, the dark brown mixture 
was washed with DCM (3 × 80 mL). After purification via ion exchange chromatography (DOWEX 50W × 
8) the product was obtained as off-white crystals (3.142 g, 79% yield). 1H NMR (D2O, 300 MHz)  (ppm) 
7.47 (m, 5H), 4.48 (d, J = 7.2 Hz, 1H), 3.05 (m, 1H), 1.28 (d, J = 6.9 Hz, 3H); 13C NMR (D2O, 75 MHz,)  (ppm) 
178.9, 134.6, 126.7, 128.6, 57.0, 44.9, 13.3; IR (cm-1): 2972, 1562, 1454, 1398, 1359, 1074, 755, 706; HRMS 
[ESI (m/z)]: calcd for C10H14NO2: 180.10245, found: 180.10176; []20D −9.5 (c 0.840, H2O). 
*ee and d.r. of this batch were not determined, for a stereoselective synthesis, see Chapter 2. 
 
(2R,3S)-3-((4-Methoxyphenyl)amino)-2-methyloctan-1-ol (32)  
A solution of p-anisidine (1 g, 8.12 mmol) and hexanal (1.998 mL, 16.24 mmol) in 
EtOAc/NMP (40 mL, 7:1) was stirred for 15 min. The EtOAc was evaporated 
under reduced pressure. The reaction mixture was diluted with NMP (5 mL) and 
cooled to –20 °C. D-proline (187 mg, 1.624 mmol) was added and the reaction 
was stirred for 10 min. After addition of propionaldehyde (1.415 g, 24.36 mmol) 
the reaction mixture was stirred for 16 h at –20 °C. NaBH4 (922 mg, 24.36 mmol) 
was added and the reaction was quenched with saturated NaHCO3 (150 mL). The reaction mixture was 
extracted with n-heptane/EtOAc (3 × 100 mL, 1:1), washed with brine (100 mL), dried (Na2SO4) and 
concentrated. The residue was purified by column chromatography (n-heptane/EtOAc, 0 → 25%) to afford 
19 (600 mg, 28%) as a brown oil. 1H NMR (CDCl3, 300 MHz) δ (ppm) 6.77 (d, J = 8.7 Hz, 2H), 6.65 (d, J = 8.7 
Hz, 2H), 3.74 (s, 3H), 3.66 (d, J = 5.4 Hz, 2H), 3.42 (m, 1H), 1.98 (m, 1H), 1.47 (m, 2H), 1.26 (m, 6H), 0.94 (d, 
J = 6.9 Hz, 3H), 0.86 (m, 3H). 13C NMR (CDCl3, 75 MHz) δ (ppm) 152.5, 142.0, 115.7, 114.9, 66.9, 57.8, 55.7, 
37.1, 32.3, 31.8, 26.5, 22.5, 14.0, 11.1. IR (cm-1) 2928. 1510, 1463, 1232, 1037, 819; HRMS [ESI (m/z)] 
calcd for C16H28NO2 (M+H)+ 266.21200, found 266.21173. HPLC ee >99%, Chiralpak AD-H (250 × 4.6 mm), 
flow 1.0 mL/min (n-hexane/2-propanol 95/5), retention times 14.2 min for 19 and 15.9 for ent-19; d.r. 
>19:1 (determined by 1H NMR); Rf 0.59 (n-heptane/EtOAc, 1:1); [α]20D +43.0 (c 0.445, CHCl3).  
 
(2R,3S)-3-Amino-2-methyloctanoic acid (2R,3S)-(29) 
(2R,3S)-3-(4-Methoxyphenylamino)-2-methyloctan-1-ol (39) (500 mg, 1.884 mmol) 
was dissolved in MeCN/water (1:1, 20 mL). Aqueous H2SO4 (1M, 1.884 ml, 1.884 mmol) 
and periodic acid (429 mg, 1.884 mmol) were subsequently added. The reaction was 
stirred for 16 h and Na2Cr2O7·2H2O (28 mg, 0.094 mmol) and periodic acid (2.15 g, 9.42 
mmol) were added subsequently. The reaction was stirred for 3 h. The mixture was 
washed with DCM (3 × 50 mL). The product was purified with ionexchange columnchromatography and 
obtained via lyophilisation. Yield 212 mg (1.22 mmol, 65 %). 1H NMR (400 MHz, D2O) δ (ppm) 3.55–3.27 
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(m, 1H), 2.75–2.52 (m, 1H), 1.76–1.52 (m, 2H), 1.50–1.25 (m, 6H), 1.17 (d, J = 6.3 Hz, 3H), 0.95–0.77 (m, 
3H).  
1H NMR data are in accordance with data obtained for 26 (opposite enantiomer). 
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7.1 Introduction 
The quinolizidine skeleton is widely encountered in drug-like compounds and natural products, 
displaying a large array of biological activities.1 Quinolizidine-based natural products have been 
mostly isolated from plants, trees and herbs.1 Lasubine I (1a) and II (1b, Scheme 1) represent 
two of these alkaloids and were isolated from the leaves of the Lagerstroemia subcostate Koehne 
by Fuji et al. in 1978.2 Synthetic efforts by various groups have resulted in a number of racemic 
and enantioselective routes to lasubine II.3 In conjunction with recent work from our group on 
the total synthesis of quinolizidine-based natural products,4 and in view of the potentially 
interesting properties of the lasubines, we set out to develop a new pathway to lasubine II based 
on the asymmetric proline-catalysed Mannich reaction. We reasoned that the commercial 
availability of both the D- and L-form of the catalyst would provide an entry to both enantiomers 
of lasubine II.  
 
7.2 Retrosynthetic analysis 
Retrosynthetic analysis of lasubine II (1b) leads to the bicyclic lactam 2 as a suitable precursor, 
of which the unsaturated ring was projectec to result from ring-closing metathesis of diene 3. 
We envisioned that the latter compound could be formed via an intramolecular Mannich 
cyclisation of imine 4, which in turn would be accessible via an asymmetric proline-catalysed 
Mannich reaction involving acetone, veratryl aldehyde (5) and p-anisidine (6).5  
 
Scheme 1 Lasubine I (1a) and retrosynthetic analysis of lasubine II (1b). 
 
7.3 Results 
With this plan in mind, we set out to study the intended asymmetric three-component Mannich 
reaction (Scheme 2), employing D-proline which would lead to the unnatural enantiomer (+)-
lasubine II. This reaction was investigated previously by the group of Hayashi, that was unable 
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to isolate the desired aminoketone with proline as the catalyst.6 Instead, they used a more 
expensive protected 4-hydroxyproline derivative. In our hands, careful analysis of the D-proline-
catalysed Mannich reaction (20 mol% D-proline, DMSO, rt) revealed that the product was 
formed, but accompanied by the formation of enone 9. We discovered that enone 9 was formed 
under the reaction conditions via elimination of p-anisidine from the desired product 7. 
Gratifyingly, by employing D-proline as the catalyst and by careful monitoring of the reaction 
progress by HPLC and quenching the reaction mixture at ca. 50% conversion, we were able to 
isolate the (R)-aminoketone 7 by precipitation from the reaction mixture as a crystalline solid in 
50% yield and >99% ee. This crystallisation protocol allowed us to scale up the reaction to 10 g, 
furnishing the product in the same yield and enantiopurity. The (S)-enantiomer was also 
prepared in comparable yield and selectivity with L-proline as the catalyst. 
 
 
Scheme 2 Synthesis of 1,3-aminoketone 8. 
 
Subsequently, we deprotected N-PMP amine 7 employing H5IO6 under acidic conditions.7 
Although cleavage to the free amine proceeded smoothly, isolation of the β-amino ketone 
appeared troublesome due to side-reactions (e.g. condensation) during concentration of the 
organic layer after workup. This problem was circumvented by formation of the HCl-salt 8 prior 
to concentration. 
Inspired by our own research on iminium ion type cyclisations,4a,8 we envisioned that 
conversion of compound 8 into the corresponding imine 4 should lead to a precursor that would 
be prone to a Mannich cyclisation. This idea was underlined by work of Davis and co-workers,9 
who carried out similar types of Mannich cyclisations that involved furan nucleophiles. The 
precursor imine 4 was prepared by condensation of 8 with cinnamaldehyde in the presence of 
triethylamine as a base to liberate the amino group. The condensation was carried out in 1,2-
dichloroethane via repetitive concentration of the reaction mixture under reduced pressure to 
azeotropically remove water. Because this experiment was conducted in a rotatory evaporator, 
fresh triethylamine and 1,2-dichloroethane were repeatedly added to the residue after each 
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concentration step until nearly complete consumption of cinnamaldehyde was observed by 
HPLC analysis. The Mannich cyclisation was then effected by stirring a solution of the crude 
imine 4 in 1,2-dichloroethane at 60 °C in the presence of an excess of (+)-camphorsulfonic acid 
(CSA) to yield piperidone 10 as a single diastereoisomer. It appeared to be crucial to dry the CSA 
prior to use and conduct the reaction under exclusion of moisture, since imine 4 was extremely 
prone to acidic hydrolysis. Without purification of the resulting 2,6-disubstituted piperidinone 
10, the amine function was immediately acylated with vinylacetic acid via standard DCC-
coupling, leading to the stable piperidinone 12. The yield of 12 after silica gel purification was 
44% over the three steps (Scheme 3).  
 
Scheme 3 Mannich cyclisation, followed by ring-closing metathesis and reduction to give 13. 
 
Similar steps were also carried out by using the L-proline route resulting in ent-10 with a 
comparable yield and complete diastereoselectivity. HPLC analysis and 1H NMR studies (NOESY, 
Figure 1) on the purified product ent-10 proved that it was formed as a cis-disubstituted 
diastereoisomer. This outcome can be rationalised by invoking the chairlike cationic 
intermediate 11 (Scheme 3), in which both the aryl and the styrenyl substituent will 
preferentially occupy the least hindered equatorial positions. 
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Figure 1 Relevant section from the NOESY spectrum of ent-10. 
 
To avoid lactam reduction at a later stage, we tried to N-alkylate the crude piperidinone ent-10 
with 4-bromo-1-butene to obtain a metathesis precursor without this lactam functionality 
(Scheme 4). Although mass spectrometry of the reaction mixture showed formation of a product 
with the expected mass, we were unable to isolate the desired product, possibly due to 
decomposition. 
 
Scheme 4 Unsuccessful alkylation of ent-10. 
 
Anticipating on the required conversion of the ketone into the alcohol at a later stage in the 
synthesis, we reduced product ent-10 with LS-Selectride® and observed the formation of 
products 14a and b in a 14:1 ratio, favouring the product with the desired stereochemistry 
(Scheme 5). However, alkylation of 14a/b with 4-bromo-1-butene also failed and acylation 
under the aforementioned conditions only led to poor conversion into the desired amide. The 
mixture of stereoisomers in combination with the unsuccessful attempts to transform 14a/b 
into a suitable ring-closing metathesis precursor led us to return to the earlier described route 
(Scheme 3).  
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Scheme 5 LS-Selectride® reduction of piperidinone ent-10. 
 
In the D-proline-based route, we observed that treatment of piperidinone 12 with the Grubbs 2nd 
generation catalyst (6 mol%), followed by straightforward hydrogenation of the resulting 
unsaturated lactam moiety led to the bicyclic structure 13 in good overall yield (Scheme 3). 
 
As the next step, we investigated the stereoselective reduction of the ketone functionality of 13. 
Both small and more sterically demanding borohydride reducing agents were evaluated, but all 
attempts led to undesired stereochemistry at the C4 carbon. This was proven by subsequent 
LiAlH4 reduction of lactam 13, which provided 2-epi-lasubine II (15) as the exclusive 
diastereoisomer in all cases, as demonstrated by 1H NMR data comparison with the literature3c 
(Scheme 6). Thus, both carbonyls were reduced simultaneously with LiAlH4 as the reducing 
agent. The resulting 2-epi-lasubine (15) was transformed into (+)-lasubine II ((+)-1b) via a 
protocol from Zhu et al. (Scheme 6).3c  
 
Scheme 6 Final steps of the synthesis of (+)-lasubine II ((+)-1b). 
 
In addition, cyclisation product ent-10 was converted via an identical pathway into natural (–)-
lasubine II ((–)-1b) (Scheme 7). 
Scheme 7 Synthesis of natural (–)-lasubine II: (–)-1b. 
 
Analytical data of both lasubine II enantiomers were in agreement with literature data (see 
section 7.6)  
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7.4 Conclusion 
In conclusion, we developed a new stereoselective route to both enantiomers of lasubine II. Key 
steps include an enantioselective D- or L-proline-catalysed Mannich reaction, which employs 
commercially available starting compounds, and a diastereoselective Mannich cyclisation.  
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7.6 Experimental section 
For general remarks, see section 2.8. 
 
7.6.1 (+)-Lasubine II and intermediates 
(R)-4-(3,4-Dimethoxyphenyl)-4-(4-methoxyphenylamino)butan-2-one (7) 
To a mixture of DMSO (45 mL) and acetone (180 mL) was added 3,4-
dimethoxybenzaldehyde (10.5 g, 63.2 mmol), p-anisidine (7.75 g, 62.9 mmol) and 
D-proline (1.52 g, 13.2 mmol). The resulting mixture was stirred for 24 h at rt. The 
reaction was quenched by the addition of potassium phosphate buffer (0.5 M, pH 
7, 100 mL). The resulting mixture was stirred for another 10 min until a precipitate was formed. The 
precipitate was isolated by filtration and dried in vacuo to afford 7 (10.3 g, 31.3 mmol, 50%) as a white 
solid. 1H NMR (CDCl3, 300 MHz) δ (ppm) 6.92–6.87 (m, 2H) ), 6.83–6.79 (m, 1H), 6.73–6.67 (m, 2H), 6.55–
6.49 (m, 2H), 4.69 (t, J = 6.5 Hz, 1H), 4.11 (br s, 1H), 3.85 (s, 6H), 3.70 (s, 3H), 2.89 (d, J = 6.5 Hz, 2H), 2.11 
(s, 3H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 207.4, 152.4, 149.2, 148.1, 141.0, 135.4, 118.2, 115.4, 114.7, 
111.3, 109.5, 55.9, 55.7, 55.2, 51.4, 30.8; IR (cm-1) 3382, 1705, 1506, 1251, 1229, 1139, 1022, 8191; HRMS 
[ESI (m/z) calcd for C19H24NO4 (M+H)+: 330.17053, found: 330.17086; HPLC: ee: >99%, Chiralpak AD-H 
(250 × 4.6 mm), flow 1.0 mL/min, n-hexane/2-propanol 80/20, retention time: 7: 14.9 min, ent-7: 18.4 
min; Rf = 0.26 (EtOAc/heptane, 1:1); Mp 152–154 °C; []D20 –2.7 (c 0.93, CHCl3). 
 
(R)-4-Amino-4-(3,4-dimethoxyphenyl)butan-2-one hydrochloride (8) 
To a solution of (R)-4-(3,4-dimethoxyphenyl)-4-(4-methoxyphenylamino)butan-
2-one (7) (9.3 g, 28 mmol) in MeCN/H2O (250 mL, 1:1) was added aqueous H2SO4 
(1M, 28 mL, 28 mmol) and H5IO6 (6.6 g, 29 mmol). The mixture was stirred for 4 h 
at rt. The mixture was washed with DCM (3 × 125 mL) and the resulting aqueous phase was diluted with 
125 mL DCM. While stirring the mixture vigorously, the pH of the aqueous layer was brought to 9 via 
addition of 5 M aqueous KOH. The layers were separated and the aqueous layer was extracted with DCM 
(3 × 125 mL). The combined organic layers were dried (Na2SO4) and HCl/EtOAc (20 mL) was added. The 
resulting mixture was concentrated until the product precipitated. The product was isolated by filtration 
Chapter 7 
 
 
152 
and dried in vacuo to afford 8 (3.6 g, 13.9 mmol, 49%) as a pale yellow solid. 1H NMR (CD3OD, 300 MHz) δ 
(ppm) 7.06–7.04 (m, 1H), 7.00–6.98 (m, 2H), 4.62 (dd, J = 7.3, 6.3 Hz, 1H), 3.87 (s, 3H), 3.84 (s, 3H), 3.20 (d, 
J = 7.5 Hz, 1H), 3.20 (d, J = 6.1 Hz, 1H), 2.20 (s, 3H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 207.4, 151.3, 151.0, 
130.3, 121.1, 113.1, 112.1, 56.6, 56.5, 52.1, 47.6, 30.0; IR (cm-1): 3399, 2919, 1709, 1515, 1256, 1143, 
1022; HRMS [ESI (m/z)] calcd for C12H17NO3 (M+Na-Cl-)+: 246.11061, found: 246.10966; Rf = 0.38 
(MeOH/DCM, 1:1); Mp 158–161 °C; []D20 –12 (c 0.94, MeOH). 
 
(E)-4-(3,4-Dimethoxyphenyl)but-3-en-2-one (9) 
Analytical data of compound 9, which was isolated as a side product during the 
development of the route towards (−)-lasubine II: 1H NMR (CDCl3, 300 MHz)  
(ppm) 7.42 (d, J = 16.3 Hz, 1H),7.08 (dd, J = 2.1 Hz, J = 8.3 Hz, 1H), 7.06 (d, J = 2.1 
Hz, 1H), 6.84 (d, J = 8.3 Hz, 1H), 6.57 (d, J = 16.2 Hz, 1H), 3.88 (s, 6H), 2.33 (s, 3H); 13C NMR (CDCl3, 75 
MHz)  (ppm) 198.3, 151.4, 149.3, 143.5, 127.3, 125.3, 123.0, 111.1, 109.6, 56.0, 55.9, 27.3; IR (cm-1): 
2962, 1664, 1504, 1250, 1018, 976, 805, 557; (M+H+) (LRMS): 207.0; HPLC: Chiralpak AD-H (250 × 4.6 
mm), flow: 1.0 mL/min, n-hexane/2-propanol 80/20): retention time 7.7 min.  
 
(2R,6S)-1-But-3-enoyl-2-(3,4-dimethoxyphenyl)-6-styrylpiperidin-4-one (12) 
To a solution of (R)-4-amino-4-(3,4-dimethoxyphenyl)butan-2-one 
hydrochloride (8) (3.50 g, 13.5 mmol) in dry 1,2-dichloroethane (200 mL) 
was added triethylamine (1.45 mL, 10.3 mmol) and trans-cinnamaldehyde 
(1.30 mL, 10.3 mmol). The mixture was concentrated in vacuo. To the residue 
was added dry 1,2-dichloroethane (150 mL) and triethylamine (1.5 mL, 11 mmol). The mixture was 
concentrated again in vacuo. Dry 1,2-dichloroethane (150 mL), triethylamine (1.5 mL, 11 mmol) and 
trans-cinnamaldehyde (0.38 mL, 3.0 mmol) were added to the residue. The resulting mixture was 
concentrated in vacuo. To the residue was added dry 1,2-dichloroethane (125 mL) and triethylamine (1.5 
mL, 11 mmol). The resulting mixture was concentrated in vacuo to afford the crude imine. The crude imine 
4 was dissolved in dry 1,2-dichloroethane (360 mL) and the resulting mixture was added dropwise to a 
stirring solution of dry (+)-10-camphorsulfonic acid (20.2 g, 87 mmol) in dry 1,2-dichloroethane (230 mL) 
at 60 °C. The mixture was stirred for 5 h at 60 °C under an inert atmosphere. The mixture was washed 
with an aqueous half saturated NaHCO3 (3 × 350 mL), dried (Na2SO4) and concentrated in vacuo affording 
the crude piperidinone 10. Vinylacetic acid (3.8 mL, 45 mmol) and DCC (3.20 g, 15.5 mmol) were 
dissolved in dry DCM (100 mL) and stirred for 1 h at rt. The precipitate was removed by filtration and the 
solution was diluted with DCM (500 mL). The crude piperidinone 10 and DMAP (2.38 g, 19.5 mmol) were 
added to this solution. The mixture was stirred for 16 h under an argon atmosphere at rt. The mixture was 
washed with aqueous HCl (0.2 M, 500 mL), aqueous NaHCO3 (1 M, 500 mL) and brine (500 mL). The 
mixture was then dried (Na2SO4) and concentrated. The residue was purified by column chromatography 
(EtOAc/heptane, 1:2 → 1:1) to afford 12 (2.43 g, 5.99 mmol, 44% over three steps) as a yellow oil. 1H NMR 
(CDCl3, 200 MHz, T = 323K) δ (ppm) 7.37–7.04 (m, 5H), 6.90–6.70 (m, 3H), 6.51–6.33 (m, 1H), 6.11–5.78 
(m, 3H), 5.47 (br s, 1H), 5.26–5.05 (m, 2H), 3.78 (s, 3H), 3.70 (s, 3H), 3.35–3.20 (m, 2H), 3.12 (dd, J = 16.4, 
5.2 Hz, 1H), 2.80 (dd, J = 16.5 Hz, 6.8 Hz, 1H) 2.74 (d, J = 5.4 Hz, 2H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 
Total synthesis of lasubine II 
 
153 
206.6, 171.3, 149.3, 148.4, 135.8, 133.8, 131.6, 131.3, 129.1, 128.4, 128.0, 126.2, 118.7. 118.2, 111.1, 110.0, 
55.8, 55.7, 55.0–42.0 (br, 4C), 39.5; IR (cm-1) 1719, 1642, 1516, 1401, 1254, 1146, 1025; HRMS [ESI (m/z)] 
calcd for C25H27NO4Na (M+Na)+: 428.18378, found: 428.18379; HPLC: Chiralpak AD-H (250 × 4.6 mm), 
flow: 1.0 mL/min n-hexane/2-propanol 80/20), retention times: 12: 12.4 min, ent-12: 11.5 min; Rf = 0.18 
(EtOAc/heptane, 1:1); []D20 +32 (c 0.095, CHCl3).  
 
(4R,9aS)-4-(3,4-Dimethoxyphenyl)-3,4-dihydro-1H-quinolizine-2,6(7H,9aH)-dione (16) 
To a solution of (2R,6S)-1-but-3-enoyl-2-(3,4-dimethoxyphenyl)-6-styrylpiperidin-
4-one (12) (2.36 g, 5.82 mmol) in degassed DCM (125 mL) was added Grubbs 2nd 
generation catalyst (280 mg, 5.7 mol%). The mixture was stirred for 2 h at 40 °C 
under an inert atmosphere. The mixture was concentrated in vacuo and the residue 
was purified by column chromatography (MeOH/EtOAc, 0% → 1%) to afford 16 (1.30 g, 43.1 mmol, 74%) 
as an off-white solid. 1H NMR (CDCl3, 300 MHz) δ (ppm) 6.75 (d, J = 8.2 Hz, 1H), 6.66 (d, J = 2.0 Hz, 1H), 
6.63 (ddd, J = 8.2, 2.2, 0.7 Hz, 1H), 6.03 (ddt, J = 9.9, 4.6, 2.7 Hz, 1H), 5.80 (dd, J = 6.2, 2.0 Hz, 1H), 5.73 (dt, J 
= 9.9, 1.9 Hz, 1H), 4.85–4.70 (m, 1H), 3.82 (s, 3H), 3.81 (s, 3H), 3.19 (dt, J = 21.0, 4.1 Hz, 1H), 3.18 (dd, J = 
16.5 Hz, 6.3 Hz, 1H), 3.06 (ddt, J = 21.5, 6.3, 2.8 Hz, 1H), 2.92 (dd, J = 16.4, 2.3 Hz, 1H), 2.63 (d, J = 9.0 Hz, 
1H), 2.63 (d, J = 7.9 Hz, 1H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 206.0, 168.4, 149.2, 148.2, 133.6, 125.7, 
124.3, 117.0, 111.2, 109.1, 55.8, 55.7, 52.9, 51.9, 45.3, 45.0, 33.4; IR (cm-1) 2359, 1722, 1646, 1515, 1406, 
1318, 1255, 1135, 1024; HRMS [ESI (m/z)] calcd for C17H19NO4Na (M+Na)+: 324.12118, found: 324.12128; 
HPLC: Chiralpak AD-H (250 × 4.6 mm), flow: 1.0 mL/min, n-hexane/2-propanol 80/20), retention times: 
16: 24.5 min, ent-16: 34.9 min; Rf = 0.21 (EtOAc/MeOH, 49:1); Mp 148–151 °C; []D20 –67 (c 0.20, CHCl3). 
 
(4R,9aR)-4-(3,4-Dimethoxyphenyl)tetrahydro-1H-quinolizine-2,6(7H,8H)-dione (13) 
To a solution of (4R,9aS)-4-(3,4-dimethoxyphenyl)-3,4-dihydro-1H-quinolizine-
2,6(7H,9aH)-dione (16) (1.19 g, 3.95 mmol) in MeOH (60 mL) was added 10% Pd/C 
(459 mg, 11 mol%). A hydrogen atmosphere was applied (balloon) and the mixture 
was stirred for 16 h at rt. The catalyst was removed by filtration over celite and the 
solution was concentrated in vacuo. The residue was purified by column 
chromatography (MeOH/EtOAc, 0% → 2%) to afford 13 (885 mg, 2.92 mmol, 74%) as a white solid. 1H 
NMR (CDCl3, 300 MHz) δ (ppm) 6.76 (d, J = 8.3 Hz, 1H), 6.69 (d, J = 2.1 Hz, 1H), 6.65 (ddd, J = 8.2, 2.2, 0.9 
Hz, 1H), 5.84 (dd, J = 5.9, 2.3 Hz, 1H), 4.15–3.98 (m, 1H), 3.83 (s, 3H), 3.81 (s, 3H), 3.10 (dd, J = 16.7, 6.0 Hz, 
1H), 2.94 (dd, J = 16.7, 2.4 Hz, 1H), 2.67–2.53 (m, 2H), 2.46 (d, J = 6.8 Hz, 1H), 2.46 (d, J = 9.2 Hz, 1H), 2.10–
1.60 (m, 4H); 13C NMR (CDCl3, 75 MHz): δ (ppm) 206.3, 170.2, 149.1, 148.1, 133.8, 117.0, 111.2, 109.2, 
55.8, 55.7, 52.9, 52.2, 45.2, 44.8, 32.1, 30.8, 20.4; IR (cm-1) 2941, 1722, 1639, 1511, 1441, 1410, 1255, 
1143, 1024; HRMS [ESI (m/z)] calcd for C17H22NO4 (M+H)+: 304.15488, found: 304.15461; HPLC: 
Chiralpak AD-H (250 × 4.6 mm), flow: 1.0 mL/min, n-hexane/2-propanol 80/20), retention times: 13: 23.9 
min, ent-13: 27.8 min; Rf = 0.54 (DCM/MeOH, 9:1); Mp 181–183 °C; []D20 –122 (c 0.26, CHCl3). 
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(+)-2-epi-Lasubine II (15) 
To a solution of (4R,9aR)-4-(3,4-dimethoxyphenyl)tetrahydro-1H-quinolizine-
2,6(7H,8H)-dione (13) (787 mg, 2.59 mmol) in dry THF (50 mL) was added LiAlH4 
(496 mg, 13.1 mmol). The mixture was brought to 60 °C and stirred for 3 h under 
an inert atmosphere. The reaction was quenched by adding H2O (644 mg, 1.3 
mg/mg LiAlH4), NaOH (15% solution in H2O, 644 mg, 1.3 mg/mg LiAlH4) and H2O (1.61 g, 3.25 mg/mg 
LiAlH4). The resulting mixture was stirred vigorously for 10 min and the precipitate was removed by 
filtration. The filtrate was concentrated in vacuo. The residue was purified by column chromatography 
(MeOH/EtOAc, 0% → 7.5%) to afford 15 (698 mg, 2.40 mmol, 92%) as a yellow oil. 1H NMR (CDCl3, 300 
MHz) δ (ppm) 7.10–6.60 (m, 3H), 3.88 (s, 3H), 3.86 (s, 3H), 3.81–3.65 (m, 1H), 2.91 (dd, J = 11.6, 2.6 Hz, 
1H), 2.72–2.63 (m, 1H), 2.05–1.88 (m, 3H), 1.75–1.14 (m, 10H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 147.9, 
136.6, 120.0–119.0 (broad, 2C), 111.6–109.0 (broad, 2C), 68.4, 68.2, 60.9, 55.9, 55.8, 52.9, 45.1, 42.8, 33.6, 
26.0, 24.6; IR (cm-1) 3353, 2934, 2354, 1504, 1453, 1259, 1225, 1136, 1030, 738; HRMS [ESI (m/z)] calcd 
for C17H26NO3 (M+H)+: 292.19127, found: 292.18992; HPLC: Chiralpak AD-H (250 × 4.6 mm), flow: 1.0 
mL/min, n-hexane/2-propanol 80/20), retention times: 15: 6.8 min, ent-(15): 8.2 min); Rf = 0.20 
(DCM/MeOH, 9:1); []D20 +57 (c 0.46, MeOH). 
* Previously reported values for 15: [α]D20 = +53.8 (c = 1.0, CHCl3).3g 
Previously reported values for opposite enantiomer (ent-15): [α]D –56.9 (c 1.0, MeOH)3d; [α]D –44.4 (c 2.1, 
MeOH).3c 1H NMR data are in accordance with literature values.3g 
 
(+)-Lasubine II ((+)-1b) 
To a solution of (+)-2-epi-lasubine II (15) (688 mg, 2.36 mmol) in dry toluene (80 
mL) was added PPh3 (1.26 g, 4.80 mmol), p-nitrobenzoic acid (821 mg, 4.91 mmol) 
and DEAD (40% solution in toluene, 1.85 mL, 4.06 mmol). The mixture was stirred 
for 3.5 h at rt under an inert atmosphere. The reaction was quenched by addition of 
hexane (75 mL). The resulting suspension was filtered and the filtrate was diluted 
with EtOAc (150 mL). The mixture was washed with aqueous saturated NaHCO3 (150 mL). The resulting 
organic layer was dried (Na2SO4) and concentrated in vacuo. The residue was purified by column 
chromatography (heptane → heptane/EtOAc 1:2) to give the ester. This ester was dissolved in MeOH (75 
mL) and K2CO3 (343 mg, 2.48 mmol) was added. The mixture was stirred for 1.5 h at rt. The solution was 
concentrated in vacuo, diluted with EtOAc (75 mL) and the precipitate was removed by filtration. The 
filtrate was washed with brine, dried over Na2SO4 and concentrated in vacuo. The residue was purified by 
column chromatography (MeOH/EtOAc, 0% → 10%) to give (+)-lasubine II (308 mg, 1.06 mmol, 45%) as a 
yellow oil. 1H NMR (CDCl3, 300 MHz) δ (ppm) 6.98–6.73 (m, 3H), 4.17–4.11 (m, 1H), 3.88 (s, 3H), 3.85 (s, 
3H), 3.31 (dd, J = 11.2, 3.1 Hz, 1H), 2.77–2.62 (m, 1H), 2.50–2.30 (m, 1H), 1.98–1.18 (m, 12H); 13C NMR 
(CDCl3, 75 MHz) δ (ppm) 149.0, 147.8, 137.2, 119.7, 110.9, 110.4, 65.0, 63.4, 56.4, 55.9, 55.8, 53.2, 42.8, 
40.3, 33.6, 26.1, 24.8. IR (cm-1) 2928. 1591, 1510, 1459, 1258, 1134, 1028; HRMS [ESI (m/z)] calcd for 
C17H26NO3 (M+H)+: 292.19127, found: 292.18986; Rf = 0.07 (EtOAc/MeOH, 9:1); []D20 +44 (c 0.56, 
MeOH).*  
Total synthesis of lasubine II 
 
155 
* Previously reported values: ([]20
D
= +43.4 (c = 1.0, CHCl3));3g ([]20D = +50 (c = 0.3, MeOH)).
3k 
Previously reported value for (–)-lasubine II: []D23 –47.5 (c 3.7, MeOH).3a 
NMR data are in accordance with literature values.3g 
 
7.6.2 (−)-Lasubine II and intermediates 
Optimised experimental procedures are provided for the synthesis of (+)-lasubine II (Section 7.6.1). Only 
analytical data are provided for the synthesis of the natural isomer (–)-lasubine II and the intermediates.  
 
(S)-4-(3,4-Dimethoxyphenyl)-4-(4-methoxyphenylamino)butan-2-one (ent-7) 
1H NMR (CDCl3, 300 MHz) δ (ppm) 6.92–6.86 (m, 2H) ), 6.83–6.78 (m, 1H), 6.73–
6.66 (m, 2H), 6.55–6.49 (m, 2H), 4.69 (t, J = 6.5 Hz, 1H), 4.11 (br s, 1H), 3.85 (s, 6H), 
3.70 (s, 3H), 2.89 (d, J = 6.5 Hz, 2H), 2.11 (s, 3H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 
207.3, 152.4, 149.2, 148.1, 141.0, 135.3, 118.2, 115.3, 114.7, 111.3, 109.5, 55.8(2C), 55.6, 55.2, 51.4, 30.8; 
IR (cm-1) 3385, 1708, 1510, 1253, 1235, 1139, 1027, 821; HRMS [ESI (m/z)] calcd for C38H46N2O8Na 
(2M+Na)+: 681.31518, found: 681.31567; HPLC: ee: >99%, Chiralpak AD-H (250 × 4.6 mm), flow: 1.0 
mL/min, n-hexane/2-propanol 80/20, retention time: 7: 14.9 min, ent-(7): 18.4 min; Mp 147–151 °C; 
[]D20 +2.4 (c 0.41, CHCl3). 
 
(S)-4-Amino-4-(3,4-dimethoxyphenyl)butan-2-one hydrochloride (ent-8) 
1H NMR (CD3OD, 300 MHz) δ (ppm) 7.07–7.04 (m, 1H), 7.02–6.98 (m, 2H), 4.63 
(dd, J = 7.1, 6.5 Hz, 1H), 3.87 (s, 3H), 3.84 (s, 3H), 3.20 (d, J = 7.3 Hz, 1H), 3.20 (d, J 
= 6.3 Hz, 1H), 2.20 (s, 3H). 13C NMR (CDCl3, 75 MHz) δ (ppm) 207.4, 151.3, 150.9, 
130.3, 121.1, 113.1, 112.2, 56.7, 56.5, 52.2, 47.6, 30.1. IR (cm-1) 3395, 2936, 1709, 
1515, 1264, 1143, 1018; Mp 155–157 °C; []D20 +12 (c 1.05, MeOH). 
 
(2S,6R)-1-But-3-enoyl-2-(3,4-dimethoxyphenyl)-6-styrylpiperidin-4-one (ent-12) 
1H NMR (CDCl3, 300 MHz, T = 324K) δ (ppm) 7.25–7.16 (m, 3H), 7.13–7.05 
(m, 2H), 6.90–6.82 (m, 2H), 6.78–6.73 (m, 1H), 6.49–6.36 (m, 1H), 6.11–5.75 
(m, 3H), 5.48 (br s, 1H), 5.25–5.10 (m, 2H), 3.79 (s, 3H), 3.71 (s, 3H), 3.32–
3.24 (m, 2H), 3.13 (dd, J = 16.4, 5.2 Hz, 1H), 2.81 (dd, J = 16.4, 6.9 Hz, 1H), 
2.75 (d, J = 5.5, 2H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 206.6, 171.3, 149.3, 148.4, 135.8, 133.8, 131.7 (br), 
131.3, 129.1, 128.5, 128.0, 126.2, 118.8 (br) 118.2, 111.1, 110.0 (br), 55.8, 55.7, 55.5–52.0 (br, 4C), 39.5; IR 
(cm-1) 1721, 1642, 1516, 1404, 1256 1143, 1025; HRMS [ESI (m/z)] calcd for C25H27NO4Na (M+Na)+: 
428.18378, found: 428.18447; HPLC: Chiralpak AD-H (250 × 4.6 mm), flow: 1.0 mL/min, n-hexane/2-
propanol 80/20), retention times: 12: 12.4 min, ent-12: 11.5 min; Rf = 0.13 (EtOAc/heptane, 1:1); []D20 –
16 (c 0.76, CHCl3). 
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(4S,9aR)-4-(3,4-Dimethoxyphenyl)-3,4-dihydro-1H-quinolizine-2,6(7H,9aH)-dione (ent-16) 
1H NMR (CDCl3, 400 MHz) δ (ppm) 6.75 (d, J = 8.3 Hz, 1H), 6.65 (d, J = 2.1 Hz, 1H), 
6.62 (ddd. J = 0.8, 2.2, 8.3 Hz, 1H), 6.02 (ddt, J = 9.9, 4.7, 2.6 Hz, 1H), 5.79 (dd, J = 6.2, 
2.0 Hz, 1H), 5.75–5.69 (m, 1H), 4.81–4.70 (m, 1H), 3.82 (s, 3H), 3.80 (s, 3H), 3.17 (dt, 
21.3, 4.3 Hz, 1H), 3.17 (dd, J = 16.4, 6.3, 1H), 3.06 (ddt, J = 21.5, 6.4, 2.8 Hz, 1H), 2.91 
(dd, J = 16.4, 2.2 Hz, 1H), 2.62 (d, J = 8.9, 1H), 2.62 (d, J = 7.9, 1H); 13C NMR (CDCl3, 75 
MHz) δ (ppm) 206.0, 168.4, 149.1, 148.1, 133.6, 125.6, 124.3, 116.9, 111.2, 109.0, 55.8, 55.8, 52.9, 51.9, 
45.3, 45.0, 33.3; IR (cm-1) 1722, 1647, 1515, 1406, 1318, 1256, 1135, 1024; HRMS [ESI (m/z)] calcd for 
C17H19NO4Na (M+Na)+: 324.12118, found: 324.12049; HPLC: Chiralpak AD-H (250 × 4.6 mm), flow: 1.0 
mL/min n-hexane/2-propanol 80/20), retention times: 16: 24.5 min, ent-16: 34.9 min; Rf = 0.20 
(EtOAc/MeOH, 49:1); Mp 143–147 °C; []D20 +31 (c 0.08, CHCl3).  
 
(4S,9aS)-4-(3,4-Dimethoxyphenyl)tetrahydro-1H-quinolizine-2,6(7H,8H)-dione (ent-13) 
1H NMR (CDCl3, 300 MHz) δ (ppm) 6.76 (d, J = 8.3, 1H), 6.70 (d, J = 2.0 Hz, 1H), 6.66 
(ddd, J = 0.8, 2.2, 8.3, 1H), 5.85 (dd, J = 5.8, 2.0 Hz, 1H), 4.11–3.98 (m, 1H), 3.84 (s, 
3H), 3.82 (s, 3H), 3.11 (dd, J = 16.7, 6.0 Hz, 1H), 2.95 (dd, J = 16.7, 2.4 Hz, 1H), 2.73–
2.50 (m, 2H), 2.47 (d, J = 6.8, 1H), 2.47 (d, J = 9.1, 1H), 2.10–1.57 (m, 4H); 13C NMR 
(CDCl3, 75 MHz) δ (ppm) 206.3, 170.2, 149.1, 148.1, 133.8, 117.0, 111.2, 109.2, 55.9, 55.8, 52.9, 52.3, 45.2, 
44.9, 32.1, 30.8, 20.5; IR (cm-1) 1721, 1636, 1514, 1409, 1255, 1141, 1024; HRMS [ESI (m/z)] calcd for 
C17H21NO4Na (M+Na)+: 326.13683, found: 326.13734; HPLC: Chiralpak AD-H (250 × 4.6 mm), flow: 1.0 
mL/min; n-hexane/2-propanol 80/20), retention times: 13: 23.9 min, ent-13: 27.8 min; Rf = 0.51 
(DCM/MeOH, 9:1); Mp 174–179 °C. []D20 +90 (c 0.32, CHCl3). 
 
(–)-2-epi-Lasubine II (ent-15) 
1H NMR (CDCl3, 300 MHz) δ (ppm) 7.10–6.40 (m, 3H), 3.88 (s, 3H), 3.86 (s, 3H), 
3.80–3.60 (m, 1H), 2.98–2.80 (m, 1H), 2.78–2.56 (m, 1H), 2.05–0.70 (m, 13H); 13C 
NMR (CDCl3, 75 MHz) δ (ppm) 147.9, 136.7, 120.0–119.0 (br, 2C), 111.0–109.0 (br, 
2C), 68.5, 68.2, 60.9, 56.0, 55.8, 52.9, 45.2, 42.8, 33.7, 26.1, 24.6. IR (cm-1) 3350, 
2933, 1512, 1463, 1262, 1138, 1029, 731; HRMS [ESI (m/z)] calcd for C17H26NO3 (M+H)+: 292.19127, 
found: 292.19038; HPLC: Chiralpak AD-H (250 × 4.6 mm), flow: 1.0 mL/min, n-hexane/2-propanol 
80/20), retention times: 15: 6.8 min, ent-15: 8.2 min; Rf = 0.23 (DCM/MeOH, 9:1); []D20 –49 (c 1.7, 
MeOH)*. 1H NMR data in accordance with literature values.3c 
 
(–)-Lasubine II ((–)-1b) 
1H NMR (CDCl3, 300 MHz) δ (ppm) 7.10–6.69 (m, 3H), 4.30–4.10 (m, 1H), 3.88 (s, 3H), 
3.86 (s, 3H), 3.36–3.33 (m, 1H), 2.90–2.60 (m, 1H), 2.43 (br s, 1H), 2.04–0.70 (m, 
12H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 149.1, 147.9, 137.1, 119.8, 110.9, 110.5, 65.0, 
63.5, 56.6, 56.0, 55.8, 53.2, 42.6, 40.2, 33.5, 26.0, 24.8; IR (cm-1) 2928, 1514, 1463, 
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1260, 1260, 1136, 1027; HRMS [ESI (m/z) calcd for C17H26NO3 (M+H)+: 292.19127, found: 292.19027; Rf = 
0.06 (EtOAc/MeOH, 9:1); []D20 –56 (c 0.32, MeOH).* 
 
*See Section 7.6.1 for literature values of ent-15 and (–)-lasubine II 
NMR data are in accordance with literature values3g ((+)-lasubine). 
 
7.6.3 Procedure, 1H NMR, 13C NMR for ent-10 
A stock solution was prepared by mixing dry toluene (375 mL), dry DCM 
(125 mL) and dry triethylamine (10 mL). To a mixture of (S)-4-amino-4-(3,4-
dimethoxyphenyl)butan-2-one hydrochloride (ent-8) (6.33 g, 24.4 mmol) 
and trans-cinnamaldehyde (3.05 mL, 24.2 mmol) was added 150 mL of the 
stock solution. The resulting mixture was concentrated in vacuo. To the residue was added 150 mL stock 
solution and the resulting mixture was concentrated again in vacuo. 150 mL of stock solution was added to 
the residue and the resulting mixture was concentrated in vacuo to afford the crude imine. The crude 
imine was dissolved in dry 1,2-dichloroethane (350 mL) and dry (+)-10-camphorsulfonic acid (14.39 g, 
61.9 mmol) was added. The mixture was stirred for 16 h at 60 °C under an inert atmosphere. The mixture 
was washed with half saturated aqueous Na2CO3 (3 × 350 mL) and concentrated in vacuo. The residue was 
purified by two successive column chromatography steps (toluene/EtOAc, 4:1 and MeOH/DCM, 1:99, 
respectively) to afford ent-10. 1H NMR (CDCl3, 400 MHz) δ (ppm) 7.41–7.22 (m, 5H), 6.99 (d, J = 2.0 Hz, 
1H), 6.95 (dd, J = 8.5, 2.0 Hz, 1H), 6.85 (d, J = 8.2 Hz, 1H), 6.61 (d, J = 15.8 Hz, 1H), 6.27 (dd, J = 15.9, 7.3 Hz, 
1H), 3.97 (dd, J = 10.8, 3.9 Hz, 1H), 3.92 (s, 3H), 3.88 (s, 3H), 3.73 (dddd, J = 9.8, 7.3, 4.9, 0.83 Hz, 1H), 2.61–
2.45 (m, 4H); 13C NMR (CDCl3, 75 MHz) δ (ppm) 207.9, 149.2, 148.7, 136.4, 135.2, 131.3, 130.5, 128.6, 
127.9, 126.4, 118.7, 111.2, 109.6, 60.7, 59.3, 56.0 (2C), 50.4, 48.0; Rf = 0.18 (toluene/EtOAc, 4:1). 
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8.1 Ultimate Chiral Technology 
The research project Ultimate Chiral Technology was performed within a consortium of 
industrial and academic partners. Industry showed a great interest in the development of new 
industrially applicable routes towards multi-chiral centre compounds. The large scale 
accessibility of all stereoisomers of these chiral building blocks was considered important to 
custom manufacturing of pharmaceuticals (and pharmaceutical intermediates) since druglike 
molecules increasingly carry multiple chiral centres. To this end the consortium set the objective 
to develop new chiral technologies for the synthesis of these high value targets. The newly 
developed proline-catalysed Mannich reaction was considered a promising approach to the 
industrial synthesis of optically pure 1,3-amino alcohols and heterocycles. We identified the 
following three challenges for rendering the organocatalysed Mannich reaction applicable to the 
industrial synthesis of multichiral centre compounds:  
1. Is it possible to find a cost-efficient and a more environmentally friendly alternative for 
the commonly used ceric ammonium nitrate (CAN) deprotection of the N-PMP group? 
2. Can we identify industrially attractive methods to transform chiral β-amino ketones into 
all stereoisomers of the corresponding 1,3-amino alcohols? 
3. Can we transform Mannich products into other valuable (stereoisomerically pure) 
compounds? 
This thesis contains the results of the efforts to answer these questions. 
 
8.2 Results 
The research started with the evaluation of alternative N-deprotection methods, which resulted 
in the discovery of a new chemical and a new enzymatic method for this transformation. We 
substituted CAN for electrophilic halogen reagents (Chapter 2) and found that the desired free 
amines could in most cases be obtained without laborious chromatographic procedures, which 
is most desirable from environmental and cost perspectives. We developed an enzymatic 
method for the PMP-group removal using laccases (Chapter 3), but the obtained crude products 
were not as pure as with the chemical method. Moreover, the employed laccase amounts were 
high and within the timeframe of this project, we have not been able to evaluate their recycling. 
From an industrial point of view, the use of trichloroisocyanuric acid (TCCA) could be 
recommended as the best alternative for CAN-deprotection, because of its extremely low cost 
and environmental impact. The industrial applicability of the PMP-deprotection by TCCA was 
further demonstrated by the synthesis of amino acid derivative 5 (Scheme 1) in the pilot plant 
facility at DSM in Geleen, one of the consortium partners. A one-pot two-step protocol was 
developed and carried out on 345 g (p-anisidine) scale. The desired product 5 was obtained in 
~50% yield and of sufficient purity after TCCA deprotection.  
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Scheme 1 Large scale N-PMP deprotection using TCCA. 
 
We subsequently set out to diastereoselectively transform β-amino ketones into anti- or syn-1,3-
amino alcohols (Chapter 4). After an unsuccessful screening of borohydride reductions, we 
discovered two catalytic approaches, which can provide all desired stereoisomers. Asymmetric 
transfer hydrogenation in the presence of an Ir-based homogeneous catalyst gave rise to the 
formation of anti-1,3-amino alcohols. Short reaction times and low catalyst loadings were 
sufficient to efficiently allow the β-amino ketones to be diastereoselectively transformed into the 
corresponding 1,3-amino alcohols. The cheap, practical and easy-to-perform protocol meets the 
conditions for industrial application. The synthesis of syn-1,3-amino alcohols was achieved 
through asymmetric hydrogenation with a Rh/BINAP-based catalyst. Despite the extremely high 
selectivities of this reaction, industrial implementation is presently still hampered due to high 
catalyst loadings and long reaction times. Future research could include the development of a 
more active catalyst system with equally high diastereoselectivity. 
 
We have subsequently shown that the proline-catalysed Mannich reaction forms an interesting 
starting point for the industrial synthesis of two important compound classes, i.e. 
tetrahydroisoquinolines (Chapter 5) and β-amino acids (Chapter 6). In the final Chapter 7, we 
have shown that the excellent selectivity of the reaction can be applied for the synthesis of both 
enantiomers of the natural product lasubine II.  
Furthermore, the synthesis of a range of Mannich products using literature procedures was 
required for our investigations, which provided us with a view on the industrial scope and 
limitations of the proline-catalysed Mannich reaction. In the early stage of our investigations we 
encountered difficulties in reproducing previously reported results. Our observed yields and 
enantio- and diastereoselectivities were often lower than literature values. This initially 
hampered the progress of our research. Later we found that careful temperature control is 
required to obtain the desired results (e.g. during the exothermic NaBH4 reduction), which is a 
factor that should be taken into account during industrial application. Furthermore, the 
incriminating racemisation of the acetone-derived N-PMP-protected β-amino ketones during 
column chromatography and prolonged storage should be avoided by using alternative 
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purification methods (such as crystallisation, as was demonstrated in the synthesis of lasubine 
II) or by performing a consecutive synthetic step prior to purification.  
 
8.3 Conclusions 
To our opinion, the results described in this thesis have brought the proline-catalysed Mannich 
reaction closer to industrial application. It can be considered a realistic option when developing 
strategies toward target molecules, which contain the β-amino ketone, γ-amino alcohol or β-
amino acid structural element. However, the limitations described in Section 8.2 must be taken 
into account during the process of route scouting. Naturally, the process of determining the best 
route is a unique process for each individual target compound but we nevertheless feel that our 
efforts have demonstrated the value of the proline-catalysed Mannich reaction and further 
established it amongst other chemical transformations. 
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Summary 
 
In the continuous search for biological activity, there is a clear trend that the complexity of 
molecules being evaluated in lead discovery research is increasing. This includes an increased 
focus on small molecules which contain multiple stereocentres, so-called multichiral centre 
compounds. As a result, the demand for new and efficient enantio- and diastereoselective routes 
to synthesise such pharmaceutically relevant molecules has increased considerably. In this 
thesis, it was our goal to evaluate the industrial applicability of the organocatalysed Mannich 
reaction (Scheme 1), and to explore novel downstream chemistry to synthesise enantiomerically 
pure 1,3-amino alcohols and heterocycles, representing specific examples of multichiral centre 
compounds. This research was performed within a consortium of industrial and academic 
partners, called the Ultimate Chiral Technology project.  
 
Scheme 1 The organocatalysed Mannich reaction. 
 
We identified the following three scientific challenges for rendering the organocatalysed 
Mannich reaction applicable to the industrial synthesis of multichiral centre compounds:  
1. Develop a cost-efficient and environmentally more friendly alternative for the commonly 
used ceric ammonium nitrate (CAN) deprotection of the nitrogen protecting p-
methoxyphenyl (N-PMP) group 
2. Identify industrially attractive methods to transform enantiopure β-amino ketones 
diastereoselectively into the corresponding 1,3-amino alcohols 
3. Transform Mannich products into other high value stereoisomerically pure products 
This thesis contains the results of our efforts to meet these challenges. In this perspective, 
Chapter 1 describes recent developments in the field of organocatalysed Mannich reactions and 
provides an overview of the current state-of-the-art. It was concluded that despite the increasing 
number of organocatalytic systems, proline still holds a special position as a cheap and readily 
available catalyst for the synthesis of a plethora of highly valuable β-amino carbonyl compounds.  
In Chapter 2, a novel oxidative method to replace the CAN-mediated removal of the N-PMP 
group is described. Periodic acid and trichloroisocyanuric acid (TCCA) were identified as 
particularly effective reagents for the deprotection, requiring only 1 and 0.5 equiv of oxidant, 
respectively, under acidic conditions to afford the desired products in high yields (Scheme 2). 
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Scheme 2 Periodic acid- and TCCA-mediated deprotection of N-PMP protected amines. 
 
In addition, we found that this method is applicable for the deprotection of other N-aryl 
(including o-MeO-, p-HO- and o-HO-phenyl)-protected amines.  
Chapter 3 describes a novel enzymatic oxidative deprotection procedure for N-PMP-protected 
amines involving laccases, which is effective at a pH below 4. Although the yields and purities of 
the products obtained with the ‘chemical’ deprotection (Chapter 2) are generally higher, the 
enzymatic procedure can be an alternative method when functional groups are present which do 
neither tolerate periodic nor trichloroisocyanuric acid.  
In Chapter 4, we detail two complementary methods for the hydrogenation of β-amino ketones 
to the corresponding 1,3-amino alcohols. The anti-products can be obtained through asymmetric 
transfer hydrogenation, in which 2-propanol is employed as the hydrogen donor and an Ir/α-
substituted-amino acid amide complex as the catalyst. Syn-products are accessible by 
hydrogenation under increased hydrogen pressure in the presence of a Rh-based BINAP catalyst 
(Scheme 3). In combination with the proline-catalysed Mannich reaction, these methods have 
appeared powerful tools for the enantio- and diastereoselective synthesis of all four 
diastereomers of 1,3-amino alcohols.  
 
Scheme 3 Asymmetric synthesis of anti- and syn-1,3-amino alcohols. 
 
In Chapter 5, we show that the products of the proline-catalysed Mannich reaction of ethyl 
glyoxylate-derived N-PMP-protected imines and electron-rich phenylacetaldehydes are, after 
periodic acid-mediated removal of the N-PMP-protecting group, suitable precursors for the 
Brønsted acid-catalysed Pictet-Spengler reaction with activated aldehydes. Thus, we have 
demonstrated a proof of principle of a promising new route to 3,4-disubstituted 
tetrahydroisoquinolines (Scheme 4).  
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Scheme 4 A Pictet–Spengler entry into 3,4-disubstituted tetrahydroisoquinolines. 
 
In Chapter 6, the development of a new and efficient protocol for the synthesis of β-2,3-
disubstituted amino acids is described. After formation of N-PMP-protected 1,3-amino alcohols 
via the asymmetric proline-catalysed Mannich reaction, these compounds can be transformed in 
high yields into the corresponding valuable free amino acids by treatment with periodic acid and 
sodium dichromate in a two-step one-pot protocol (Scheme 5). In addition, this new route paves 
the way for an easier and more scalable access to one of the key building blocks for the synthesis 
of the naturally occurring aflatoxin production inhibitor dioctatin A.  
 
Scheme 5 One-pot synthesis of β-2,3-disubstituted amino acids. 
 
In Chapter 7, a new stereoselective route to both enantiomers of lasubine II is disclosed 
(Scheme 5). Key steps include an enantioselective D- or L-proline-catalysed Mannich reaction, 
which employs commercially available starting compounds, and a diastereoselective Mannich 
cyclisation.  
 
Scheme 6 A new stereoselective to route to lasubine II. 
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In Chapter 8, it is contemplated to what extent the aforementioned challenges have been met. It 
is concluded that the organocatalysed Mannich reaction has the potential to establish itself as an 
industrial applicable method for the synthesis of target molecules, which contain the β-amino 
ketone, γ-amino alcohol or β-amino acid structural elements.  
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In de voortdurende zoektocht naar nieuwe biologisch actieve verbindingen is een duidelijke 
trend waarneembaar, waarbij de structuren van de onderzochte moleculen steeds complexer 
worden en het aantal stereocentra toeneemt. De toenemende interesse in deze zogenaamde 
multichiral centre compounds zorgt ervoor dat de vraag naar nieuwe, effectieve enantio- en 
diastereoselectieve routes voor het synthetiseren van deze farmaceutisch relevante moleculen 
de laatste jaren is toegenomen. In dit promotieonderzoek hebben we ons als doel gesteld om te 
bestuderen of de organogekatalyseerde Mannich reactie (Schema 1) industrieel toepasbaar is. 
Tevens hebben we de mogelijkheden onderzocht om de producten van deze reactie om te zetten 
in enantiomeerzuivere 1,3-aminoalcoholen en daarvan afgeleide ringstructuren. Dit onderzoek 
werd uitgevoerd binnen een consortium van industriële en academische partners, die samen het 
Ultimate Chiral Technology project vormden.  
 
Schema 1 De organogekatalyseerde Mannich reactie. 
 
Om de organogekatalyseerde Mannich reactie industrieel toepasbaar te maken voor de synthese 
van enantiomeerzuivere β-aminoketonen en daarvan afgeleide multichiral centre compounds zijn 
in dit project de volgende drie wetenschappelijke uitdagingen geadresseerd: 
1. Het ontwikkelen van een goedkoop en duurzaam alternatief voor het gebruik van 
ceriumammoniumnitraat als reagens voor de ontscherming van N-PMP-beschermde 
aminen 
2. Het ontwikkelen van methoden om enantiomeerzuivere β-aminoketonen 
diastereoselectief om te zetten in de overeenkomstige 1,3-aminoalcoholen 
3. Het omzetten van Mannich producten in andere klassen hoogwaardige druglike 
producten 
In dit proefschrift wordt beschreven hoe deze uitdagingen zijn opgepakt en welke resultaten 
hierbij zijn behaald. Het inleidende Hoofdstuk 1 beschrijft de recente ontwikkelingen op het 
gebied van organogekatalyseerde Mannich reacties. Hieruit wordt duidelijk wat momenteel de 
mogelijkheden en beperkingen zijn van deze reactie. Proline blijkt, als een van de eerst ontdekte 
organokatalysatoren voor de Mannich reactie, nog steeds een bijzondere positie te hebben in het 
veld. De lage prijs en goede verkrijgbaarheid maken proline nog altijd van waarde voor de 
synthese van een keur aan sterk gefunctionaliseerde β-aminocarbonylverbindingen.  
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In Hoofdstuk 2 wordt een nieuwe oxidatieve ontschermingsmethode van de N-PMP-groep 
beschreven. De oxidatiemiddelen perjoodzuur en trichloorisocyanuurzuur, waarvan 
respectievelijk slechts 1 en 0,5 equivalent nodig was, bleken efficient te werken onder zure 
omstandigheden om de gewenste producten in hoge opbrengsten te verkrijgen. 
 
Schema 2 Ontscherming van N-PMP-aminen door middel van perjoodzuur of trichloorisocyanuurzuur 
(TCCA). 
 
We ontdekten dat deze methode ook toepasbaar was voor de ontscherming van andere 
elektronenrijke N-aryl-beschermde aminen. Zowel de o-MeO-, p-HO- als de o-HO-fenylgroep 
konden hiermee goed worden verwijderd. 
In Hoofdstuk 3 wordt beschreven hoe N-PMP-beschermde aminen in aanwezigheid van 
oxidatieve enzymen, zogenaamde laccases, kunnen worden ontschermd. Door middel van deze 
methode, die werkt bij een pH lager dan 4, worden de gewenste producten verkregen in een wat 
lagere opbrengst en zuiverheid dan via de in Hoofdstuk 2 beschreven ‘chemische’ methode. 
Echter kan de enzymatische methode wel een alternatief bieden voor de chemische variant 
indien de substraten en/of producten niet bestand zijn tegen perjood- dan wel 
trichloorisocyanuurzuur. 
In Hoofdstuk 4 wordt uiteengezet hoe β-aminoketonen door middel van hydrogenering kunnen 
worden omgezet in de daaraan verwante 1,3-amino alcoholen. Asymmetrische 
transferhydrogenering in de aanwezigheid van 2-propanol en een katalysator op basis van 
iridium en een α-gesubstitueerd aminozuuramide leidt tot de vorming van de overeenkomstige 
anti-producten. Syn-producten kunnen worden verkregen met behulp van hydrogenering onder 
verhoogde waterstofdruk. In dit geval werd een op rhodium gebaseerde BINAP-katalysator 
gebruikt. Door de proline-gekatalyseerde Mannich reactie nu te combineren met elk van de 
diastereoselectieve hydrogeneringsmethoden is een generieke strategie ontwikkeld waarmee de 
vier mogelijke stereoisomeren van specifieke 1,3-aminoalcoholen kunnen worden 
gesynthetiseerd. 
 
Schema 3 Asymmetrische synthese van anti- en syn-1,3-aminoalcoholen. 
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In Hoofdstuk 5 wordt aangetoond dat de producten van de proline-gekatalyseerde Mannich 
reactie van N-PMP-beschermde iminen afgeleid van ethylglyoxylaat met elektronenrijke 
fenylacetaldehyden, na ontscherming door middel van perjoodzuur, geschikte grondstoffen zijn 
voor de Brønstedzuur-gekatalyseerde Pictet–Spengler reactie met geactiveerde aldehyden. De 
methodologie, die in dit hoofdstuk beschreven wordt, biedt een veelbelovende nieuwe route 
naar 3,4-digesubstitueerde tetrahydroisochinolines (Schema 4). 
 
Schema 4 Synthese van 3,4-digesubstitueerde tetrahydroisochinolines via de Pictet–Spengler reactie. 
 
De ontwikkeling van een nieuwe en effectieve procedure voor de synthese van β-2,3-
digesubstitueerde aminozuren wordt beschreven in Hoofdstuk 6. Door behandeling met 
perjoodzuur en natriumdichromaat kunnen N-PMP-beschermde 1,3-aminoalcoholen, bereid via 
de asymmetrische proline-gekatalyseerde Mannich reactie, met hoge opbrengsten worden 
omgezet in de overeenkomstige hoogwaardige vrije aminozuren. De ontscherming en oxidatie 
van de primaire alcoholen kunnen na elkaar in hetzelfde reactievat worden uitgevoerd zonder 
tussentijdse opwerking (Schema 5). Met behulp van deze methode kan ook één van de 
aminozuurbouwstenen van dioctatine A op een eenvoudigere en meer opschaalbare manier 
worden gemaakt dan tot nu toe is beschreven. Dioctatine A is een in de natuur voorkomende 
remmer van de productie van aflatoxines. 
 
Schema 5 Eénpots synthese van β-2,3-digesubstitueerde aminozuren. 
 
In Hoofdstuk 7 wordt uiteengezet hoe met de proline-gekatalyseerde Mannich reactie van 
commercieel verkrijgbare grondstoffen als uitgangspunt en een diastereoselectieve cyclisatie op 
een later moment, beide enantiomeren van lasubine II afzonderlijk kunnen worden 
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gesynthetiseerd. Het gebruik van L-proline als katalysator leidt uiteindelijk tot de synthese van 
het in de natuur voorkomende (–)-enantiomeer (Schema 6).  
 
 
Schema 6 Een nieuwe stereoselectieve route naar lasubine II. 
 
In Hoofdstuk 8 wordt geëvalueerd in hoeverre de doelstellingen van het project zijn gehaald. Na 
een terugblik op de eerder genoemde wetenschappelijke uitdagingen is de conclusie dat de 
organogekatalyseerde Mannich reactie de mogelijkheid biedt om zich in de toekomst te bewijzen 
als een industrieel toepasbare methode voor de synthese van doelmoleculen met een β-
aminoketon-, γ-aminoalcohol- of β-aminozuurmotief in hun structuur. 
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Dankwoord 
Als de dag van gisteren kan ik me herinneren dat ik werd gebeld door Floris Rutjes met de vraag 
of ik interesse had in een promotieonderzoek binnen zijn groep. Dat had ik wel. Echter, ik had 
toen niet verwacht dat het me zoveel moeite zou gaan kosten om dit af te ronden. Gelukkig heb 
jij, Floris, altijd het vertrouwen in me gehouden. Toen ik na een periode van afwezigheid weer 
aan je bureau zat om te praten over een voortzetting/afronding van mijn promotieonderzoek en 
ik je vroeg of je daar nog heil in zag, was je antwoord dan ook: “Ja, zonder twijfel”. Dat heeft me 
gesterkt. Bedankt daarvoor. Ook voor de prettige manier van begeleiden. Het was bijzonder 
prettig om je kantoor in te lopen met vastgelopen gedachten en er met volledig nieuwe inzichten 
weer vandaan te vertrekken. Ik heb veel van je geleerd! 
Floris van Delft, ook jou wil ik bedanken. Jij hebt me in 2010 weer uit de goot gehaald. Ook jouw 
telefoontje kan ik me nog goed herinneren. Of ik bij SynAffix wilde komen werken was de vraag. 
Ik was van plan om naar aanleiding van mijn gezondheidsproblemen nooit meer terug te keren 
naar een laboratorium, maar heb het toch gedaan en heb er de jaren erna heel veel plezier gehad 
tot op de dag van vandaag. Ook ben ik je erkentelijk voor de begeleiding gedurende de eerste 
vier jaar van mijn promotieonderzoek evenals voor het zorgvuldig lezen en becommentariëren 
van mijn manuscript. 
PQ - mentor, coach en vriend - vanaf onze eerste contact bij DSM konden wij het goed met elkaar 
vinden. Na mijn stage bij DSM ging jouw rol over van stagebegeleider in die van, zoals later 
bleek, copromotor. Dit heeft gezorgd voor een mooie samenwerking tussen de Radboud 
Universiteit en DSM. De keren dat ik op werkbezoek kwam in Geleen heb ik me bijzonder 
welkom gevoeld als logé in Elsloo. Ook onze ‘Wandel-Eet-Biljart’-afspraken heb ik altijd met 
bijzonder veel plezier beleefd. Over alles kon gesproken worden en dat was bijzonder prettig. In 
onze discussies werden we het lang niet altijd eens, hetgeen vele nieuwe inzichten en kennis 
heeft opgeleverd. Ondanks het feit dat we goede vrienden zijn geworden, ben je toch altijd 
kritisch gebleven op mijn werk. Het was soms confronterend om te merken dat mijn teksten en 
presentaties nooit perfect waren (en dat waarschijnlijk ook wel nooit zullen worden), maar door 
jouw op- en aanmerkingen heb ik veel geleerd. Petre, gratias maximas tibi ago. 
Prof. dr. Binne Zwanenburg, prof. dr. Richard Kellogg en Dr. Thomas Boltje, bedankt voor jullie 
zitting in de manuscriptcommissie. 
Tijdens mijn onderzoek heb ik ook hulp gehad van een groot aantal studenten. Velen van jullie 
hebben na afloop ook voor een (tijdelijke) carrière in het onderzoek gekozen en dat vind ik 
mooi. Ik neem aan dat dit betekent dat ik toch iets van mijn enthousiasme voor het vak heb 
kunnen overbrengen. Lieke, Marian, Ferdi, Niek, Jacques, Moniek, Rens, Koen, Matthijs, Andreas, 
Bram en Peter, hoewel niet van ieder van jullie het werk in dit proefschrift is opgenomen bedank 
ik jullie allen voor de inzet gedurende jullie stages. Ik heb veel plezier beleefd aan het mogen 
begeleiden van jullie projecten en ook vele nieuwe inzichten opgedaan, zowel op persoonlijk als 
professioneel gebied. Margot, Steven, Lieke en Donny worden bedankt voor het uitvoeren van 
hun nuttige literatuurstudies. 
Ook wil ik al het ondersteunend personeel van de Radboud Universiteit bedanken voor hun 
hulp. Peter van Dijk en René Aben bedank ik in het bijzonder. Peter, jouw tomeloze 
behulpzaamheid en immer warme begroetingen zijn geweldig. Het was altijd prettig om een 
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praatje met je te komen maken. René, jij van harte bedankt voor de opvang in “jouw” lab tijdens 
episode 2 van mijn promotieonderzoek.  
Met veel plezier heb ik samengewerkt met een groot aantal medepromovendi, post-docs en 
studenten. Een aantal mensen wil ik hiervan met name bedanken. Roseri, onze gesprekken heb 
ik altijd zeer gewaardeerd. Ik weet niet wat het antoniem van wrevel is, maar dat is zo ongeveer 
wat jij bij me opwekt. Ik vind je een symphatieke dame en ik hoop dat we elkaar in de komende 
jaren blijven zien. Marloes, wij begonnen zo ongeveer gelijk aan ons promotietraject en zijn nu 
wederom collega’s. Fijn dat ik af en toe mijn soms vreemde ideeën bij jou kan toetsen. Dani, 
hulde voor jouw onmetelijke kennis der NMR-spectroscopie en chemische nomenclatuur. Het 
was een genot om daaruit te kunnen en mogen putten. Gracias. 
Ook een woord van dank voor de DSMers in Geleen: Bernard, Gerard, Laurent, Hans de Vries, 
Martin, Stefaan, Paul, Rinus en Hans Schoemaker. Jullie kennis en behulpzaamheid heeft ook 
bijgedragen aan de totstandkoming van dit proefschrift.  
Bart, jij wist me vroeger altijd al te vertellen dat ik alles wist van scheikunde, maar dat ik het 
leven niet begreep. Hoewel je me wat dat eerste punt betreft aardig overschat, had of heb je 
misschien wel een beetje gelijk met je tweede punt. Gelukkig heb ik veel van je geleerd en ben ik 
blij dat ik je mag rekenen tot mijn beste vrienden. Moge het jou, Margot, Eva en jullie nieuwe, nu 
waarschijnlijk inmiddels geboren, kindje voor de wind blijven gaan.  
Nicky en Yvonne, wat een ongekende vrienden zijn jullie. In voor- en tegenspoed, door weer en 
wind, en door dik en dun kan ik op jullie rekenen en dat is fantastisch. Hoewel ik inschat dat 
jullie weinig begrijpen van organische chemie in het algemeen en van organogekatalyseerde 
Mannich reacties in het bijzonder, zijn jullie van groot belang geweest voor het afmaken van 
mijn proefschrift. Superbedankt daarvoor! 
Lidy, jij bedankt voor de steun en interesse, die je altijd hebt getoond. Het is fijn om bij jou op 
bezoek te zijn of je bij ons over de vloer te hebben. 
Pap, ik meen me te herinneren dat je me adviseerde om scheikunde te gaan studeren toen ik 
klaar was met het VWO. Na twee niet-passende studies heb ik toch maar geluisterd. Bedankt 
voor je goede advies! 
Mam, wat is het toch fijn om een moeder te hebben waarop je altijd kunt rekenen. Wat ik ook 
doe, voor jou is het altijd perfect en dat is een heerlijk gevoel. Bedankt voor de 
onvoorwaardelijke steun die je me mijn hele leven gegeven hebt. Ik wens jou en Hans het 
allerbeste samen! 
Tenslotte bedank ik mijn allerliefste Renée. Ik weet nog goed dat ik je vol enthousiasme vertelde 
dat me een baan was aangeboden, als promovendus nog wel. Ik zou doctor worden. Vier jaar 
later zag de toekomst er even heel anders uit. Nu is het dan alsnog zover gekomen. Zonder jou 
was het me nooit ofte nimmer gelukt. Bedankt voor de onvoorwaardelijke steun en liefde, maar 
vooral, bedankt voor wie je bent! Ik hou van je! 
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